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Preface
Perhaps the most valuable result of all education is the ability to
make yourself do the thing you have to do, when it ought to be
done, whether you like it or not; it is the first lesson that ought
to be learned; and however early a man’s training begins, it is
probably the last lesson that he learns thoroughly.
Thomas H. Huxley, English biologist (1825 - 1895)
The work which comprise this thesis was done at the Norwegian Univer-
sity of Science and Technology in Trondheim, Norway, from January 2003
to November 2006 under the supervision of professor Lars Othar Svaasand.
As I climbed the steep hill toward the Gløshaugen campus early one
morning in November 2002, I was imbued by a spirit of academia. The towers
of the main building reminded me of famous classical institutions like Yale,
Oxford and Johns Hopkins University: Brilliant professors in tweed jackets,
libraries filled with dusty books, profound discussion in dimly lit halls and
secret high-tech laboratories. Unfortunately, the feeling of grand academic
architecture was vaporized as I rounded the corner of the main building
and witnessed the architectural wasteland that lay behind. However, during
my interview with professor, and later advisor, Lars Othar Svaasand the
associations to classic academia returned. As he scratched his beard and
lectured on nonlinear optical phenomena with sparkling eyes, I thought that
NTNU could be a good place to study. Through countless discussions in the
library (ehh...maybe coffee room is more exact) he has given me physical
insights in a wide array of physical phenomena that made me realize that I
knew close to nothing, but also moved me infinitely further away from the
ignorance that was mine when I began the pursuit of a PhD degree.
Several people have made these four years a gratifying experience. Lise
Lyngsnes Randeberg provided invaluable support on many occasions, espe-
cially during my first fumbling year when I had no signs to point me in the
right direction.
The cross-disciplinary nature of this work has been very rewarding. I
would like to thank all the people at St. Olav’s Hospital and especially Olav
Anton Haugen for providing medical insight, tissue samples and hunting
advice.
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Also, a great thanks to Eivind Larsen and Bertil Nistad who, through
uncountable coffee breaks, have inspired a great interest in the the field of
extracurricular applied physics. Andreas Winnem and the people in SMIDA
must be mentioned for providing a social life where little existed before.
I have very much enjoyed working with professors Odd Gutteberg, Trond
Ytterdal, Morten Olavsbr˚aten and Helge Engan in my mandatory teaching
hours, making it less of a hassle than it could be.
Thanks to all my students that have slaved for me and shown that stu-
dents are still hard working and enthusiastic, just like they were in my time.
To my girlfriend Kari, family, and friends in Oslo: I could not have
accomplished this without you....or yes, actually I could, but the process
would probably have been all the less pleasurable.
And to everybody else I have worked with, it has been a great time, but
unfortunately you did not quite make it to be mentioned in the preface :-P
Abstract
Heart attacks are the cause for the majority of deaths in the industrialized
world. The underlying cause of most of these deaths is the rupture of vul-
nerable plaque. As of this day, no widely accepted clinical tool exists for
detecting plaques that are prone to rupture, although several techniques are
being investigated. This thesis gives an overview of detection modalities
that have been proposed for detecting vulnerable plaque with special em-
phasis on three methods, diffuse reflection spectroscopy, thermography and
multiphoton microscopy.
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Outline of thesis
Introduction
This chapter gives an outline of the thesis and a list of the included papers.
The author’s contributions to the various published works are specified and
a brief description of the papers is given. The papers are listed chrono-
logically. All the papers are related to the detection and characterization
of vulnerable plaques. The work has centered around several topics within
this field, namely diffuse reflection spectroscopy, thermography, multipho-
ton spectroscopy and fluorescence spectroscopy. In addition, a list of other
publications completed during the PhD period, but not related to vulnerable
plaque, is included.
Outline
Chapter 2 reviews the basic physiology of atherosclerosis and the features
that are relevant for vulnerable plaque detection. Then a review of technolo-
gies that are in use for characterization of cardiovascular disease is presented.
Not only those modalities that measure individual plaques, but also tech-
niques for measuring their effects, i.e. indirect measures of atherosclerosis
are included. The modalities are grouped according to the level of phys-
iological detail they measure: Systemic parameters, heart function, vessel
anatomy and vessel wall anatomy. More details are included in those fields
were active research has been conducted.
List of papers
• Characterization of atherosclerotic plaque by reflection spec-
troscopy and thermography: A comparison
Magnus B. Lilledahl, Olav A. Haugen, Lise L. Randeberg and Lars O.
Svaasand.
Proceedings of SPIE, vol. 5686, 415-425 (2005)
Absorption spectra of pure substances likely to dominate near infrared
absorption spectra in arteries were measured. These basis spectra
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were used in a diffusion type model to determine the expected shape
of measured spectra. Samples of human aorta were examined spec-
troscopically and a measure of the lipid content based on the spectra
is presented. No correlation between the size of the plaques and the
spectra was found.
Simple models of heat distribution in a plaque were developed to de-
termine temperature increases in plaques due to higher metabolism.
The expected temperature at the surface was found to be less than
0.05◦. This value was in agreement with thermographic, in-vivo mea-
surements performed in rabbit aortas.
Contributions: Conducting spectroscopic measurements and analy-
sis of data with existing models. Development of lipid-index. Mathe-
matical analysis of thermal distributions in plaque.
• The effect of a thin bloodlayer on fluorescence spectroscopy
Magnus B. Lilledahl, Marianne Barkost, Mari W. Gran, Olav A. Hau-
gen and Lars O. Svaasand
Proceedings of SPIE, vol. 6078, 60782J-1 (2006)
Fluorescence from samples of human aorta were excited using a light
emitting diode and the fluorescence was collected with a fiber optic
probe. The level of fluorescence could detect calcifications but the
differentiation between fibrous and lipid rich plaque was poor. Fluo-
rescent tissue phantoms of fluorescein and agar with a surface layer of
blood was investigated to determine the effect of the interfering blood.
When a random layer of blood was added to the spectra from the aorta
samples the different tissue states could no longer be determined ac-
curately.
Contributions: Spectral measurements of aorta. Analysis of spectral
data and the effect of the added blood layer.
• Reflection spectroscopy of atherosclerotic plaque
Magnus B. Lilledahl, Olav A. Haugen, Marianne Barkost and Lars O.
Svaasand.
Journal of Biomedical Optics 11(2), 0210051-0210057 (2006)
A series of reflectance spectra were collected from human aorta with
varying degrees of atherosclerosis. The spectra were collected both
with an optical fiber probe and an integrating sphere. The reflected
spectra were compared to histology and it was found that near infrared
spectroscopy could be used to detect lipids in plaques with good sen-
sitivity and specificity.
Contributions: Experimental work and development of method of
analysis.
vii
• An analytic and numerical study of intravascular thermogra-
phy of vulnerable plaque
Magnus B. Lilledahl, Eivind L. P. Larsen and Lars O. Svaasand
Physics in medicine and biology.
52 (2007), 961-979
An estimate of the upper limit of heat generation that could be ex-
pected in a plaque was developed from physiological considerations.
This value was used in numerical and analytic models of the heat dis-
tribution in a plaque to calculate a limit on the temperature increase
that could be expected in a plaque due to inflammation. It was found
that the an upper limit on the temperature due to a plaque was 0.1◦C.
Possible explanations for higher values reported in the literature is pre-
sented.
Contributions: Numerical analysis and analytic model development
in cooperation with Lars O. Svaasand.
• Characterization of vulnerable plaques by multiphoton mi-
croscopy
Magnus B. Lilledahl, Olav A. Haugen, Catharina Davies and Lars O.
Svaasand
Journal of Biomedical Optics Conditionally accepted.
Multiphoton microscopy could be used to image the connective fibers
that constitute the fibrous plaque, which again could be used to deter-
mine its mechanical strength. Samples of human aorta were imaged
in a microscope coupled to a Ti:Sapphire laser to excite second har-
monic generation and two-photon excited fluorescence. It was found
that individual collagen fibers and elastic fibers could be seen down to
a depth of about 100 µm.
Contributions: Collection of microscopy images and analysis.
Other publications
This section includes publications which do not fall under the subject of this
thesis and is thus not included, but was completed during the Ph.D period.
• Subcutaneous transport of extravascular blood
Lise L. Randeberg, Eivind L. P. Larsen, Magnus B Lilledahl, Rune
Haaverstad, Olav A. Haugen, Bjorn Skallerud and Lars O. Svaasand.
Proceedings of SPIE, vol. 6078 (2006), 607808-9
Models of fluid transport in tissue was developed based on measure-
ments of fluorescein transport in a porcine model.
Contributions: Assisted in the experimental work.
viii
• Skin changes following minor trauma
Lise L. Randeberg, Andreas M. Winnem, Neil E. Langlois, Eivind L.
P. Larsen, Magnus B. Lilledahl, Rune Haaverstad, Bjørn Skallerud,
Olav A. Haugen and Lars O. Svaasand.
Spectroscopic and histological investigation of blunt trauma in a porcine
model was investigated. It was found that reflection spectroscopy
could be used to characterize age and type of trauma.
Contributions: Assisted in the experimental work.
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Chapter 1
Introduction
1.1 Motivation
Only two things are infinite, the universe and human stupidity,
and I’m not sure about the former.
Albert Einstein, US (German-born) physicist (1879 -
1955)
Cardiovascular disease places an enormous medical and economic burden
on society, being the cause of the majority of deaths in the western world.
Most of these deaths are caused by the rupture of atherosclerotic plaques in
the coronary arteries. A lot is known about lifestyle habits that accelerate
the development of atherosclerotic plaque, yet it seems as if the general pop-
ulation is unwilling to heed the advice and change their detrimental habits.
Hence, the medical personnel are left with the option of treating patients
after the development of the disease. It is established that the majority
of acute coronary events are caused by the rupture or erosion of so-called
vulnerable plaque (defined as plaques prone to causing atherothrombosis).
Two thirds of all coronary deaths are caused by plaque rupture with the re-
maining being due to plaque erosion[60]. However, equipment for detecting
these types of plaques are still in the research laboratories. This leaves us in
the worrisome situation where we both know the risk factors of atheroscle-
rotic development, and when the plaques begin to put the patient at risk,
yet neither of the problems can be addressed. The first due to the lack of
knowledge and will-power in the population and the second due to the lack
of technology for the clinical personnel. The goal of this thesis is to provide
a contribution for solving the second issue.
There are two important aspects that motivates this work. One is to
develop a sensor that can detect a vulnerable plaque and indicate for the
clinician the appropriate treatment. However, the treatment for vulnerable
plaque is not fully developed. The other goal is to design a sensor that
can characterize plaques and can be used to monitor their development to
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better understand the disease process and monitor the effect of medication.
Even though clinical tools in the end must rely on proven clinical effects, a
better understanding of the physiological process can aid the development
of appropriate treatments.
Chapter 2
Atherosclerosis
Now there are more overweight people in America than average-
weight people. So overweight people are now average. Which
means you’ve met your New Year’s resolution.
Jay Leno, US talk-show host
2.1 Introduction
Atherosclerosis (from the greek athere -porridge, gruel and sklerosis - hard-
ening) is believed to be the underlying cause for the majority of cardio-
vascular disease (CVD)[72]. The early stages of atherosclerosis (described
below) can be seen in virtually everybody from the first decade of life. These
early stages are reversible, but can, due to certain conditions, develop into a
life-threatening condition. In the early stages the changes in the vessel wall
occur at localized areas called plaques, as they are often elevated from the
surrounding vessel wall. In advanced stages of the disease the whole vessel
can be affected, and no normal areas can be found. The exact development
of atherosclerotic plaques is still an area of active research, but numerous risk
factors have been determined, e.g. high cholesterol levels, smoking, family
history of CVD, high blood pressure, obesity, sedentary lifestyle, stress and
many more. In the following a brief description of the disease and properties
that are relevant for new detection modalities are presented.
2.2 Normal vessel anatomy
In all arteries in the body, three distinct regions can be defined. These are
called the tunica intima, tunica media and tunica adventitia (see figure 2.1).
The tunica intima consists of a continuous endothelium facing the lumen,
resting on a basement membrane. The endothelium is a continous layer of
endothelial cells which serves as the signaling pathway between the vessel
3
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Figure 2.1: The figure shows schemtically the structure of a muscular artery
where the major structural features are illustrated. (Courtesy of Stijn A.I.
Ghesquiere[118]).
and cytokines circulating in the blood. Under the endothelium is the suben-
dothelium which consists of fibroelastic tissue and a few scattered muscle
cells. Between the tunica intima and the tunica media is the internal elastic
lamina, which is a thick layer of elastic fibers. The tunica media differs
slightly in elastic arteries (the aorta and its major branches) and muscu-
lar arteries (all other arteries). In elastic arteries the tunica media consists
primarily of elastic membranes separated by ground substance, while in
muscular arteries the media consists of layers of muscle cells with connec-
tive tissue in between. The elastic arteries are responsible for maintaining
blood pressure during diastole while muscular arteries can contract or di-
late according to the oxygen demand of the tissue distal to the vessel. The
outermost layer, the tunica adventitia consists of loose connective tissue, fat
cells and blood vessels. The blood vessels in the adventitia are called the
vasa vasorum, literally meaning the vasculature of the vessel. An external
elastic lamina can sometimes be seen between the media and adventitia.
2.3 Physiology of atherosclerotic lesions
2.3.1 Histological classification
The following classification of atherosclerotic plaques is based on a series
of consensus documents issued by the American Heart Association (AHA)
[87, 89, 88]. The motivation for this classification was based on histological
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studies that indicate that each type of plaque is temporarily or permanently
stable. Refer to figure 2.2.
Type I-III lesions are often called early lesions. These lesions show no
disruption of intimal structure and there is no effect on the media or adven-
titia. They are considered to be reversible changes.
• Type I: Initial lesion
– Increase in number of macrophages.
– Appearance of macrophages filled with lipid droplets.
• Type II: Fatty streak
– Grossly visible.
– Layers of macrophage foam cells, increased number of macrophages.
– Lipid droplets within intimal smooth muscle cells.
– Minimal extracellular lipids.
• Type III: Intermediate lesion
– All of type II characteristics.
– Pools of extracellular lipids.
Type IV-VI lesions are often called advanced lesions. These lesions show
intimal disorganization and are often symptomatic. They predispose to
sudden lesion progression and are not reversible.
• Type IV: Atheroma
– Lipid core of extracellular lipid.
– Intimal disorganization.
– No fibrous (collagenous) cap.
• Type V: Fibrous
– Thick layers of fibrous tissue.
– Type Va if presence of lipid core (fibroatheroma).
– Type Vb if calcified.
– Type Vc if no lipid accumulation.
• Type VI: Complicated lesions.
– Type IV or V with additional fissure (VIa), hematoma (VIb) or
thrombus (VIc).
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Figure 2.2: Illustration of the development of atherosclerosis within
the artery. (Reprinted by permission from Macmillan Publishers Ltd:
Nature[54], copyright 2002.)
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Virmani et al. have published a paper suggesting some changes to this
classification based on what they view as certain shortcomings[112]. First,
the classification is based on postmortem histological studies, and thus the
chronological progression suggested by the roman numbering is uncertain
and should be avoided. Furthermore, later studies have shown that not only
plaque rupture is associated with thrombosis but also plaque erosion, and,
less frequently, calcified nodules. Since thromboses, erosions, rupture etc.
occure over various plaque morphologies, they should not be classified as
separate plaque types but rater to be used as adjectives to describe different
states of the same plaque type. The plaque types proposed by this Virmani
et al. was,
• Intimal thickening
• Intimal xanthoma (fatty streak)
• Pathological intimal thickening
• Fibrous cap atheroma
• Thin cap fibroatheroma
• Calcified nodule
• Fibrocalcific plaque
The first two plaque types are considered normal and reversible and are
thus not atherosclerotic.
2.3.2 Lesion initiation and development
The exact process that initiates atherosclerotic plaques and cause them to
develop into advanced lesions is not known in detail. The problem is that
practically all information about plaques is from retrospective pahtological
studies.
It is believed that plaque development is initiated by lipoproteins being
absorbed in the intima due to high concentrations circulating in the plasma.
Plaques often appear at branches and bifurcations of the artery indicating
that hemodynamics play a role. Perhaps increased turbulence and reduced
sheer stress increase the likelihood of molecules adsorbing to the endothe-
lium. A small damage to the endothelium has also been proposed as the
starting point for atherosclerotic plaques. The absorped lipids are oxidized
in the plaque which triggers an immune response that recruits monocytes.
Atherosclerosis is therefore characterized as an inflammatory disease. The
monocytes digest the lipids and turn into macrophages. The process which
then makes the plaque develop into an advanced lesion instead of regress-
ing is not known, but it is believed to be a complicated process with many
mediators being involved[65].
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2.4 Vulnerable plaque
The definition of vulnerable plaque is a functional one and not based on
anatomic appearance. This is due to the fact that many types of plaques
can cause obstructive thrombosis in the coronary arteries, and as of yet there
exists very few prospective studies that have determined which plaques are
most likely to develop thrombosis. Therefore the title of this thesis could
perhaps have been determining the vulnerable plaque rather than detect-
ing. The first task of new detection modalities that are being developed
(described in chapter 3) is to prospectively determine what actually charac-
terizes a vulnerable plaque. Only when this information has been confirmed
can the development of the ideal detection technique begin.
A vulnerable plaque is therefore defined as a plaque at increased risk of
thrombosis and lesion progression[113]. Retrospective studies have shown
that ruptured plaques seem to be the cause of most thrombi, though also
intimal erosions also cause thrombosis[34]. These studies have indicated that
most ruptured plaques are so called thin-cap fibroatheromas with macrophage
infiltration. These types of plaques would be classified as a type IV or V
in the AHA classification. Other types of plaques that have been associ-
ated with thrombosis is proteoglycan rich plaques and plaques with calcified
nodules[72]. Mauriallo et al. found that inflammation is increased four-fold
(by counting inflammatory cells in histological sections) in patients hav-
ing suffered a myocardial infaraction, compared to controls[63], and that
inflammation was also present in stable plaques and non-culprit coronary
segments. Vulnerable plaques were found to only have a 30% increased in
inflammatory cells compared to stable plaques. This study thus indicates
that the role of inflammation in atherosclerosis is primarily systemic.
One prospective study with angioscopy has shown that glistening yellow
plaques have an increased risk of developing thrombosis[75]. This yellow
color could be due to lipophilic carotenoids being absorbed in lipid rich
plaques[8]. The plaques were hypothesized to be thin-cap fibroatheromas.
A reason for the lack of prospective studies has been limitations in avail-
able imaging techniques for individual plaques. With the advent of the
modalities described herein, this obstacle will now be cleared. The informa-
tion that is most relevant clinically has yet to be determined and must also
be seen in light of cost, time, and available treatment.
2.5 Vulnerable patient
Vulnerable patient is a term coined for patients that are at increased risk of
experiencing an acute coronary event[72]. Vulnerable patients are defined
not only by the presence of vulnerable plaques, but also blood that is prone
to thrombosis (vulnerable blood) and a myocardium that is prone to fatal
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arrhythmias (vulnerable myocardium). Diabetes is one condition that can
lead to vulnerable blood, and many other serum markers have also been
associated with a thrombosis prone blood[72]. A vulnerable myocardium
can be caused by ventricular hypertrophy and electrical instabilities in the
heart.
2.6 Detection features
It has been shown that the majority of plaques that cause acute coronary
events are not hemodynamically significant and are not visible during an-
giography. This does not, however, mean that the plaques are small but
rather that they exhibit positive remodeling (i.e. not stenotic)[38]. This
has been shown both by histological and intravascular studies[36]. Stenotic
plaques also cause acute events but are often symptomatic (angina) before
the occurence of a myocardial infarction. Some also included plaques with
greater than 90% stenosis as vulnerable[72], the present work will however
use the definition of a plaque prone to thrombosis by plaque rupture or
erosion. The important features that is believed to characterize vulnerable
plaques are: A large lipid core, a thin fibrous cap covering the lipid core,
and the presence of macrophages. One study reported that 95% of ruptured
plaques had a cap thickness less than 64 µm (mean 23 µm) and therefore
put 65 µm as a limit of vulnerability[16]. Further prospective studies are
needed to confirm these findings and this is now possible with the new image
modalities described herein.
Another important feature of atherosclerosis is that it is a diffuse disease
that affects the entire arterial tree. Burke et al. reported 1.22 ± 1.44 addi-
tional vulnerable plaques in men who died suddenly of coronary disease[16].
This raises the important issue of whether it is helpful to find individual
atherosclerotic plaques since there are several of them. Treating all of them
individually might not be a cost effective solution. It might be better to as-
sess the global burden of the disease and then use systemic medication. The
global extent of atherosclerosis can be determined noninvasively by imaging
larger and more accessible arteries than the coronary arteries.
As opposed some forms of cancer (cervical and breast), there exists no
current screening for cardiovascular disease, even though the latter is the
cause of more deaths. The SHAPE report calls for screening for atheroscle-
rosis beyond traditional risk factor assessment like the Framingham risk (see
section 3.2.2)[71]. They propose that the traditional assessments are ex-
panded for selected moderate risk patients, with noninvasive assessments of
coronary calcium score by computed tomography (section 3.4.3) or measure-
ment of carotid intima-media thickness by ultrasonography (section 3.4.4).
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2.7 Treatment
The treatments that are proposed for vulnerable plaques are mainly lifestyle
changes and pharmacological medication e.g. statins, lipid-lowering drugs,
anti-thrombotic medication, beta-blockers, nitrates and hypertensive-drugs.
Treatment will depend on risk assessment and age. At increasing age long
term side effects are not so important, but the body might respond poorly
to strong medication. Since medications are mostly systemic, the question
again arises of whether characterization of individual plaques in coronary
arteries is valuable. Perhaps a general plaque burden can be assessed from
more easily accessible vessels?
With high throughput genomic and proteomic studies with micro arrays
the actual expressions of mRNA and proteins in plaques can be determined.
This might lead to drugs that more directly interfere with the processes that
cause plaques to develop.
Stenting has been proposed as focal treatment of plaques. However,
it has been shown that if there is one vulnerable plaque there are usually
more. Drug-eluting stens have been very successful in avoiding restenosis
problems. Whether stenting of several non-stenotic plaques due to risk of
plaque rupture is clinically favorable is uncertain and must be investigated.
It is also uncertain to what degree the stenting will make the plaques less
prone to thrombosis. It might reduce the risk of rupture, but as already
mentioned endothelial erosion can also cause thrombosis and it is not clear
what effect stenting would have on this process.
Chapter 3
Detection modalities
3.1 Introduction
This chapter organizes detection modalities of atherosclerosis according to
the level of spatial physiological detail they deliver. The parameter mea-
sured can be systemic, that is, a property of the whole body. By zooming
in, usually including imaging, the modality can look at the function of the
myocardium, trying to determine whether it is affected by atherosclerosis
or if a myocardial infarction has already occurred. By including even more
detail the function of the arteries themselves can be assessed, which usu-
ally amounts to determining the anatomy of the lumen. This is usually
done with an imaging modality but indirect methods also exist (e.g. ankle-
brachial pressure index). Finally, with even better resolution, one can resolve
structures within the vessel wall, i.e. try to characterize the plaque itself
and the structures that renders it vulnerable to rupture or erosion.
A discussion of existing technological diagnostic tools that are used in
the monitoring of cardiovascular disease are included in addition to emerging
technologies. The chapter aims for completeness in the types of detection
modalities included, even though only outlines and important results for
each technique are given. The rationale behind including existing technology
is that new detection modalities that characterize individual plaques must
be able to show improved clinical information or cost- or time-effectiveness
compared to existing methods. If thickness of the fibrous cap of a plaque is
not a better predictor of clinical outcome than family history of cardiovascu-
lar disease, the former is not likely to be a cost-effective diagnostic modality.
More details are included in those sections where active research has been
done (i.e. diffuse reflection spectroscopy, thermography and multiphoton
microscopy).
Important parameters when evaluating modalities are time, cost, radi-
ation dose, side effects, invasiveness and of course the clinical information
that can be collected. Clinically, the value of a detection modality is given
11
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by its ability to determine the appropriate treatment in a time and cost
efficient way. The treatment is prescribed from the risk of something bad
happening, determined by the diagnostic modality, compared to the cost
and side-effects of the treatment. If a pill that cures atherosclerosis is free
and without side-effects there is no need for diagnosis. Just take your pill.
Also, if the most aggressive treatment is already applied based on one risk
assessment method, there is no need to further stratify the risk. There is
nothing more you can do. If the most aggressive lipid lowering drug and
statin therapy is prescribed, based on a Framingham risk score, there is no
need for complicated invasive catheter-based assessment of coronary plaques.
However, for research purposes the technological tools play a different
role. Many of the detection modalities described herein can have great value
in gaining a better understanding of atherosclerosis and how risk factors are
related, even though they will not make it into a clinical tool.
3.2 Systemic parameters
3.2.1 Traditional risk factors
There are certain risk factors that are easily and quickly measured and
provide a risk value for the chance of developing cardiovascular disease.
These are primarily obesity, high blood pressure, family history of CVD,
smoking and diabetes. Based on these results, patients can be signed up for
more detailed assessment that can either lower or increase the assumed risk
of a cardiovascular event.
3.2.2 Biomarkers
Constituents of the serum can provide additional risk assessment over the
traditional methods. Most notably are low and high density lipoprotein
(LDL and HDL), and total cholesterol level. But there are other markers
that have also been associated with CVD, the best known being C-reactive
protein (CRP). The concentration of CRP in the blood is a marker of the
overall state of inflammation in the body. It is well known that inflamma-
tion plays an important role in the progress of atherosclerosis and elevated
CRP levels have been associated with increased risk of myocardial infarc-
tion. However, whether CRP is the cause or an effect of plaque rupture
is unknown[65]. There is a vast array of proteins, both pro-inflammatory
and anti-inflammatory that have been associated with atherosclerosis[65, 6].
With high throughput micro-array techniques, both for genomic and pro-
teomic analysis, detailed knowledge about which proteins or genes have in-
creased expression in atherosclerosis and vulnerable plaques is increasing. If
these markers have corresponding concentrations in the blood, the risk of a
ruptured plaque could perhaps be well assessed by a blood sample[42, 62].
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The Framingham risk score combines traditional risk factors and biomark-
ers (cholesterol levels, blood pressure, diabetes, smoking and age) into a
value estimating the 10 year risk of developing cardiovascular disease[117],
and is used to prescribe an appropriate lipid lowering therapy. However,
the risk estimates based on the Framingham study have been shown not
to be accurate for all populations[102]. Another problem with the Fram-
ingham risk score is that the risk factors are present in almost everybody
in some populations so that it is unable to really yield any additional risk
stratification of the population. Also, this risk assessment programs provide
no information about the short term risk for developing an acute coronary
event[73].
3.3 Heart function
3.3.1 Electrocardiography
As the autorythmic muscle fibers depolarize throughout the heart they set
up electric potentials. By attaching electrodes to the chest (usually six)
and the limbs, these potentials can be measured. Different combinations of
these electrodes give information about the potential in different directions
across the heart. From these signals it is possible to determine enlarged
myocardium, conduction problems, arrhythmias, damaged regions and cur-
rent heart attacks. For atherosclerosis the relevance of electrocardiography
(EKG) is to detect stenosis (which cause reduced blood flow to the my-
ocardium) and detection of past and current heart attacks. Within the
framework of the vulnerable patient, it is an important tool for characteriz-
ing a vulnerable myocardium.
The electrocardiogram is usually described by a P-wave, a T-wave and a
QRS complex. By different changes in the shape of these waves, a diagnosis
of the heart can be given. For example, a flatter T-wave indicates insufficient
oxygen supply that might be due to stenosis of an atherosclerotic plaque.
Even though the electrocardiogram is normal at rest, a stress test can find
that the heart is not receiving enough oxygen under exercise and might have
a small stenosis. Since it says something about the state of the vessel, this
modality might also belong to the section on modalities characterizing vessel
anatomy (section 3.4). A branch of EKG is high resolution EKG. This is
basically a method to improve the signal to noise ratio by averaging several
signals thereby making very low signals called late potentials visible. The
late potentials have been shown to be indicative of the prognosis after a
heart attack[11].
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3.3.2 Echocardiography
Echocardiography (ECG)1 uses ultrasound to produce images of the heart.
Ultrasound images are produced by sending mechanical waves into the tissue.
When these waves encounter a change in acoustic impedance, the wave will
be partially reflected. By measuring the time from the emitted wave to
the reflected signal (about 10-100µs) the position of the object causing the
reflectance can be determined. The radial resolution (parallel to the beam),
∆xr, is thus dependent on the width of the pulse, τ , which again is dependent
on the bandwidth B
∆xr =
cτ
2
=
c
2B
, (3.1)
where c is the speed of sound in the medium (about 1540 m/s for most
soft tissue). The lateral resolution of the image, ∆xl, is dependent on the
focusing of the beam and is described by
∆xl = λ
F
D
, (3.2)
where λ is the wavelength and F and D are the focal length and aperture,
respectively. Frequencies used in biomedical imaging range from 2-30 MHz.
This gives a theoretical maximum resolution in the radial direction of 20−
400 µm. Increasing frequency improves resolution but decreases penetration
depth (rule of thumb is 0.5 dB per cm per MHz at center frequency). The
resolution can also be improved by using the nonlinear part of the generated
signal (usually the second harmonic).
The transducer for ECG consists of a piezoelectric ceramic with an elec-
trode on each side. Piezoelectric materials contract or expand as a function
of the applied electric field and also generate an electric field as a function
of externally applied pressure. The same piezoelectric material is thus used
as both detector and transducer. Focusing is achieved either by a curvature
of the ceramic or an array of transducers where a phase change between the
transducers cause the beam to be focused. This focusing, by adding a phase
to the signals, can be used both for transmitting and detection.
Another type of ultrasound transducer is the capacitive micromachined
ultrasound transducer (CMUT). This transducer consists of micromachined
membrane with an electrode on top. By applying a time varying voltage
between the electrode and the substrated the membrane can be made to
oscillate and thereby generate the ultrasound signal. The small size of the
membranes allow for higher frequencies than what is acheivable by ceramic
transducers, thereby improving the resolution. These capacitors are usually
fabricated in arrays and their small size make them ideal for intravascular
ultrasound (IVUS, see section 3.5.1).
1Note that ECG is echocardiography and EKG is electrocardiography (from the german
elektrokardiogram).
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ECG is used to image the myocardium and heart valves. When used as
an image modality for the heart, it can quantify heart function parameters
like ejection fraction (fraction of blood emptied from ventricle during systole)
and cardiac output (volume of blood emptied into the aorta per minute).
Abnormalities in the contraction of the myocardium can be seen in ECG
images. Such abnormalities seen at rest indicate a diseased myocardium,
possibly due to a myocardial infarction. If the movement is normal during
rest but abnormal during a stress test (induced either by exercise or drug
administration), insufficient blood supply, possibly due to stenotic arteries,
is indicated. Imaging of the heart is performed either through the chest
(transthoracic) or through the esophagus (transesophageal, requires light
sedation and is considered an invasive technique).
With doppler ultrasound, blood flow direction and velocity in the cham-
bers of the heart can be determined. This is especially useful to investigate
blood flow across heart valves and to determine septal defects.
Contrast enhancement techniques with gas-filled microbubbles exist. These
microbubbles are 1-4 µm in diameter and can thus easily pass through the
capillaries. The shell is made of varying materials (albumin, galactose, lipid
polymers) and the gas core can consist of varying gases like air, perfluor-
carbon and nitrogen. These gas bubbles have a very strong echogenicety,
due to the large difference in acoustic impedance between blood and gas,
and can better outline the myocardium for a more accurate determination of
heart wall movement and ejection fractions. Clinical research has also been
done of myocardial perfusion measurement (myocardial contrast echocardio-
graphy). The microbubbles are then destroyed by the ultrasound beam, and
the speed of replenishment of the bubbles in the ultrasound beam is quan-
tified, and used as a measure of perfusion in the myocardium[52]. Targeted
contrast agents consist of various receptors in the body that are attached to
the shell of the microbubble. Molecules can be attached to the microbubbles
to make targeted contrast agents but the high velocity of the blood gives
low absorption rates.
3.3.3 Nuclear imaging
Nuclear imaging methods are not used for imaging of anatomical structures
on the size of vessels due to their low resolution, but rather provide in-
formation about the function of the organ in question. It is therefore not
part of the arsenal of vulnerable detection techniques. A description of
the technique is included here for completeness and because it is an im-
portant tool in the management of cardiovascular disease. In addition, the
results of positron emission tomography (PET) on myocardial perfusion and
metabolism are relevant for the thermography technique described in section
3.5.2.
Nuclear imaging is based on the emission of gamma-rays from radioac-
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tive atoms injected into the body. These radioactive materials are usually
incorporated into a molecule that enters into specific biological reactions.
Also pure radioactive materials are preferentially taken up in some tissue
types (e.g. 131I in the thyroid gland). This radioactive, biologically active
molecule is often called a tracer.
Gamma-rays can interact with matter in several ways. One is the pho-
toelectric effect where a photon is absorbed and a high energy electron is
ejected from an inner orbital of an atom. The path of the electron will be
bent as it passes nearby nuclei, thereby emitting radiation (brehmsstrahlung).
This emitted radiation can be in the ultraviolet or visible range (scintilla-
tion) and can be detected by standard photodetectors. Another process
is Compton scattering where a high energy photon is scattered by inter-
action with an electron. This scattering can be elastic if the interaction
is with a tightly bound electron, or inelastic if the interaction is with a
weakly bound electron that gains enough energy to ionize the atom. Lastly,
when a high energy photon comes near a nucleus, it can be converted to an
electron/positron pair, so-called pair production.
The detectors of gamma rays are called gamma cameras and basically
consist of three parts. First, a collimator, which is a metallic grid, only
passes rays within a small solid angle. The gamma rays then hit a scintilla-
tion detector (usually made of NaI) that converts the gamma rays to visible
light, which again is detected by photomultiplier tubes.
Single photon emission computed tomography (SPECT) measures gamma
rays emitted from radiopharmaceuticals. The gamma rays are recorded by
a gamma camera which can be used to compute a one dimensional profile
of the concentration of the radiopharmaceuticals. By rotating the camera
around the body, a two dimensional structure can be computed, in the same
manner as for x-ray computed tomography (CT). Several cameras can be
included to reduce the acquisition time. The resolution of the method is
about 3-6 mm. As opposed to PET, this resolution is not based on funda-
mental limitations in the technique but because of low signal to noise ratio,
requiring large area detectors for adequate signals. With better scintilla-
tion detectors or perhaps gamma-ray sensitive semiconductors it could be
possible to improve the resolution of this technique.
SPECT is a slow imaging modality, generating an image takes 15-30 min-
utes (due to the low signal generation). Therefore, gating with an ECG sig-
nal is necessary to reduce motion artifacts from a beating heart. SPECT can
measure parameters like perfusion, heart wall thickness, contractility and
left ventricular ejection fraction. In myocardial perfusion imaging (MPI),
an image of the myocardium is collected both under stress and under rest
and regions of low perfusion can be determined, indicating diseased my-
ocardium.
Positron emission tomography (PET) uses other nucleotides which emit
positrons by the decay of a proton,
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p+ → n+ e+. (3.3)
The nucleotides used in PET (e.g. 11C, 13N, 15O) are substituted for
their non-radioactive counterparts in biological molecules without changing
their chemical properties (generally not the case for radiopharmacueticals
used in SPECT). These radioactive nucletoids are made by in-house cy-
clotrons that bombard specific materials with protons. Various biological
substances are then synthesized using these radioactive nucleotides. A prob-
lem overcome by in-house production is that some of the nucleotides have
very short half-lives (on the order of minutes).
The positrons that are emitted are slowed down through interaction with
the material. When they interact with the electrons they are almost at rest,
and since the electrons are bound to an atom the kinetic energy is very low
and linear momentum is close to zero[7]. The electron and positron can also
combine into an atomic structure called positronium, such that the kinetic
energy and linear momentum is zero. When the positron and electron and
annihilates, two photons of 0.511 MeV are produced which is equal to the
rest mass of the electron (and positron). Since the linear momentum is
zero before the annihilation, the photons must move in exactly opposite
directions. If the electron and positron annihilate at higher kinetic energies,
the emitted photons will not travel along a straight line and will be rejected
by the conicidence circuit of the PET detector. This effect is used in the
measurement of electron momenta in solids[32].
The PET detector system consists of a ring of detectors positioned
around the body (usually a row of ring-detectors to expand the field of
view). These detectors are connected to a coincidence circuit that de-
termines whether the detected gamma rays were generated by the same
positron, by measuring the time difference between two detected photons
(which is very small, it takes a photon about 1 ns to cross the PET scanner
tube). From this, the system can determine whether there is a radioactive
molecule along the line of sight between the two detectors. The line can
be drawn between any detectors that are within each other’s line of sight
(such that each detector has a fan shaped field of view). By recording the
signal along many lines a 2D plane of the concentrations of these nucleotides
can be determined by data processing similar to the one used in CT. PET
currently gives better resolution than SPECT, but is more expensive and its
cost-effectiveness in cardiology has not been proven[6]. However, the resolu-
tion of PET is fundamentally limited by the length that the positron travels
before it annihilates. This length varies from 2 mm (18F) to 16 mm (82Rb)
and the resolution can not be improved beyond this.
In cardiology, PET is used to measure perfusion and metabolism in
the myocardium. The perfusion measurements are usually performed with
13NH3 or 82Rb. Because these have fairly short half-lives, rest- and stress-
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tests can be performed at relatively short intervals. Metabolism in the my-
ocardium can be assessed by 18-fluorodeoxygluocose, which enters into the
glucose metabolism. These images can be used to diagnose several condi-
tions in the myocardium, e.g. ischemia, viability after myocardial infarction
and dilated myopathy.
SPECT and PET provides a complimentary imaging to the other modal-
ities described herein, in that they describe heart function rather than the
plaque burden as is done by for example coronary calcium score determined
by computed tomography (CT). In this sense it provides information about
short term risk compared to long term risk determined by CT[6]. SPECT
and PET can detect subclinical disease with a stress-test to assess the de-
gree of stenosis in the coronary artery. However, highly specific radiolabeled
molecular markers that bind specifically to atherosclerotic lesions are de-
veloped, thereby making imaging of the degree of atherosclerosis possible
with nuclear imaging techniques. Some of the processes in atherosclerotic
plaques where specific tracers have been developed are monocyte recruit-
ment, lipoprotein phagocytosis, matrix breakdown and apoptosis. In ad-
dition FDG-18 has been used to detect macrophage activity[25]. However,
the limited resolution of nuclear imaging probably limits this technique to
larger vessels than the coronary arteries.
3.4 Vessel anatomy
3.4.1 Coronary Angiography
Coronary angiography is the most common imaging modality in cardiovas-
cular disease. A catheter is advanced to the ostia of the coronary arteries
where an x-ray contrast medium is released, at which time the collection of
X-ray images is commenced. This procedure is repeated for several angles
between the x-ray machine and the body. The resulting image shows the
location of the x-ray contrast medium, that is, it shows the lumen of the
coronary arteries. These images can then be used to determine the degree of
stenosis. The information can be used to guide interventions like coronary
angioplasty, stenting and coronary bypass surgery.
Coronary angiography yields little information on the degree of atheroscle-
rosis and cannot determine the vulnerability of a plaque. Most thrombi
occur over mildly stenotic plaque which are difficult to detect with angiog-
raphy due to positive remodeling. Also, no reduction in stenosis due to
statin therapy was found with angiography even though the treatment had
a profound effect on clinical outcome[24].
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3.4.2 Magnetic Resonance Imaging
Spin is a fundamental property of particles and exists in two different states,
up and down. When a particle is placed in a magnetic field, the energy of
these states separate, forming a two level system. The energy difference be-
tween the states are given by the gyromagnetic ratio γ, which is an intrinsic
property of a particle,
∆E = hγB = hν, (3.4)
where ν is the frequency of a photon with the corresponding energy, and
B is the applied magnetic field. h is Planck’s constant. For biomedical appli-
cations, the most important particle with non-zero net spin is the hydrogen
nucleus resulting in ν in the range of 15-80 MHz for commonly used B-fields
in biomedical imaging. At equilibrium the ratio of population in the two
states are given by a Boltzman distribution, with slightly fewer occupying
the higher states at room temperature, resulting in a net magnetization.
By applying a gradient along the body, a narrow band radio frequency
(RF) signal can be used to interact with only a thin slice of the body where
the energy difference of the two spin states correspond to the energy of
the photons in the RF signal. By applying such a pulse the population of
spins can be saturated or even inverted by absorption of RF photons. When
the RF beam is turned off the population will decay back to equilibrium
through spin-lattice interactions. The time of this relaxation is described by
a parameter T1, that varies from tissue to tissue.
If a spin (or the magnetization) experiences a perpendicular magnetic
field, it will start to precess. This precession moves at a frequency called the
Larmor frequency which is equal to the frequency of the RF signal that is
used to interact with the spins. By applying a magnetic field perpendicular
to the magnetization (actually done with an RF pulse which is seen as a
static field due to the precession), the magnetization can be moved down to
the transverse plane (90◦). When the RF pulse is turned off, the magnetiza-
tion will precess due to the original magnetic field. However, due to so-called
spin-spin interactions the individual spins will experience slightly different
fields and precess at slightly different frequencies. Thus, the spins will de-
phase and the magnetization will decay. The parameter that describes this
dephasing is called the spin-spin relaxation time and is denoted by T2. This
parameter is also dependent on the tissue type.
The actual measurement is done by RF receiver coils that measure the
strength and precession of the magnetization and can extract T1 and T2
by complicated signal processing algorithms. In addition the density of
hydrogen nuclei can be extracted from these measurements.
In addition to the gradient field defining a thin slice of tissue with which
the RF signals interact, other gradient fields are applied during the mea-
surement process that impose different precession speed and phase to the
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magnetization at different positions within the slice. By the appropriate
filtering, the signal from a single voxel (volume element) can be found, and
can be used to generate a three dimensional image of the tissue.
Within the field of cardiology, MRI has two applications, one is to char-
acterize the vessel wall by standard imaging procedures and the other is
to measure blood flow. One common pulse sequence used in MRI is the
spin-echo sequence. Here, the magnetization is rotated 90◦ and allowed to
dephase slightly before a 180◦ rotation is applied. This in effect causes those
spins that precess faster to be moved behind those that precess slower. The
spins will therefore rephase causing a so called spin-echo. Since the blood is
moving the spins will have moved during the pulse sequence and no echo is
generated. This makes the blood vessels appear black in images and can be
visualized with good contrast (so called black-blood imaging). By applying
the two pulses at different slices one can determine where the echo reap-
pears and how far the blood has moved, thereby determining the blood flow
(time of flight imaging). Similar effect can be achieved with phase contrast
imaging where gradients with opposite signs are applied. If the object is sta-
tionary the signals will cancel, but if the object has moved, a non-zero signal
will be generated. MRI is hampered by relatively long acquisition times(45
minutes[24]) to achieve sufficient quality images, especially problematic for
moving organs like the heart[6].
The resolution of current MRI scanners (at 1.5 T) is about 300 µm
within a slice and 2-5 mm between slices[121]. This is too large to image,
with detail, the walls of the coronary arteries, but it has been used to image
the walls of the carotid arteries and the aorta. By combining several contrast
mechanisms in MRI (e.g. T1, T2 and proton density) it has been shown that
plaque components like fibrous cap, lipid core, calcification, hemorrhage and
vessel area can be determined. This was done by comparing MRI images of
the carotid arteries, to histological sections acquired from endarterectomy
samples[82, 20]. Resolution can be improved by stronger magnetic fields.
One study with 3 T fields found improved signal-to-noise and contrast-to-
noise in the images[48]. In the coronary arteries MRI found thicker vessel
walls in patients with cardiovascular disease compared to healthy patients,
indicating that plaques with positive remodeling can be found by MRI[47].
However, for details in the vessel wall structure, the resolution is not yet
good enough for the coronary arteries[67].
Clinically MRI has shown the ability to prospectively assess risk of cere-
brovascular events[95]. This could perhaps also be used as a global assess-
ment of the degree of vulnerability of the plaques and prospectively assess
the risk of cardiovascular events. MRI has also been used to show the effect
of treatment by statins by imaging plaques in larger arteries[22, 23].
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Contrast agents
Paramagnetic contrast agents have been used to enhance imaging of blood
since it reduces the T1 parameter compared to the surrounding tissue. A
study with gadolinium found that vessel wall volume changed by almost
30% compared to the same vessel with noncontrast imaging, possibly due
to improvement in resolution[77].
Gadolinium has also been shown to have preferential uptake in extra-
cellular matrix and could be used as a molecular marker for fibrous cap
detection[116]. Gadolinium can also be labeled with LDL, HDL, fibrin and
tissue factor to be preferentially absorbed in various tissues.
Ultrasmall paramagnetic iron oxide (USPIO) have been shown to be
preferentially absorbed in macrophages[106]. Since inflammation is an im-
portant factor for plaque vulnerability, USPIO could perhaps be used as a
molecular marker that can improve the detection and imaging of vulnerable
plaques.
3.4.3 Computed tomography
Computed tomography (CT) images the x-ray attenuation in small volumes
within the body. This is achieved by measuring the attenuation at var-
ious different angles. By a mathematical reconstruction technique called
backscatter projection, or more properly by the Radon transform, the x-ray
attenuation in a single volume element (voxel) can be calculated and three
dimensional images of the x-ray absorption can be generated.
The source of x-rays in CT-scanners is a cathode ray tube. Electrons that
are released from a hot filament are accelerated across an electrical field in a
vacuum tube. The electrons hit a metal disc where they excite tightly bound
electrons. As an electron decays back, it emits an x-ray photon. X-rays are
also produced as bremsstrahlung when electrona are accelerated (bent) by
nuclei. One of the challenges for x-ray sources is to produce very steady
x-ray fluxes so that small contrast changes in the image is not obscured.
Furthermore the resolution depends on the aperture of source, but there
is a trade off between signal strength and resolution that is limited by the
heating of the x-ray source material.
Several classes of CT scanners exist, for example electron beam tomogra-
phy (EBT), helical computed tomography (HCT) and multislice computed
tomography (MSCT). Usually the source moves in a ring around the patient
emitting a fan of electrons that is detected by a row of detectors that moves
with the source. If the patient is moved through the tube at the same time,
the source will describe a helix around the patient (HCT). Several slices
can be detected at the same time to reduce imaging time by adding rows
of detectors, and possibly also more sources (MSCT). For cardiac imaging
very short image times are necessary due to the beating heart. EBT was
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designed especially for this. The source is then stationary and the scan-
ning is achieved by electrically deflecting the electron beam across the x-ray
material.
At the present, the resolution of CT (about 0.4 mm) is not good enough
to image individual plaque components in the coronary arteries. The res-
olution of CT is fundamentally limited only by Compton scattering, but
presently by source and detector sizes. Synchrotron radiation (produced
by electrons accelerated in a particle accelerator) has been used to image
paleontolgical samples with micrometer resolution[30]. Contrast is also a
problem to overcome for imaging plaques since the x-ray absorption does
not vary much between the different components. With advances in biolog-
ical markers labeled with x-ray absorbers, this obstacle could be overcome.
Clinically, CT is presently used in cardiovascular management to mea-
sure the amount of calcifications in the coronary vessels. Coronary calcium
score (CCS, or coronary artery calcium score, CACS) gives an indication of
the global atherosclerotic burden and have strong predictive power for long
term outcome of coronary artery disease[6]. de Weert et al. have shown
that CT can be used to differentiate between lipids and fibrous tissue in the
carotid artery[28]. By correlating CT measurements with histology from
endarterectomy samples, they found that the x-ray absorption in Hounds-
field units (HU)2 of calcifications, lipids and fibrous tissue was 657±416 HU,
88±18 HU and 25±19 HU, respectively.
CT angiography with contrast agents as a noninvasive alternative to
coronary angiography has also been tested. Since regular angiography has
been so successful in guiding treatment, a noninvasive procedure with the
same clinical information could be very useful. CT angiography can be com-
bined with CCS in one measurement to reduce radiation dose (even though
this somewhat reduces the quality of both assessments). The presence of ex-
tensive calcification and stents makes CT for angiography difficult since they
scatter the x-rays strongly, masking nearby objects. One study compared
CT angiography with intravascular ultrasound (IVUS) for determining ves-
sel wall composition and found good agreement[24]. The radiation dose in
CT is higher than for conventional angiography but avoiding an invasive
procedure could still be clinically advantageous.
As an example of how modalities without the necessary resolution to im-
age coronary arteries can be valuable, it was shown that noninvasive (non-
contrast) CT misses stenoses that can be seen functionally by SPECT [6].
The combination of CT and PET could provide a powerful combination
with CT providing high resolution anatomical information, and PET giving
metabolic information.
2Houndsfiel units (HU) are a measure of x-ray absorption and are defined by setting
water to HU = 0 and air to HU = −1000.
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3.4.4 Ultrasonography
Ultrasonography uses equipment similar to echocardiography (section 3.3.2)
to produce images of the walls of larger vessels. It can be used to image
plaques in larger arteries like the carotid and femoral arteries and the aorta.
In plaque imaging, ultrasonography has shown the ability to measure the
thickness of the vessel between the intima and media. The external elastic
membrane and the lumen can in general be easily seen in ultrasound images
and thus defines the thickness of the intima and media, which can be used as
a measure of plaque thickness. This thickness in the carotid arteries (called
CIMT, carotid intima-media thickness) has been proposed as a screening
variable that describes the systemic burden of atherosclerosis[71]. With
contrast agents, ultrasonography has been used to image the vasa vasorum in
carotid arteries, thereby giving information on the neovascularization during
atherosclerosis[35]. With the advent of targeted contrast agents that can
attach to sites of inflammation, it could be possible to say something about
the physiological state of the plaque. A problem with targeted microbubbles
is that for flows with large sheer stress values, as they are in the aorta and
carotid arteries, the fractional binding of microbubbles to the vessel wall
will be very low.
3.4.5 Ankle-Brachial pressure index
If there are stenotic parts in the lower limbs, this will cause the pressure
to drop along the vessel. This can be assessed by measuring the blood
pressure at the ankle and the arm with a standard cuff. The difference
in pressure at these two sites is called the Ankle-brachial pressure index
(ABPI or ABI) If pressure difference is large, atherosclerosis in the lower
extremities is indicated. This techniques is used to quickly and cheaply
assess the systemic burden of atherosclerosis.
3.5 Vessel wall anatomy, composition and
function
3.5.1 Intravascular ultrasound
Intravascular ultrasound (IVUS) uses a catheter based imaging technique
where an ultrasound transducer is located at the tip of the catheter. The
transducer is advanced through the coronary arteries, guided by x-ray imag-
ing (fluoroscopy). Motorized pullback of the catheter is then performed at
constant speed, usually acquiring images every 1 mm[24]. Imaging rates
up to 30 frames per second are achieved. Angular scanning of a vessel can
be achieved by mechanical rotation of the transducer by an electrical rotor
outside the body which is connected to the transducer with a torque wire.
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Another method, that allows for quicker image collection is to have an array
of transducer elements located circumferentially around the catheter tip so
that the angular scanning is achieved electronically.
An advantage of IVUS is the proximity to the object in question so
that high frequency ultrasound, allowing for higher resolution, can be used
in spite of the strong attenuation. The excitation signal used in IVUS is
generally around 30MHz, yielding an axial resolution around 100 µm, even
though the theoretical limit is lower. The lateral resolution is slightly higher,
usually around 300 µm[113]. The resolution is therefore not good enough to
determine the thickness of a thin fibrous cap.
The disadvantages of IVUS are the radiation dose (from the fluoroscopy)
and the invasive nature of the procedure. In addition, IVUS is currently
quite expensive.
The American college of cardiology (ACC) has published a guideline
document for interpreting and reporting IVUS images[66]. The primary
features detectable with IVUS are the geometry of the lumen, calcifications,
lipid-rich regions and the external elastic lamina. The lumen geometry gives
an indication of the degree of stenosis. The lumen surface together with the
external elastic lamina can be used to calculate the total vessel wall cross-
sectional area[66]. This is usually called the intima-media thickness, and
gives a measure of the size of a plaque. It thus offers an advantage compared
to angiography as it is also able to detect plaques with positive modeling.
Calcifications are seen very clearly due to their strong echogenecity but with
the drawback that they shadow for the underlying layers. Calcifications are
detected with a sensitivity of 86-97%[113]. Plaques with calcified nodules
have been proposed as a type of vulnerable plaque and IVUS could play a
significant role in detecting these. Lipid rich areas are characterized by low
echogenecity compared to fibrous tissue, but the contrast is low as indicated
by the low sensitivities (around 40%) reported in attempts to differentiate
between between fibrous and lipid rich tissue[113].
IVUS has also been used to better assess the effects of angioplasty and
stenting than what is possible with angiography. It has also been used as an
endpoint in clinical trials of medication treatments[24] where it was found
that statins increased the echogenecity of plaques, hypothesized to be due
to increased fibrous or decreased lipid content in the plaques. In one study
IVUS was used to determine that ruptured plaques do not occur at minimal
plaques but rather at large plaques with minimal stenosis due to positive
remodeling[36].
Radiofrequency analysis
Conventional IVUS measures the intensity of the backscatterd signal and the
recorded signal has gone through several signal processing steps like enve-
lope filtering and gain compensation before it is recorded. Radiofrequency
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(RF) ultrasound records the raw signal that is collected by the detector.
Since a problem with conventional IVUS is that it differentiates poorly be-
tween fibrous and lipid-rich plaques, it was proposed that perhaps the fre-
quency spectrum of the raw RF signal contained information to improve
this differentiation. Several methods for analyzing the frequency signal has
been proposed, e.g integrated backscatter[46] and frequency spectral anal-
ysis (Virtual Histology)[74]. Murashige et al. used wavelet analysis on the
RF signals and found that lipid-rich plaques could be detected in-vivo with
a sensitivity of 81% and a specificity of 85%[70]. A challenge has been to de-
velop analog-to-digital converters operating at sufficient frequencies (a few
times the ultrasound frequency) and sufficient bit depth, but commercial
equipment is now available.
Elastography
Elastography (also called palpography) is a method for extracting the me-
chanical properties of the vessel wall. The tissue is imaged using IVUS at
two different pressures. By correlation analysis of the two images the move-
ment or strain of the vessel during systole is determined. Several techniques
for analyzing the signal to derive the strain are used[113]. By comparing the
strain to the stress induced by the blood pressure, the mechanical properties
of the tissue can be extracted. The technique gives the ability to improve the
contrast between soft and hard tissue that is a problem with standard IVUS,
since the echogenecity difference between soft and hard tissue is small. The
excitation of stress in the vessel can either be achieved using the normal
variation in blood pressure or using an inflatable balloon[50].
Shear stress imaging
By combining IVUS with biplane angiography (collecting x-ray images in
two orthogonal planes), the actual three dimensional geometry of the lumen
can be determined. This data can be used to create a finite element model of
the lumen which can be used to accurately determine the flow pattern in the
vessel. From this pattern the shear stress at the surface can be determined.
The shear stress is important both as a factor for plaque rupture and that
it has strong effect on the endothelium and its production of cytokines and
regulation of vascular tone.
Endothelial vasodilator dysfunction
The endothelium plays a key role in the development of atherosclerosis.
Improper function of this organ has been associated with increased risk of
cardiovascular events. The function of the endothelium can be assessed
by various different methods. The vessels can be exposed to various types
of stimuli, either pharmacologically or by exercise, which would cause a
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reaction in the vessel wall. By measuring this response, e.g. by IVUS, the
actual functioning of the vessel wall can be assessed.
3.5.2 Thermography
Temperature is a tightly regulated parameter in the human body. Just
a few degrees of change during a fever quickly reduces the ability to do
work. A few degrees more can be fatal (44-46◦C). Too low temperatures
can lead to cardiac arrythmias while too high temperatures leads to protein
denaturation.
Temperature is regulated by a thermostat in the preoptic area in the hy-
pothalamus. This center receives impulses from thermal sensors in the skin
and in the hypothalamus. When the temperature falls below the desired
level the preoptic center triggers several heat promoting effects: contraction
of blood vessels, release of hormones that increase metabolism (thyroid,
epenephrine), and shivering. The opposite process is triggered if the tem-
perature is too high. Fever occurs when the thermostat in the hypothalamus
is reset to regulate at a higher temperature. This process can for example
be initiated by phagocytes eating bacteria that release interleukin-1 which
again initiates the production of prostaglandines which reset the hypotha-
lamus thermostat[103].
Increased heat generation has been linked to inflammation by two macro-
scopically apparent phenomena. One is that if the body is infected, we get
a fever. This is, as explained above, related to a regulatory mechanism and
not increased metabolism. The other is that a local inflammation causes the
skin to appear red and feel hot. However, this heat is not due to increased
metabolism only (if at all), but also that the vessels are dilated (the in-
creased optical absorption of hemoglobin causing the redness), so that more
blood from the central body reaches the skin circulation. Normally, the core
body temperature is higher than the skin temperature by a few degrees.
To make a mathematical model of the temperature distribution in the
body, the physical mechanisms of heat transport must be determined. On
the surface of the body the transport mechanisms are radiation into the
surroundings (60%), convection due to heated air at the skin surface (15%),
evaporation of water on the skin and in the lungs (22%) and convection
into the surroundings (2%). The percentages are given for a person at
rest in normal room temperature with normal humidity, and can change
significantly in other conditions. E.g. at 100% humidity, evaporation can
not transport temperature away from the body.
Within the human body, the primary heat transport is by convection of
the flowing blood. Radiation is not a significant source of thermal conduction
within the body[57]. Thermal transport by conduction requires a thermal
gradient, and is not a major factor within the body since the temperature is
quite similar throughout the body. The temperature in the body is regulated
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by the blood moving the heat generated in the tissue to the skin and lungs
where it is dissipated (by conduction, radiation or vaporization). Therefore
the arterial blood must necessarily be colder than the internal organs, but
warmer than the skin.
If every capillary in a given tissue volume to be modeled was to be
included, the resulting geometry would be unwieldly, even for numerical
methods. Therefore an assumption (and simplification) is made that for
capillaries and small vessels, that the flow is so slow that the blood reaches
thermal equilibrium with the surrounding tissue during its passage. Thus,
the cooling by the blood is assumed to be proportional to the perfusion of
the tissue, and the temperature difference between the arterial and venous
blood. This model is not valid when the flow velocity increases to the point
where the blood does not reach equilibrium on its pass through the tissue.
The vessel must then be modeled as a separate geometry.
Based on these physical assumptions the so-called bioheat equation can
be derived[76].
κ∇2T − ρtct∂T
∂t
= −q + ρbcbω(T − T0) + ρbcb~vb · ∇T. (3.5)
The two last terms on the right side represent perfusion and the con-
vection, respectively. Usually, the convection term (the last term) is not
included in the bioheat equation.
From autopsy studies it has been shown that macrophages are present
in great numbers in ruptured plaques[26]. This prompted the hypothesis
that matrix digesting enzymes released by the macrophages degrade the fi-
brous cap, increasing the vulnerability of the plaque. Since macrophages
represent an inflammatory process, it was postulated that an increase in
temperature of the plaque would accompany the macrophage infiltration.
However, a recent autopsy study has shown that in patients with acute my-
ocardial infaraction, the number of inflammatory cells was four-fold higher
than in a control group but that the increased inflammation was present in
stable plaque as well as non-culprit segments. The difference in inflamma-
tion was only 30% between stable and vulnerable plaques within the same
group. This study indicates that inflammation is primarily systemic and not
located in individual plaques.
The first investigation of thermography was performed by Casscells et al.
whom examined the temperature variations in carotid plaques, excised dur-
ing endarterectomy, and measured the temperature using a thermistor[21].
This was compared to the density of macrophages, determined from histol-
ogy. They found good correlation between macrophages and temperature
and found temperature variations up to 1 K.
Many in-vivo studies have been performed both on humans and ani-
mals. The first in-vivo study was performed by Stefanadis et al. who mea-
sured the thermal heterogeneity in coronary vessels in patients with differ-
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ent diagnoses[93]. They found that the thermal heterogeneity was greater
in patients having suffered a myocardial infarction compared to patients
suffering from unstable angina. Patients with stable angina had the lowest
thermal heterogeneity. The interpretation was that patients who had suf-
fered a myocardial infarction had a higher probability of having an inflamed
vulnerable plaque which caused the increased thermal heterogeneity. This
group has in several subsequent clinical studies shown the effect of ther-
mography. It has been shown to be a predictor of clinical outcome after
percutaneous coronary intervention[91], statin treatment has been shown
to reduce thermal heterogeneity[90] in patients, and thermal heterogeniety
has shown good correlation with concentration of acute phase proteins[92].
Results of intracoronary thermography is quite varied, so it is interesting to
note that already papers are published where thermography is considered to
be a standard measuring technique from which secondary information can
be derived, e.g. the effect of medication on plaques[94]. It has been previ-
ously mentioned that there is a dispute about whether vulnerable plaques
should be considered as a diffuse or focal diseases. A study from Stefanadis
group used thermography to investigate whether temperature heterogene-
ity varies between culprit and non-culprit lesions[105]. Several companies
(Volcano therapeutics, Thermocoil guidewire and Imetrix) have developed
commercial equipment, indicating their belief in the method.
Recent studies have found much lower values than the initial studies
by Stefanadis[85, 81, 104] and did not find thermal heterogeneity over 0.1
K in more than 40% of the patients[81]. Interestingly, one study found
that the measured temperature heterogeneity that has been reported in the
litterature have decreased over the years[99]. Perhaps the laws of physics
are not as constant as Einstein assumed[31].
However, only a few studies have tried to analyze the physics of the
temperature generation and measurement process. These were finite el-
ement studies that investigated the effect of plaque geometry[98], probe
geometry[97] and heat source location on temperature measurements[40].
Since no direct experimental values for the heat generation in plaques exist,
these studies used heat generation which were derived by requiring that they
fit experimental values (i.e. 1 K temperature increase).
There are two important facts that are almost never considered in the
published thermography studies. One is that arterial blood must be slightly
colder than the tissue. The arterial blood must be colder than the tissue
(except at the skin and lungs) so that it can absorb the heat generated in
the organs and transport it to the skin and lungs where it is dissipated.
The other is that temperatures between organs vary. The lungs will for
example be cooler than the heart since it is in contact with the colder air. In
other organs the temperature difference will not be large due to the efficient
perfusion. These factors are important to consider in the measurement
process.
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Since the arterial blood is cooler than the tissue, the thermal contact
with the vessel wall will have a significant effect on the measurements. If the
probe moves but a tiny bit from the vessel wall, the measured temperature
will fall rapidly. Also the vessel wall temperature will depend on surrounding
organs. This is especially true for the aorta which pass by diverse organs as
lungs, heart, liver and intestines[111].
A study included in this thesis took another approach (Paper IV). Based
on physiological consideration we found an upper limit on heat generation
that could be expected in a plaque and found that a temperature increase
in the center of the plaque was less than 0.1 K[57].
3.5.3 Optical coherence tomography
Optical coherence tomography (OCT) quantifies the amount of optical scat-
tering within a small volume of tissue. The tissue is irradiated and the
reflected light due to scattering is measured. By measuring the time it takes
the light to go from the source via the tissue and to the detector, the point
within the tissue where the reflected light originated can be determined.
In this respect it is equivalent to intravascular ultrasound except that it
measures the reflection of light waves instead of sound waves.
The time difference at the detector between two signals generated at
locations separated by 10 µm is on the order of 10−13 s, and only interfer-
ometric methods can be used to measure such small time differences. The
light from the source passes a beam splitter where one beam is directed to
the tissue and the other to a reference mirror. If a broad band light source is
used there will be maximal constructive interference at the detector between
the two beams only when their optical path lengths are identical.
Light sources that are used in OCT are usually super luminescent diodes
(SLD) or Ti:Sapphire lasers with bandwidths 70 nm and 120 nm, respec-
tively. Their center wavelengths are usually 1300 nm and 800 nm respec-
tively. The resolution in the direction parallel to the beam is dependent on
the bandwidth and the center wavelength. The theoretical limit lc is given
by[14],
lc =
2 ln(2)λ20
pi∆λ
, (3.6)
where λ0 is the center wavelength and ∆λ is the bandwidth. For a SLD
system the resolution is about 13 µm and about 4 µm for a Ti:Sapphire
system.
The penetration depth depends on the scattering and absorption in the
tissue. The absorption loss can be somewhat compensated for by increasing
the incident power. Due to the scattering there will be some photons that
have travelled the same optical length as the volume in question even though
they originate somewhere else. At a certain depth there will be more of these
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scattered photons than those originating from the volume in question and
the signal cannot be improved by increasing incident power. The penetration
depth in coronary tissue have been investigated for the various layers and
pathological states[64]. It was found that the attenuation coefficient at 800
nm (Ti:Sapphire laser) ranged from 3 − 10 mm−1 and from 2.3 − 7 mm−1
at 1300 nm (SLD). We see that the penetration depth is higher at 1300 nm
than at 800 nm even though the absorption is probably highest at 1300 nm,
indicating that scattering is the primary limiting factor.
The resolution in the direction perpendicular to the direction of light
propagation is achieved by a lens and the resolution depends on the waist
of the focused beam at the volume in question. Two different systems have
been used for intravascular applications. One system (LightLab Inc.) uses
a miniaturized microscope consisting of two lenses, one converging and one
diverging. The other uses a gradient index lens (Massachusetts General
Hospital). In both systems the light is guided through the catheter by an
optical fiber and directed towards the vessel wall by a prism. Scanning in
the transverse directions are achieved by rotation and pullback of the probe.
The systems achieve frame rates of 30 and 8 frames/s, respectively.
OCT is equally invasive to IVUS and in-vivo studies have shown that
complications (ECG changes indicating ischemia and chest pain) are equally
frequent in these two modalities with no serious events reported. Due to the
high scattering of blood, saline flushing is necessary during measurement
and puts an additional burden on the myocardium. The scattering of blood
is due to the index mismatch between the erythrocytes and the plasma.
Some work on index-matching by adding dextran and ioxaglate (a contrast
agent) to the plasma has been shown to increase the reflected signal from
the tissue by 70% and 40%, respectively[13]. The incident power used was in
the range of 5-8 mW and is considered safe. However, this depends entirely
on the irradiation time and the focus of the beam but is usually safe in this
application due to the high scanning rate (see paper V).
Since the resolution of OCT is an order of magnitude higher than the
resolution of IVUS, it seems likely that new physiological information can
be gained.
A study of 357 artery segments from the aorta, carotid and coronary
arteries found OCT image criteria for physiological classification[119]. They
correlated strong reflection with fibrous cap, calcifications with echolucent
regions with sharp borders and lipid rich regions with echolucent regions
with diffuse borders. A subset of the measurements were used as a training
set for two investigators to classify plaques based on OCT images. They
showed good specificity and sensitivity in the remaining samples for detect-
ing fibrous cap, lipid rich regions and calcifications, compared to histological
classification.
An in-vivo study found that OCT could detect all physiological char-
acteristics that were detectable with IVUS, but in addition also detected
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features related to intimal hyperplasia and lipid-rich regions, indicating that
OCT provides additional information compared to IVUS[44].
The high resolution of OCT makes it ideal for measuring cap thickness.
Two studies have shown that there is good correlation between cap thickness
measured by OCT compared to histology[64, 43]. Oddly enough one of the
studies reported the linear coefficient between OCT and histology less than
one and the other greater than one.
Macrophage infiltration is an important parameter in plaque vulnera-
bility because it is believed that the enzymes released by the macrophages
degrade the fibrous cap. Since the index of refraction is different in the lipid
rich macrophages compared to the surrounding tissue it was proposed that
this would lead to a greater variance in the OCT signal. This was tested in-
vitro and good correlation between OCT variance and macrophage density
was found[96]. An in-vivo study found that the OCT variance was greater in
patients with unstable angina compared to stable angina, speculating that
higher incidence of vulnerable plaques with large macrophage densities can
be found in unstable patients[59].
Another area where OCT could have an impact is stenting. Due to its
high resolution it can better monitor neointimal growth and dissections after
stent placement, thereby providing information that can be used to improve
the procedure.
Since apparently vulnerable plaques have been found in several vessels
during autopsy studies, it has been proposed that further information must
be found to delineate which plaques are vulnerable. One such feature could
be the collagen content of the fibrous cap. Since collagen is birefringent,
a measure of the degree of birefringence in the cap could be a measure of
the collagen content in the cap. One study using polarization sensitive OCT
found that the degree of birefringence in the cap could be correlated with the
collagen content, determined from histological stains with picrosirious[37].
OCT could also be combined with spectroscopy for even better charac-
terization of tissue, but this has of yet not been investigated.
3.5.4 Multiphoton microscopy
Nonlinear optics
The polarization of a medium due to an electrical field can be described by
the susceptibility,
P = 0(χ(1)E + χ(2)E2 + ...) (3.7)
Here we have used scalars but in reality P and E are vectors and χ(1)
is a second rank tensor, χ(2) is third rank tensor and so on[10]. This is for
a bulk medium. For a single molecule a similar equation can be used by
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exchanging the polarization with the dipole moment and the susceptibility
with the polarizability.
If monochromatic light is used the polarization due to the second term in
the above equation results in polarization oscillating at the double frequency,
hence light of half the wavelength of the incident light is generated, this is
called second harmonic generation (SHG). In addition, the molecules can
also absorb two photons at the same time. Thus, fluorescent states in a
molecule can be excited by two photons with half the energy of the excited
state. This is called two-photon excited fluorescence (TPEF). SHG and
TPEF are the most common nonlinear optical processes used in imaging of
biological tissue even though other processes like third harmonic generation
and coherent anti-stokes Raman scattering (CARS) are used.
The second order susceptibility is very small so that very strong electric
fields must be used to generate detectable signals. To avoid high average
power from the laser that could cause photothermal damage to the tissue,
pulsed lasers with very short pulses (resulting in high peak intensities) are
used. The most popular laser system is the Ti:Sapphire laser that delivers
pulses of about 100 fs, with a repetition rate of about 100 MHz, and average
power of about 1 W. To achieve short pulses relatively large bandwidths are
needed (about 10 nm) so the generated signal is not only second harmonic
generation but also sum frequency generation.
Multiphoton microscopy
Using nonlinear properties of tissues have several advantages in microscopy.
Red light penetrates deeper than the blue light traditionally used for exciting
fluorophores and can therefore provide imaging deeper into the tissue. Also
the excited signal depends quadratically on the intensity so that if a high
numerical aperture objective is used, a signal is only generated near the
focus. The signal will in the geometrical approximation decay as d−4, where
d is the distance from the focus. This approximation is not valid near the
focus where the geometrical optics approximation is not valid. This means
that a confocal effect is achieved without a confocal pinhole and the excited
light can be collected more efficiently. Also, photobleaching is reduced since
the long wavelength light is very weakly absorbed outside the focus.
Exogenous dyes can be added to a sample to improve TPEF imaging
of specific structures, but also endogenous fluorophores generate TPEF and
some molecules also generate SHG. Collagen I and III are the only biological
molecules known to produce SHG. TPEF, on the other hand, is generated
by several different proteins.
Multiphoton microscopy (MPM), the combination of microscopy and
nonlinear excitation, has been used for imaging many biological tissues,
both at the cellular and tissue level of organization. This include brain[41,
100, 53, 45], tumors[15], cartilage[120] and skin[49].
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Figure 3.1: MPM image of a normal artery, near the surface. TPEF is
shown in green and SHG in red. A dense layer of elastic fibers exhibiting
TPEF can be seen over a layer of thin, scattered collagen fibers that give
SHG. The image is 230 x 230 µm.
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MPM has also been used to image cardiovascular structures. One study
of atherosclerotic mice found that different structures of the plaques could
be seen both in intact tissue and in stained thin sections[110]. A few studies
have also confirmed that elastin and collagen can be differentiated in human
vessel walls[122, 84]. As an example of a clinical application, one group
investigated the vessel of rats where the parents had been exposed to lindane
(a pesticide), and found changes in the vessel structure of the offspring[9]
It has thus been shown that MPM can efficiently image connective fibers
within tissue, both elastin and collagen. In atherosclerosis, advanced plaques
are characterized by a collagenous cap that covers the lipid-rich necrotic core.
For vulnerable plaque the danger is that this cap ruptures exposing the lipid
core. It is thus the mechanical strength of the cap that ultimately determines
the vulnerability of the plaque to rupture (even though thrombotic blood and
health of myocardium are important factors for the outcome). By imaging
the individual collagen fibers within the cap, a better understanding of its
mechanical properties can be gained[58]. (See figures 3.1 and 3.2.)
Developing an intravascular probe for multiphoton microscopy seems
challenging but not impossible. There are two main obstacles. One is to
develop a miniaturized microscope objective with focus control. This could
perhaps be achieved by microoptical devices. The other challenge is to guide
the necessary high intensity pulse through a fiber. The problem is that the
broad wavelength will lead to both linear and nonlinear dispersion. However,
this problem can also be overcome by prechirping techniques[107].
3.5.5 Optical spectroscopy
This section will present optical methods where light is collected in the
backscatter mode, but without imaging. The reflected light gives informa-
tion on the bulk optical properties of the sample which can be used to par-
tially derive its chemical composition. Techniques that have been used for
characterization of plaque are diffuse reflection spectroscopy (using visible
or near-infrared (NIR) light), fluorescence spectroscopy and Raman spec-
troscopy.
Diffuse reflection spectroscopy
Tissue is a very turbid medium and the refractive index varies between
interstitial fluid, membranes, connective fibers, lipids and cell nuclei. This
variation in the refractive index causes the light to be scattered, i.e. the
electromagnetic field changes its direction of propagation. When the light
is scattered enough times it can be reemitted from the surface, appearing
as reflected light. In the field of tissue characterization this is commonly
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Figure 3.2: MPM image of an atherosclerotic plaque. Notice the difference
in structure of the collagen fibers in this image compared to the normal
artery (figure 3.1). In between the fibers are small fluorescent spheres whos
nature have not been determined but could perhaps be lipid droplets within
macrophages, or other cellular components. The image is 230 x 230 µm.
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referred to as diffuse reflectance3.
As the light propagates through the tissue it can encounter molecules
that have energy states that correspond to the photons in the beam and
can absorb part of the light. The spectral dependence of the reflected light
will depend on the type, location and concentration of such molecules, and
therefore this information about the tissue can be extracted from the dif-
fusely scattered light. Only the linear absorption is considered (see equation
3.7).
In addition, the scattering of the inhomogeneities in the tissue is not
the same for all wavelengths, usually it will tend to decrease for longer
wavelengths. Less scattering effectively means that the light travels deeper
into the tissue before it can be reemitted. Scattering from tissue is usually
divided into Mie-scattering (for objects on the order of the wavelength) and
Rayleigh scattering (for objects that are much smaller than the wavelength).
The scattering as a function of wavelength for Mie-scattering depends on
the ratio of the wavelength and the size of the object, but is generally less
wavelength dependent than Rayleigh scattering which goes as λ−4.
The refractive index mismatch between the tissue and the surrounding
medium is also important as it can cause the light to be internally reflected
at the surface, thereby traveling further through the tissue.
Since the scattering quickly makes the light incoherent, phase and po-
larization of the light field is usually ignored and only the intensity of the
light is considered. This is called the model of radiative transfer. The basic
equation describing radiative transfer is the Boltzmann equation.
1
c
∂L(~r, sˆ, t)
∂t
+ sˆ · ∇L(~r, sˆ, t) = −(µa + µs)L(~r, sˆ, t)
+ µs
∫∫
4pi
dΩ′L(~r, sˆ′, t)f(sˆ · sˆ′) +Q
(3.8)
Here L is the radiance, defined as the power through an infinitesimal
small area at point ~r and in the direction of an infinitesimal small solid
angle dΩ in the direction sˆ,
L(~r, sˆ, t) =
dP
dAdΩ
(3.9)
µa and µs are the absorption and scattering coefficients, respectively,
which are defined as the change in light intensity over an infinitesimally
3In tissue characterization, light reflected from the surface (without penetrating the
tissue) is referred to as specular reflection. In other fields specular reflection refers to
surface reflection obeying Snell’s law of reflection at equal angles, and diffuse reflection
refers to surface reflection from a coarse surface so that light is reflected at all angles.
What is called diffuse reflection in the field of tissue characterization (and this thesis) is
also known as transflection.
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Figure 3.3: Monte carlo simulation of a layer of fat of various thickness 0.1
mm below the surface, giving the diffuse reflection as a function of wave-
length. The absorption of pure porcine fat was used for the lipid layer. The
only absorber in the rest of the tissue was water at a 70% concentration.
The absorption peak of fat at 1210 nm can be seen.
small length dx, dI = µiIdx, where i can be substituted by either a or s.
The term f(sˆ · sˆ′) is the probability that a photon travelling in the direction
sˆ will be scattered in the direction sˆ′. This factor is also called the phase
function. Q is a source term and c the speed of light. The source term can
for example represent fluorescent light generated in the tissue, or collimated
light that is diffused when the diffusion approximation is used (see below).
The Boltzmann equation cannot be solved analytically. Simplifications
must be made or one must resolve to numerical methods. One common sim-
plification for samples where the scattering dominates over the absorption
is the diffusion approximation. The basis of this model is that since the
medium is highly scattering, the radiance will be nearly isotropic and can
be described by an isotropic fluence rate together with a small directional
flux
L =
φ
4pi
+
3
4pi
~j · sˆ (3.10)
Substituting this expression in the Boltzmann equation and integrating
over the appropriate variables yields a diffusion type equation that can be
solved analytically[39].
Monte Carlo simulation is a popular numerical tool. This technique
simulates packages of photons that are launched into the tissue and their
path is traced using probabilities based on µa, µs and f . By repeating this
many times a statistical distribution of the light in the tissue can be found.
Figure 3.3 shows Monte Carlo simulations of a one dimensional model of
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Figure 3.4: Absorbance A of porcine fat, cholesterol and water. Measured
in the liquid phase in a 1 cm cuvette.
a layer of fat of varying thickness, embedded in tissue, 0.1 mm below the
surface.
The most common methods to collect the reflected light from a tissue
is either by a fiber optic probe or an integrating sphere. These are usually
connected via an optical fiber to a spectrometer which sends the data to a
computer. The integrating sphere collects light down to a depth of about
one penetration depth. The penetration depth in highly scattering media
can be defined from the diffusion approximation to be δ = 1√
3µaµtr
where
µtr = µa + (1− g)µs. With optical fibers one can change the volume which
is investigated. One fiber can be used for the illumination and one for the
collection of the reflected light. By increasing this distance, the light will
travel deeper before reaching the detector and a larger volume is sampled.
For example in the work presented in paper III, we used a probe with a
central collection fiber with seven illumination fibers in a tight circle around
the central fiber. Another had four fibers placed in a linear array, each
separated by 150 µm. Usually the reflectance spectra are reported relative
to a reflectance standard which is assumed to have wavelength independent
reflection of almost 100%.
In the NIR part of the spectrum, the primary absorbers are water and
lipids of various types (e.g. free or esterified cholesterol and triglycerides),
and hemoglobin up to about 1100nm. Figure 3.4 shows the absorbance, A =
−log(I/I0) of important absorbers in the NIR region, relevant to detection
of plaque.
Water is always present in biological tissue and usually dominates the
NIR reflectance spectra unless the measurement is performed through whole
blood (see figure 3.7). However, one can see in figure 3.4 that the absorption
of lipids around 1210 nm is comparable to the water absorption, indicating
that this wavelength could be used to detect lipids in tissue. As a preliminary
experiment to test whether NIR spectroscopy could be used to detect lipids,
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Figure 3.5: Reflection spectra taken at various sites on the outside of a
bovine heart, both muscular areas and of thick adipose tissue. The spectra of
muscular tissue shows the water absorption at 980 nm, 1190nm and around
1450nm. The spectra of thick adipose tissue shows lipid absorption peaks at
930 nm, 1080 nm and 1210 nm. In addition the large water absorption peak
at 1450 nm dominates the spectra at higher wavelengths. The area with
thin adipose tissue had some dried blood over it which can be seen by the
broad absorption from 900 nm to about 1100 nm due to oxy-hemoglobin.
we measured the diffuse reflectance at various sites on the surface of a bovine
heart. Figure 3.5 shows the reflectance from muscle and adipose tissue. The
absorption peaks from figure 3.4 are clearly visible. Water at 980 nm, 1190
nm and 1450 nm and lipids at 930 nm, 1050 nm and 1210 nm.
A few studies have been published in this field. The first study used
Fourier transform infrared (FTIR) spectroscopy and found that they could
spatially differentiate between lipids and connective tissue in sections of
aortic tissue[61]. They collected spectra from 3-12 µm. This has since been
developed to include imaging and it has been found that elastic lamella
and foam cells could be imaged[19]. Spectra were collected in the range
2.6-10 µm However IR light is not very useful for in-vivo applications since
the penetration depth is only about 10 µm. Using NIR light gives good
penetration depth, especially in the so-called optical window from 800-1200
nm. One study using light from 1100-2200 nm for reflection spectroscopy
using partial least squares analysis found that they could detect lipids, thin
cap and inflammatory cells with good sensitivity and specificity (90% and
93%, 77% and 93%, 84% and 89%, respectively)[68]. A similar study using
cluster analysis found that lipid/protein ratio extracted from the spectra
correlated with histological classification according to the American Heart
Association[114]. A company called Infraredx is trying to commercialize this
technique and claims to be on the brink of clinical trials.
In the visible range important absorbers are blood and carotenoids. Clin-
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Figure 3.6: Reflectance spectra from healthy and atherosclerotic rabbit aorta
ical studies with angioscopy have shown that a ”yellow glistening plaque” is
associated with vulnerable plaques, determined from histology. This yellow
color could be due to carotenoids that bind to the lipids within the plaque.
It has been shown that beta-carotene taken orally has preferential absorp-
tion in plaques[8]. The reflectance spectra of plaques in the visible region
was investigated, but it was found that it offered poor sensitivity and speci-
ficity for detecting plaques compared to the NIR spectrum[56]. This could
be due to the strong overlap of the blood absorption with the carotenoid ab-
sorption. Only small amounts of blood in the vasa vasorum would strongly
affect the spectra.
Previously published work on the reflection spectra from atherosclerotic
plaques use statistical methods to determine whether vulnerable plaques can
be differentiated from stable ones[68]. A drawback of statistical methods is
that the measurement must be performed in its actual setting (i.e. in-vivo)
to develop the actual training set that serves the basis for diagnosis.
We used a more analytic approach, which makes it easier to determine
how the spectra will vary in an in-vivo setting.
To test the technique on an atherosclerotic plaque, aorta samples from
atherosclerotic rabbits were excised and the diffuse reflectance was measured
using a fiber optic probe. The results are shown in figure 3.6. One can see
that the scattering from plaques are higher than for healthy aorta, probably
due to increased scattering from fibrous cap or lipid droplets in the necrotic
core. Also, for the atherosclerotic sample, at 1210 nm there is a small dip
in the reflectance superimposed on the water absorption at 1190 nm. This
could be due to the lipids in the plaque. The amount of lipid in the plaque
was based on the change in the derivative of the spectra close to the lipid
absorption line at 1200 nm[56].
To explore this further, reflectance measurements on human aorta was
performed and it was shown that it could detect lipids in plaques with quite
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Figure 3.7: Measurement of a piece of adipose tissue taken from a bovine
heart measured through a thin layer of blood, the thickness which is specified
in the legend.
good sensitivity and specificity[56].
In intravascular measurements, the presence of blood might cause a prob-
lem for detection of plaque since blood has a significant absorption in the
NIR range. Figure 3.7 shows the reflectance spectra when a sample of adi-
pose tissue was measured through a layer of blood and how the signal varies
with increasing distance between the probe and the sample. Through 3 mm
of blood the absorption peaks due to lipids could no longer be seen.
Raman spectroscopy
When a photon interacts with a molecule it can be scattered inelastically,
thereby slightly changing its wavelength. This is called Raman scattering.
The wavelength change is highly characteristic of the type of molecule and
depends on the structure of the vibrational bands. The photon can both
loose and gain energy in this process (Stokes and anti-Stokes scattering, re-
spectively). The interaction is very weak so that relatively high intensity
light and efficient light collection methods must be used. Traditional Ra-
man spectroscopy used in material characterization used visible light. In
biological tissue the absorption of visible light is quite strong leading to low
penetration depths, and a lot of background fluorescence, making the Raman
signal harder to detect. Therefore, near-infrared sources were used instead.
Since the Raman signal is so weak, many different statistical methods have
been investigated to extract the signal in an efficient manner[86, 27].
The first studies on arterial tissue used a Nd:Yag laser and found strong
Raman bands that could be attributed to vibrations in amid groups, C-H
groups and phosphate groups[78, 5]. This indicated that the method was
useful for detecting collagen (amid groups), lipids (C-H groups) and calcifi-
42 CHAPTER 3. DETECTION MODALITIES
cations (phosphate groups). Later this was confirmed by quantifying these
components by Raman spectroscopy and comparing the results to chemical
methods, where good agreement was found[12]. In a preliminary test of
the clinical application of Raman spectroscopy, spectra were collected from
excised coronary arteries[80]. A subset of the samples was defined as a train-
ing set that was used to determine component spectra that indicated various
states of disease. They then used these component spectra on the remain-
ing samples and found that Raman spectroscopy served as a good predictor
for non-atherosclerotic vessel, non-calcified and calcified lesions. Buschman
et al. collected Raman spectra from different morphological structures and
found that these could serve as a complete basis set for spectra that were col-
lected from an intact vessel, i.e. the measured spectra could be completely
reconstructed by adding various weights of the component spectra[18]. In-
vivo trials on lamb and sheep found that blood only affected the signal as
an added component and therefore relatively easily could be removed from
the spectra[17]. Human in-vivo studies have recently been performed on
vessels scheduled for endarterectomy and femoral bypass[69]. They found
that vulnerable plaques could be detected with specificity of 84% and sen-
sitivity of 79%. Raman spectroscopy has also been used in the monitoring
of pharmacological treatment of atherosclerotic mice, where it was found
that there was a strong reduction in cholesterol and calcifications within the
artery after treatment of atorvastatin[109, 108].
Fluorescence spectroscopy
When a molecule is irradiated by light the electrons can be excited by the
absorption of a photon. This atom will then emit a photon as it decays
back to the ground state. However, some of the energy is lost to molecular
vibrations before the decay so that the emitted photon has slightly longer
wavelength. This process is called fluorescence.
There are several substances in the arteries that exhibit fluorescence.
The most important are collagen, calcifications, ceroid and carotenoids. The
problem with fluorescence is that all the different components have broad
fluorescence spectra with large overlap, making it difficult to discern the
various components. The fluorescence is also dependent on the chemical
environment of the molecule. One study compared the fluorescence of pure
elements with different features of a plaque[4]. They found that the fluo-
rescence spectra of atherosclerotic plaque was similar to collagen, the lipid
core to oxidized lipoproteins, and normal vessel to collagen.
The earliest works on fluorescence of atherosclerosis were for the auto-
matic guiding of laser ablation techniques[51, 29]. Later, studies of whether
fluorescence can differentiate different types of plaques seem to end up with
the conclusion that they can differentiate between calcified and non-calcified
regions[83, 79, 55]. Recently, it has also been shown that a combination of
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diffuse reflectance spectroscopy and intrinsic fluorescence could detect su-
perficial foam cells in atherosclerotic plaques[3].
A problem with in-vivo fluorescence is the strong absorption of blood.
Just a small amount of blood between the probe and tissue will have a
significant effect on the recorded spectra. One way to overcome this problem
is to measure the blood layer and calibrate for it. One study used IVUS for
measuring the blood layer and found improved diagnostic ability with this
calibration[115].
Another method is to use time resolved fluorescence spectroscopy and dif-
ferentiate the plaques based on varying fluorescent decay time constants[33,
2, 1]. The advantage is that this parameter is not affected by a layer of
blood between the probe and tissue.
3.5.6 Angioscopy
Angioscopy is a method to directly visualize the surface of the lumen. Angio-
scopic catheters usually consist of a fiberoptic bundle attached to a detector
system, where each fiber creates a pixel in the image. This technique is
one of the few where prospective studies have been conducted. It has been
found that plaques with a yellowish color (xanthomatous plaques) are cor-
related with unstable angina and higher risk of developing acute coronary
events[75, 101]. A disadvantage of coronary angioscopy is that the vessels
have to be flushed with phosphate buffered saline during imaging, due to
the strong blood absorption.
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Chapter 4
Conclusions
4.1 Conclusions
Do not fear to be eccentric in opinion, for every opinion now
accepted was once eccentric.
Bertrand Russell, british philosopher and mathemati-
cian.
The technology stands today at a point where it is possible for the clin-
ician to get almost unlimited detail of the tissue in question if he so desires.
From the movement of the myocardium as a whole to individual collagen
fibers in a plaque (about five orders of magnitude different in size). How-
ever, the drawback of more detail, is often higher cost, time expenditure,
and invasiveness.
The question is then: How much detail is needed to find the necessary
clinical information. Many methods now exist for characterizing coronary
plaques and it seems likely that vulnerable plaques can be detected. The
best method for characterizing plaques depends on the exact feature to be
detected and the resources available. More prospective studies are necessary
to determine this.
If treatment of vulnerable plaques is systemic, one might as well look for
plaques in more accessible arteries to assess a more global plaque burden.
This seems likely to give a more cost-effective clinical solution. However, if
local treatment of vulnerable plaques is developed, methods for localizing
them within coronary arteries will become more valuable. Still, detailed
imaging procedures are important for research purposes to determine what
a vulnerable plaque really is.
If the future should bring us local treatment modalities that warrants
individual plaque detection, a likely superior detection modality could be
a combination of ultrasound for rapid size determination, NIR reflection
spectroscopy for rapid lipid-determination, and multiphoton techniques (or
OCT) for cap thickness and structure characterization.
45
46 CHAPTER 4. CONCLUSIONS
Modality Invasive Resolution VP Comments
Systemic
markers
No - Inflammation (?).
Biomarkers for atheroscle-
rotic and non-specific in-
flammation. Detect vulner-
able blood.
EKG No - -
Stress test for subclinical
stenosis. Detect vulnerable
heart.
ECG No - -
Stress test for subclinical
stenosis. Vulnerable heart.
SPECT No 10-15 mm Inflammation
Stress test for subclinical
stenosis. Targeted contrast
agents for plaque compo-
nents.
PET No 4-5 mm Inflammation
Stress test for subclinical
stenosis. Targeted contrast
agents for plaque compo-
nents. Image larger arteries.
MRI No 300 µm
Size, inflammation,
lipids.
Image carotid arteries and
aorta.
CT No 500 µm Size, lipid
Measure stenosis and coro-
nary calcium score. Image
larger arteries
Ultrasono-
graphy
No 200 µm Size, lipid (?).
Image carotid arteries and
aorta.
ABI No - -
Angiography Yes 500µm - Image stenosis.
IVUS Yes 50-100 µm Size, lipid.
Thermography Yes - Inflammation (?) Probably not working.
OCT Yes 10 µm
Fibrous cap, lipid
core, inflammation
(?)
Multiphoton
microscopy
Yes 1 µm Cap thickness and
structure
Optical
spec-
troscopy
Yes - Lipid
NIR, fluorescence and Ra-
man
Table 4.1: An overview of the properties of the detection modalities pre-
sented in this work. The resolution of imaging techniques and the various
features of vulnerable plaques that can be detected. A question mark is
added where the possibility of detecting a feature is uncertain.
Chapter 5
Future work
5.1 Future Work
Fear to be eccentric in opinion, for many opinions once eccentric
are still eccentric.
Magnus Lilledahl, Norwegian poet.
Even though the techniques of spectroscopy and multiphoton microscopy
might be too advanced for plaque detection (since treatments are lacking),
they will be a valuable tool in understanding plaque development that war-
rants further development of the modalities. Furthermore, they show great
promise for locally characterizing tissue. A microscopic tool that can be
used in multiple organs with multiple sensors for characterizing tissue could
be quite useful. This will open up in-vivo information to clinicians that
were once the domain of pathologists. A miniaturized microscope, measur-
ing various optical interactions (SHG, TPEF, CARS,....) could realize a true
optical biopsy that has been promised for so long.
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2. MATERIALS AND METHODS
2.1. Reﬂectance measurements
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2.1.3. Histology
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2.2. Modelling
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2.3. Thermographic measurements
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3. ANALYSIS AND RESULTS
3.1. Reﬂectance measurements
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H<9 @=D=8 7CBH9BH .<9 75@7I@5H=CB =G =@@IGHF5H98 =B !=;  $: H<9 @=D=8 56GCFDH=CB =G GA5@@ H<=G A95GIF9 K=@@ 69
GA5@@ 5B8 =B7F95G9 K=H< =B7F95G=B; 5ACIBH C: @=D=8 =B H<9 D@5EI9
3.1.2. Measurement results
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3.1.3. Modelling
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H<=7?B9GG
3.2. Thermographic measurements
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4. DISCUSSION
4.1. Reﬂection measurements
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 5BCH<9F DCGG=6@9 A95GIF9 C: D@5EI9 =B89L 7CI@8 69
H<9 F997H5B79 @9J9@ .<=G <CK9J9F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@=D=8F=7< D@5EI9 KCI@8 =B7F95G9 H<9 F997H=CB CH< H<9 <=;<9F 7C@@5;9B 7CBH9BH =B H<9 6FCIG 75D 5B8 H<9 @=D=8
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 9; H<9 7CBH57H K=H< H<9 H=GGI9 GIF:579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4.2. Thermographic measurements
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K5G B99898 HC 57<=9J9 H<9 C:H9B F9DCFH98  H9AD9F5HIF9 8=9F9B79 69HK99B <95@H<M 5B8 5H<9FCG7@9FCH=7 J9GG9@
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4.3. Conclusion and future work
5G98 CB H<9 5B5@MG=G =B H<=G D5D9F =H 75B 69 7CB7@I898 H<5H H<9FAC;F5D<M =G BCH 5 ;CC8 A9H<C8 :CF 89H97H=B;
JI@B9F56@9 D@5EI9 )C 7CB7@IG=CBG 56CIH )$,- 75B 69 8F5KB :FCA H<9 F9GI@HG =B H<=G 5FH=7@9 !IHIF9 KCF? B998
HC 7CAD5F9 GD97HF5 K=H< <=GHC@C;=75@ GHI8=9G H<5H 75B 89H9FA=B9 H<9 @=D=8 7CBH9BH =B H<9 D@5EI9 .<9 @=D=8=B89L
DF9G9BH98 =B H<=G D5D9F 75B DFC656@M 69 =ADFCJ98 5B8 H<=G AIGH 69 =BJ9GH=;5H98 :IFH<9F @GC HC 89H9FA=B9 H<9
FC6IGHB9GG C: H<9 A9H<C8 H<9 B5HIF5@ J5F=56=@=HM =B 7CADCG=H=CB 69HK99B JI@B9F56@9 D@5EI9 5B8 <CK H<=G 597H
H<9 A95GIF98 GD97HFIA AIGH 69 GHI8=98
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1. ABSTRACT
When performing intravascular spectroscopy there is always the possibility that there will be a thin layer of
blood between the probe and the vessel wall. This will aﬀect measurements espescially below 600 nm where
blood absorption is strong (important for ﬂuorescence and Raman measurements) and above 1400 nm where the
water absorption is strong. Between these two regions (the theraputic window) the absorption is fairly low and
can be neglected. This article explores the possibility of performing measurements outside the optical window
by minimizing blood layer and increasing the excitation signal.
Keywords: Fluorescence spectroscopy, atherosclerosis, intravascular, blood layer
2. INTRODUCTION
In recent years the paradigm has emerged that it is not the degree of stenosis but rather the composition of the
arterial plaque which determines the risk of an acute coronary event. Plaque which are composed of a thick,
necrotic, lipid-rich core, covered by a thin ﬁbrous cap are typically prone to rupture and are thus denoted as
vulnerable plaques.
Current non-invasive detection modalities (CT, MRI) are mainly eﬀective at determining the geometry of
the plaque, that is, the degree of stenosis, but is limited in determining the actual chemical and physiological
composition. To determine the composition it might be necessary to perform an intravascular measurement of
the plaques. Several optical methods have been proposed for intravascular spectroscopy: near infrared (NIR)
reﬂection spectroscopy, ﬂuorescence spectrosocpy and Raman spectroscopy. This work mainly deals with the
eﬀect of a blood layer on ﬂuorescence spectrosocpy.
Probably the earliest work in the ﬁeld of ﬂuorescence spectroscopy of atherosclerotic plaques was by Blanken-
horn in 1957 which measured the ﬂuorescence of various types of plaques and compared this to the presence of
various chromophores, especially carotenoids.1 Several studies have later conﬁrmed these ﬁndings2–6 Filipidies
used double wavelength excitation of ﬂuorescence to improve the detection of various types of plaque.7 A review
of the ﬁeld was given by Papazouglou in 1995.8
Most of the published studies investigating the possible uses of optical methods in plaque classiﬁcation have
been in-vitro studies except one study performed in rabbit aorta.9 In the ex-vivo studies there have been no
signiﬁcant amount of blood present in the experiments. Since blood could have an interfering eﬀect on the
measurements, eﬀectively as noise and reduction of signal level, conclusions on the feasability of the methods
based on ex-vivo studies might need to be modiﬁed. In the in-vivo study in a rabbit model they were able to
diﬀerentiate between various types of atherosclerotic lesions using both the lifetime and ﬂuorescence intensity
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of the signal.9 They avoided the interference of blood by saline irrigation and clamping of arteries during
measurement.
There are several techniques for removing or correcting for the eﬀect of a blood layer between the probe and
the vessel wall. Flushing the vessel with saline is possible but how eﬀective this removes the blood has to our
knowledge not been investigated. Constant irrigation or blocking of the artery could put too much of a burden
on the heart to be clinically safe. Lin et al. investigated the feasability of optical spectrosocpy in the prescence
of blood.10 Using signal processing methods they improved the detection of the ﬂuorescence signal. Fluorescence
lifetime measurements have also been shown to be independent of an interfering blood layer.11,12
The goal of the present work is to gain an understanding of how a blood layer can adversely aﬀect an optical
measurement which seeks to determine the composition of atherosclerotic plaques. Firstly it is investigated how
variation in the signal due to a varying layer of blood will aﬀect the diﬀerentation of various types of plaque
based on ﬂuorescence spectroscopy. Secondly, it is considered how the temperature rise in a thin layer of blood
will limit the allowed irradiation intensity.
Section 3 gives a description of measurements performed: 3.1 gives a description of ﬂuorescent measurements
on human plaques in the aorta, measured ex-vivo. 3.2 gives a description of measurements performed on a
ﬂuorescent tissue phantom through a layer of blood with various thickness. In 3.4 are some calculations on
theoretically expected values on heat generation in blood due to light absorption and in 3.3 are models on the
signal reduction due to the blood layer.
3. MATERIALS AND METHODS
3.1. Fluorescence measurements of plaque
A section of the thoracic aorta was excised during autopsy from 21 patients. The work was approved by the
Norwegian Board on Ethics in Medicine. The samples were opened longitudinally and ﬂuorescent measurements
were performed on various locations, which from visual inspection appeared to be in various pathological states.
The same samples were used for another study and a more complete description of the samples and their handling
is given there.13
The ﬂuorescence measurements were performed with an optical ﬁber probe. The probe consisted of four 270
µm optical ﬁbers which were inserted in four equally spaced holes, drilled in the tip of an SMA ﬁber connector
(Ocean Optics, Duiven, The Netherlands. Custom design). The distance between the centers of two adjacent
ﬁbers was about 500 µm. Only two adjacent ﬁbers were used, one for the excitation light and one for collection
of ﬂuorescent light. On the other end, each of the ﬁbers were terminated in separate SMA connectors. A blue
LED source at 470 nm (Ocean Optics, LS450), delivering about 10 µW into the ﬁber, was used as the excitation
light and a ﬁber optic spectrometer (SD2000, Ocean Optics) was used to measure the collected light.
The measurement sites were cut out in pieces roughly 4x10 mm. These were again divided in two with one
of the slices being frozen in liquid nitrogen and the other ﬁxated in formalin. The sections were then sliced and
stained for histology, one with Hemotoxylin-Eosin-Safron and the other with Sudan Red. From the histology the
thickness of the lipid pool and the ﬁbrous cap were found and the pathological classiﬁcation were determined.
3.2. Fluorescence measurements of phantom through blood
Small ﬂuorescent tissue phantoms approximately 1 cm thick and 1 cm in diameter were prepared in cylindrical
steel cups using a mixture of agar, intralipid and ﬂuorescein. The agar was made from 3.1 g of agar (Sigma-
Aldrich, agar-agar, A7002) disolved in 210 ml of water. 150 µl of intralipid solution (200 mg/l, Fresenius Kabi,
Uppsala, Sweden) was then added to 10 ml of the agar/water mixture. Various amounts (100-500 µl) of a
ﬂuorescein (ﬂuorescin sodium salt, 67844, Sigma-Aldrich)/water solution (73 mg/l) were then added to 10 ml
of the agar/intralipid mixture. This mixture was then poured into the steel cylinders while still hot and left to
solidify at room temperature covered with plastic ﬁlm to avoid water evaporation.
The same equipment that was used for the measurements of the ﬂuorescence of the aorta was used for the
measurements on the tissue phantoms. The ﬁber optic probe was positioned just at the surface of the sample
with a stand that could be adjusted up and down using a micrometer positioning system. A ﬂuorescent spectrum
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Figure 1. A schematic illustration of the measurement of ﬂuorescence from a tissue phantom through a layer of blood.
was collected, excited by the 470 nm LED. The measurements were performed in a dark room to avoid aﬀects of
stray light. The probe was then lifted without loosing the height reference to the phantom and a plastic ﬁlm was
put on the phantom, assuring that it clung thigthly to the surface. This was done to avoid that blood diﬀused
into the phantom, which it otherwise did quite rapidly. A small amount of blood (red blood cells in Sagman
solution, hematocrit≈40%) was then added on top of this ﬁlm (see Fig. 1). The probe was then lowered towards
the phantom, using the positioning screw, through the layer of blood and the reﬂected spectra were recorded at
various heights. In the end the plastic ﬁlm and blood was removed and another measurement was performed on
the top of the phantom surface.
3.3. Optical models
To model theoretically the reduction in signal due to a thin bloodlayer a simple one dimensional model was used.
The signal reduction is then given by
I(x) = I0 exp
�−(µa,470 + µ�s,470 + µa,518 + µ�s,518)x
�
(1)
470 nm was the excitation wavelength of the LED and 518 nm is the emission maximum of ﬂuorescein. The
absorption coeﬃcient µa was taken as 4.74 mm−1 and 4.02 mm−1 at 470 nm and 518 nm respectively∗ and
the reduced scattering coeﬃcient µ�s as 20 mm−1 as a mean value of various values reported, was used for both
wavelengths.14 The reduced scattering is used since it seems unreasonable to assume that every scattering event
will remove the scattered light from the measured region. The light that is absorbed in the blood layer is given
by,
I0 (1− exp(−µa,470x)) (2)
if one assumes that the light absorbed from the reﬂected light is negligable compared to what is absorbed
from the incident light. This is valid if the thickness of the blood layer is at least two penetration depths,
d = 2δ =
2
µt
=
2
µa,470 + µs,470
≈ 30µm. (3)
∗taken from http://omlc.ogi.edu/spectra/hemoglobin/summary.html
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3.4. Temperature models
Analytical solutions to the heat diﬀusion equation quickly becomes unwieldly for complicated geomtries so
simpliﬁcations are necessary to ﬁnd a managable solution in terms of familiar functions. Another method is
to use numerical methods (FEM analysis), but often the response of the system to changes in variables is less
transparent when using this method.
3.4.1. Model 1
As a ﬁrst approximation one can use a simple model where it is assumed that no heat diﬀuses out from the
irradiated volume during the irradiation (the validity of this will be discussed further down). The temperature
change in the volume of blood irradiated by the light will be,
∆T =
P t
ρcV
(1− exp(−µa,470x)) , (4)
where P is the incident power, t is the time of irradiation and ρ and c the density and speciﬁc heat of the
irradiated volume V.
3.4.2. Model 2
During the absorption process some of the heat will diﬀuse out of the irradiated area, especially through the
probe if it is made of a highly conductive material, e.g. steel. A rule of thumb for the distance d that heat diﬀuses
in a time interval ∆t is d =
√
χ∆t where χ is the diﬀusitivity of the material. Using for steel χst = 1.2 · 10−5
m2/s † and for blood χst = 1.5 · 10−7 m2/s we ﬁnd that the diﬀusion depth during 0.1 s is 1 mm and 0.1 mm
respectively which is signiﬁcant since the volume of the irradiated sample is less than 1 mm3. Hence, a more
complicated model must be considered.
A more sophisticated model incorporating this eﬀect is that of a heat generating sphere embedded in a con-
ductive medium. The heat generation in the sphere represents the light absorbed by the blood. By surrounding
the sphere both by medium with similar properties as blood/tissue and by steel one can ﬁnd bounds on the
possible temperature increase. The solution to this is given in.15
However the solution is so complicated that the advantages of an analytical solution is lost and it is more
advantagous to use the more ﬂexible ﬁnite element method (FEM).
3.4.3. FEM
A FEM structure was anlayzed using FEMLAB (Comsol AB, Stockholm, Sweden). The FEM analysis gives
more information on how the geometry aﬀects the solution as complicated geometries are very diﬃcult to solve
analytically. This consisted of a rectangular region (3x3x0.2 mm) representing the vessel wall, on top of this
a rectangular (3x3x0.5 mm) region representing the blood with a smaller cylindrical region (r = h = 0.5 mm)
embedded in the blood representing the irradiated volume and on top of this a rectangular region (3x3x0.5 mm)
representing the probe. The model is illustrated in ﬁgure 2 The thermal properties that were used in the model
was given in the FEMLAB model library. For the probe, the properties of steel AISI 4340 was used. Blood
was assumed to have the same thermal properties as water. For the tissue the thermal conductivity was set to
κ = 0.4W/m·K, the speciﬁc heat capacity 2000 J/kg·K and 800 kg/m3 for the density.
4. RESULTS
4.1. Fluorescent spectra of plaque
The measurement sites on the aortas were classﬁed into six pathological classes based on the histology: Normal,
fatty streak, ﬁbrous, thin cap ﬁberatheroma, calciﬁed and ruptured.16 Generally atheromas had low ﬂuores-
cence, normal, ﬁbrous, and fatty streak had fairly similar ﬂuorescence, while calciﬁed plaques had the highest
ﬂuorescence.
†from FEMLAB material library
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Figure 2. FEM geometry.
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Figure 3. Reﬂection spectra of a normal area of the vessel wall from two diﬀerent aortas. The A curve is from a 78 year
old male and the B curve from 24 year old male. One can see that there is a large variation in the absorption which will
aﬀect how much of the excitation signal that is absorbed. This can be seen as a redder color on visual inspection of the
aortas.
However, there were large diﬀerences in the general level of ﬂuorescence between various aorta samples. The
general color of the aorta varied. The older the person from which the aorta was taken, generally the aorta had
a more reddish color. This can be seen in the two absorption spectra in ﬁgure 3 which were taken from two
diﬀerent aortas.
In ﬁgure 4 is a typical ﬂuorescence spectrum from a single aorta. The spectra indicate that the diﬀerence in
ﬂuorescence between calciﬁed, ﬁbrous and atheromatous plaques can be diﬀerentiated.
In ﬁgure 5 is a plot of the mean value of the ﬂuorescence at 560 nm for each of the classiﬁcations of plaque
from all the aortas with error bars indicating the standard deviation. The ﬂuorescence level of the calciﬁed
plaques clearly stand out. The trend in the other classes are masked by the large standard deviation.
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Figure 4. A typical ﬂuorescence spectrum for a single aorta sample with various pathological classiﬁcation of the mea-
surement sites.
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Figure 5. Mean values of the ﬂuoresence for the various pathological conditions for all the aorta samples with error bars
indication the standard deviation.
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Figure 6. Same as ﬁgure 5 but here each spectrum from each aorta has been normalized with the value of the spectrum
of normal aorta from the same sample. We can see that the errorbars are smaller and diﬀerentiation between various
pathological states are better. The sample which had calciﬁed plaques did not have a measurement of normal aorta and
is therfore removed from this analysis.
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Figure 7. Same as ﬁgure 6 but here each spectrum has had a random reduction in signal intensity due to a random layer
of blood between 10-100 µm
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Figure 8. Curve B shows the ﬂuorescence level at 560 nm with varying blood layer between the probe and the tissue
phantom, while A shows the corresponding theortical spectra using the model given in section 3.3. Curve C is the original
ﬂuorescence intensity without the blood and plastic ﬁlm while D is the same after removing the plastic ﬁlm and the blood.
4.2. Eﬀect of blood layer
In our measurements, the layer of blood masked any signal from the tissue phantom until the probe was about
100 microns from the aorta. In ﬁgure 8 is a plot of the measurements on the phantom and the theoretical
model described in section 3.3. Except for a shift in position we see that the graphs agree fairly well but that
the measured spectra falls oﬀ as the probe approaches the phantom surface. All the measurements only got up
to about 80-90% of the original ﬂuorescence value when measuring through blood. When the probe was lifted
and the plastic ﬁlm and the blood removed, the orginal ﬂuorescence level was recovered within a few percent.
This reduction in signal level while the blood was present was interpreted as a thin layer of blood between the
probe and the surface even when the probe was pressed against the surface. We can estimate this thickness by
assuming that the reduction in the signal is given by exp(−µ�s + µa). Using the values from section 3.3 we ﬁnd
that the reduction in signal by 10-20% corresponds to a blood layer of 5-10 µm.
4.3. Heat generation in blood
Loss in signal level due to absorption of light in the blood could be compensated by an increase in the power
of the excitation signal or using a longer integration time in the detector. There is, however, a limit to both
methods. The integration time must be less than the heart’s pulse rate as the probe cannot be expected to be
kept steady for longer periods of time. An order of magnitude estimate is 0.1 s. At such small times the blood
can withstand quite high temperature levels but a 40◦C temperature increase is a maximum where cell damage
is instantenous. The probe also needs a certain amount of lateral resolution so in the following calculations it is
assumed that the irradiated area covers 1 mm3.
The power that can be applied is limited by heating of the blood and the surrounding tissue. At 470 nm the
absorption coeﬃcient is 4.7 mm−1. Three times the penetration depth will be 630 µm and at this depth 95% of
the incoming light will be absorbed. If precise positioning of the probe inside a vessel is not possible it must be
assumed that such a high absorption can occur.
Using material parameters indicated in section 3.4.3 gives that the maximum power that can be delivered in
0.1 s is 1 W, given that the 40 degrees is the maximum allowed temperature increase. In ﬁgure 10 is a plot of the
temperature increase as a function of blood layer thickness and the power of the incident light using eq. 4. The
equation actually approaches a constant as x→0 but cannot be expected to be valid when the layer thickness
approaches the size of a red blood cell (∼ 10µm).
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Figure 9. The temperature increase in a blood layer between the probe and the vessel wall using FEM. The probe is
located at 0.7 µm and the vessel wall at 0.2µm. The power irradiated on the area was 1 W during 0.1 s. The irradiated
area was a circle with radius 0.5µm.
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Figure 10. Temperature in blood layer as a function of incident power and thickness of the blood layer.
These models slightly underestimate the allowed power as some heat will diﬀuse away from the irradiated
volume. Using the FEM model described in section 3.4.3 and using a 1 W source and a 500 µm layer between
the probe and detector and 0.1 s irradiation gave a maximum temperature increase of 43◦C indicating that the
eﬀect of heat being diﬀused away from the irradiated area is not important for these values.
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5. DISCUSSION
5.1. Eﬀect of blood layer on ﬂuorescence measurements
Fluorescence spectra can without the prescence of blood diﬀerentiate between various types of plaques based on
the level of ﬂuorescence. However, it was found that at thin blood layer will form between the probe and the
vessel wall that is about 10-20 microns thick. In addition the vessel wall is not completly ﬂat, especially in the
presence of plaques so that even larger ﬁlms of blood must be expected. If the ﬁlm can vary up to 150 microns
the signal variation due to the blood layer will be much larger than the expected variation in the ﬂuorescence
spectra. Washing the artery with saline could be possible but is stressfull for the organs and might be clinically
undesirable. Especially when large parts of the coronary tree is to be mapped constant ﬂushing might be too
stressfull for this to be used as a screening method.
Some works have proposed variations in ﬂuorescence lifetimes as a detection modality for plaque to avoid the
interference of the blood but here signal and heating issues could be important.9,11,12 As shown, about 1 W
is the limit on the power that can be used to irradiate to vessel wall to avoid serious damage to the blood. A
security margin should probably be incorporated into this number. The temperature issue is dependent on the
excitation wavelength used but 470 nm is close to the minimum in blood absorption in the wavelength region
where autoﬂuorescence can be excited. If the temperature issue turns out to be a problem, perhaps some cooling
method of the blood layer could be incorporated.
6. CONCLUSION
To conclude ﬂuorescence measurements of aorta are not feasable unless an eﬀective ﬂushing method that is clin-
ically safe can be incorporated in the method. If this is possible ﬂuorescence spectra can diﬀerentiate atheroscle-
rotic plaques and calciﬁed plaques from other pathological or normal states of the vessel wall. Without ﬂushing
heating of the blood is an issue when increasing the power of the excitation signal to achieve enough power on
the detector due to the strong scattering and absorption of blood.
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Abstract. Heart disease is the primary cause of death in the western
world. Many of these deaths are caused by the rupture of vulnerable
plaque. Vulnerable plaques are characterized by a large lipid core
covered by a thin ﬁbrous cap. One method for detecting these
plaques is reﬂection spectroscopy. Several studies have investigated
this method using statistical methods. A more analytic and quantita-
tive study might yield more insight into the sensitivity of this detection
modality. This is the approach taken in this work. Reﬂectance spectra
in the spectral region from 400 to 1700 nm are collected from 77
measurement points from 23 human aortas. A measure of lipid con-
tent in a plaque based on reﬂection spectra is presented. The measure
of lipid content is compared with the thickness of the lipid core, de-
termined from histology. Deﬁning vulnerable plaque as having a lipid
core 500 m and ﬁbrous cap 500 m, vulnerable plaques are
detected with a sensitivity of 88% and a speciﬁcity of 94%. Although
the method can detect lipid content, it is not very sensitive to the
thickness of the ﬁbrous cap. Another detection modality is necessary
to detect this feature. © 2006 Society of Photo-Optical Instrumentation Engineers.
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1 Introduction
Atherosclerotic plaques can be dangerous in two ways. First,
the degree of stenosis can be severe enough to obstruct blood
ﬂow, thereby causing hypoxia in the tissue distal to the ob-
struction. Second, a plaque can rupture, exposing the blood
stream to thrombogenic material that can induce the formation
of a thrombus and sudden occlusion of the vessel. The latter is
more dangerous because it is usually nonsymptomatic before
rupture, and currently there exists no detection modality in
clinical use that can detect these plaques. Plaques that are
prone to rupture are denoted as vulnerable plaques. They are
characterized by a large lipid core covered by a thin ﬁbrous
cap. Felton et al. reported the average lipid composition of the
plaque as 25% free cholesterol, 52% cholesterol esters, 14%
phospholipids, and 9% triglycerides.1 Blankenhorn et al. have
shown that the concentration of carotenoids mainly beta-
carotene is larger in lipid-rich plaque than in a normal aorta.2
Vulnerable plaques also have a thin ﬁbrous cap, leaving them
mechanically unstable. Virmani et al. give a value for the lipid
core as less than 65 m for a plaque to be denoted
vulnerable.3 Prediman reports a cap thickness of less than
40% of total plaque size as a marker for vulnerability.4 This
work investigates the use of reﬂection spectroscopy for de-
tecting the lipid core, and whether it is possible to quantify the
thickness of the lipid core and ﬁbrous cap.
Many other methods have been proposed for the detection
of vulnerable plaques, e.g., ﬂuorescence spectroscopy, Raman
spectroscopy, elastography, thermography, and intravascular
ultrasound IVUS. Methods that are in clinical use today for
detecting plaque angiography, IVUS cannot differentiate be-
tween vulnerable and stable plaques.
Existing studies on the applicability of reﬂection spectros-
copy for detecting plaque can roughly be separated in two
groups. It has been shown that near-infrared reﬂection spec-
troscopy NIRS correlates with measurements of the chemi-
cal composition of the plaque.5 It has also been shown that
NIRS can differentiate between vulnerable and stable plaques,
as determined from histology with good sensitivity and
speciﬁcity.6–8 This has been shown using statistical methods
like principle component analysis PCA6,7 and cluster
analysis.8
In this work, a more analytic approach is taken. The region
where a change in the reﬂection spectrum is expected is de-
termined from the absorption spectra of the known constitu-
ents of plaque. It is determined if the change in spectral fea-
tures can quantitatively be correlated with lipid content in the
plaques. The major chromophores in the near-infrared NIR
region are water, lipid, and cholesterol. The absorption spectra
of these substances are shown in Fig. 1.9 Fat has three absorp-
tion peaks in the NIR region at approximately 930, 1200, and
1390 nm. The ﬁrst two bands corresponds to the third and
second overtone of the C-H stretching vibration. The third
band is a combination of stretching and deformation vibra-
tions of the C-H bond.10 Wang et al. reported absorption
peaks at 1210, 1720, and 2304 nm.8
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In the visible region, the most signiﬁcant change in the
spectrum for lipid-rich plaques is probably due to a higher
concentration of carotenoids mainly beta-carotene.2 Figure 2
shows the absorption spectrum of beta-carotene.11 Based on
the knowledge of this spectrum, regions where there is a
change in the reﬂectance spectrum due to lipid content in the
plaque has been identiﬁed. A simple measure of lipid content
in the plaque based on this information is proposed.
2 Materials and Methods
2.1 Materials
A section of the thoracic aorta from 23 patients 14 men and 9
women were excised during autopsy. No special rules were
employed in selecting the patients that were included in the
study. Age of patients at death were 56±21 years. In the time
between autopsy and measurements 2 h, the sample was
kept in phosphate buffered saline PBS at room temperature.
The section of the aorta was opened longitudinally and placed
on a piece of black cardboard with the lumen side facing up.
For two of the samples, measurements were also collected
with white copy paper as the bottom layer, but no systematic
difference in the reﬂectance was detected. Between one and
seven measurement points were selected from each sample,
depending on the prevalence of atherosclerotic plaque. The
selection was performed by visual inspection. One measure-
ment point was chosen from a region that looked normal and
the remaining points from areas that looked like plaque. The
entire measurement series took about 2 h for each sample.
During measurements, the samples were kept hydrated by
dripping PBS on the samples with a pipette. Just before plac-
ing a probe on the sample, the surface was lightly dried with
paper tissue.
2.2 Methods: Reﬂection Measurements
Reﬂection spectra in the wavelength range 400 to 1700 nm
were acquired for each measurement point using two different
spectrometers Ocean Optics SD2000, double channel; and
Ocean Optics NIR512, Ocean Optics, Duiven, The Nether-
lands. The SD2000 spectrometer is sensitive in the region
from 400 to 1100 nm, and the NIR512 spectrometer from 900
to 1700 nm. Three different probes were used in the measure-
ments: 1. an integrating sphere Ocean Optics, ISP-REF, 2. a
ﬁber reﬂection probe Ocean Optics, VIS-NIR with seven
excitation ﬁbers placed in a circular fashion around a central
collection ﬁber hereby denoted “circular probe”, and 3. a
ﬁber reﬂection probe Ocean Optics, custom design with four
ﬁbers placed in a linear array hereby denoted “linear probe”.
For the linear probe, the ﬁber furthest to the side was used as
the excitation ﬁber, and the three other ﬁbers could act inde-
pendently as collection ﬁbers. For a schematic drawing and
dimensions of the ﬁber probes, see Fig. 3. All the probes were
connected to the spectrometers via ﬁber connections.
The integrating sphere was hand-held during measure-
ments while the ﬁber probes were positioned using a mi-
crometer positioning stand and kept just in contact with the
tissue during measurements. The contact point was deter-
mined by visual inspection. The sample was not ﬁxed to the
stand, so the placement of different probes at the same point
was done visually. The error of the lateral position was esti-
mated to be less than 2 mm.
Spectra were recorded as percent reﬂection relative to a
reﬂection standard SRS-99-010, LabSphere, North Sutton,
United Kingdom. The integrating sphere was placed in direct
contact with the standard for the reference measurements. For
Fig. 1 Absorption spectra of the most important absorbers in the NIR
spectral region.9
Fig. 2 Molar extinction coefﬁcient of beta-carotene.11
Fig. 3 A schematic view of the tip of the two ﬁber probes used in the
experiment. The white circles represent excitation ﬁbers and the gray
represent collection ﬁbers.
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the circular and linear probes, the tip of the probe was posi-
tioned 15 mm from the surface of the reﬂectance standard.
The reﬂectance standard has a very high scattering coefﬁcient,
so the penetration depth is very small. If the ﬁber probes are
put on the surface, very few photons will reach a ﬁber that is
separated from the excitation ﬁber by more than one penetra-
tion depth. This effect might be wavelength dependent, and
this is the reason that the ﬁbers were positioned away from
the surface of the reﬂectance standard. The reﬂectance values
for the probes are thus not relative to 100% reﬂectance, but
relative to a spectrally ﬂat standard of unknown absolute re-
ﬂectance. A black-painted copper cylinder was placed around
the probe to shield from ambient lighting. The same black
cylinders were used during measurements to shield from the
ambient lighting, but the probes were then in contact with the
tissue. The procedure is illustrated in Fig. 4.
2.3 Methods: Histology
The samples were prepared for histology immediately after
the spectroscopic measurements. A rectangle 104 mm
was cut out around the measurement point with a scalpel and
divided along the long center line. One part was ﬁxed in 10%
buffered formalin and embedded in parafﬁn, while the other
was frozen in liquid nitrogen. The samples were then sliced
and stained. The formalin sample was stained with
hematoxylin-eosin-saffron HES and the frozen sections with
Sudan3. The sections were then photographed through a mi-
croscope at three different magniﬁcations 2, 10, and 20.
To be able to quantify the size of histological sections, a mi-
croscopic measurement stick was also photographed at the
various magniﬁcations. The size of the histological features
total plaque, lipid core, and cap thickness was measured by
manually comparing prints of the sample and the measure-
ment stick, at the same magniﬁcation, using a ruler.
3 Analysis
3.1 Spectral Analysis
The ﬁrst derivative of the NIR spectra was computed using
the method of Savitzky and Golay using the software package
Matlab Mathworks, Natick, MA.12 The lipid peak around
1200 nm causes a local minimum in the spectrum that is su-
perpositioned on the reﬂectance minimum due to the water
absorption see Fig. 5. The derivatives of these spectra are
shown in Fig. 6. For the normal vessel, the derivative in-
creases monotonically i.e., a decrease in the negative slope of
the reﬂectance spectra, while for the lipid-rich plaque, the
derivative starts to decrease around 1168 nm due to the su-
perpositioning of the lipid absorption band over the water
absorption band. The difference between the peak and the
valley of this spectrum is assigned as the lipid index denoted
Cl. This is illustrated in Fig. 6.
Fig. 4 A schematic view of the reference measurement used for the
ﬁber probes. For the reference measurement left, the ﬁber probes
were positioned 1.5 cm away from the standard but were in contact
with the tissue during reﬂection measurements right.
Fig. 5 Example reﬂectance spectra from the NIR region. For the lipid-
rich plaque solid line, there is an additional local minimum around
1200 nm that is superimposed on the broader minimum due to water
absorption.
Fig. 6 Illustration of the lipid index Cl=dR /d=1168−dR /d=1178.
The ﬁgure shows the derivative of the spectra in Fig. 5. For the normal
artery dashed line, the derivative increases monotonically, whereas
for the lipid-rich, there is a local minima due to the superimposed
lipid absorption. Cl0 when a certain amount of lipid is present in
the sampling region of the probe.
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Cl = dRd=1168 − dRd=1178. 1
In the visible region, the lipid-index Cl was taken as the
difference between the reﬂection at 560 nm where there is
little beta-carotene absorption but substantial blood absorp-
tion and the reﬂection at 450 nm the absorption peak of
beta-carotene, divided by the reﬂection at 700 nm. At
700 nm, the absorption of both beta-carotene and blood is
relatively small. Dividing by this value accounts for the over-
all reﬂectance level of the spectrum due to scattering proper-
ties.
Cl =
R560 − R450
R700
. 2
3.2 Histological Analysis
A picture was taken of a microscopic measuring stick for each
magniﬁcation so that absolute lengths could be determined in
the histological photographs. From these photographs, the
thickness of the total plaque, the ﬁbrous cap, and the lipid
core were determined. The total plaque thickness was deter-
mined from the HES stained sections as the distance from the
media deﬁned as the presence of red colored elastin ﬁbers to
the endothelium Fig. 7. The core thickness was determined
from the Sudan Red stained sections as the thickness of the
area where red stained lipid droplets were present. The ﬁbrous
cap thickness was deﬁned as the distance from the inner lining
of the vessel to the start of the lipid core Fig. 8.
4 Results
Figures 9 and 10 contain typical reﬂectance data from an ar-
tery for the NIR and visible spectral region. The correspond-
ing aorta sample is shown in Fig. 11. The only change in the
NIR reﬂectance spectra where there is known lipid absorption
was at a point around 1200 nm. In the visible region, there
seemed to be an increased absorption from 450 to 500 nm for
lipid-rich plaques.
The spectral analysis, deﬁned in Sec. 3.1 was then com-
pared with the histological studies. In Figs. 12–15, plots of Cl
and Cl are plotted against the lipid core thickness. In these
plots, plaques with a lipid core greater than 500 m or a
ﬁbrous cap less than 500 m are deﬁned as vulnerable. For
measurements in the NIR, a line has been drawn at Cl=0 as a
possible demarcation between a lipid-index, indicating a
stable or vulnerable plaque. For the visible region Fig. 15,
the demarcation line was arbitrarily put at 0.25, which seemed
to yield the best results. Only data for the circular probe are
presented for the visual region. Using these deﬁnitions, the
sensitivities and speciﬁcities for the various measurements
were calculated. The results are tabulated in Table 1.
5 Discussion
Water is an important absorber in the NIR region. Even
though the samples were put in PBS, which has the same
osmotic pressure as tissue, there might be some absorption of
water into the tissue, which can cause swelling. This might
change the optical properties of the tissue. However, the en-
dothelium of the aorta is constantly exposed to the liquid en-
vironment of the blood stream, so it seems likely that the
sample should be somewhat resistant to this effect. On the
other hand, since the combined measurements took up to 2 h,
there might be some dehydration during the experiment, even
if PBS was often dripped onto the sample. This swelling or
dehydration effect whichever is stronger might affect the
reﬂectance spectra on which the calculation of Cl is based.
The thickness of the vessel wall was different as deter-
mined from the formalin ﬁxed sections compared to the fro-
zen sections. Size artifacts are known problems in histology.13
The measurement of the lipid core thickness might therefore
have an inherent systematic error. The precision of the size
measurements was estimated to be about 50 m. This was
calculated as the average size difference of the same structure,
measured in the frozen and in the formalin ﬁxed sections. This
gives no estimate on how well the measurements compare to
the original size of the plaque, as there might be other sys-
tematic errors linked to the ﬁxation process.
From Fig. 10, it seems like the difference in the spectra
between a normal vessel and a lipid containing plaque is
stronger in the visible region than in the near-infrared region.
However, Fig. 15 shows that the correlation with lipid content
is poorer. This is most likely due to the large blood absorption
that overlaps the absorption spectra of beta-carotene. Small
differences in the vasculature of the vessel can have large
implications on the measured spectra. This can be seen in Fig.
Fig. 7 Deﬁnition of plaque thickness. Fig. 8 Deﬁnition of lipid core thickness and ﬁbrous cap thickness.
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16, where two reﬂection spectra of normal aorta from a 24
and a 78 year old male are shown. In general, the older the
person was from which the aorta was taken, the redder the
vessel appeared. This variation had a stronger effect on the
spectra the deeper the penetration depth of the probe was. No
trends could therefore be seen for the integrating sphere and
the linear probe, and they have hence not been included. Also,
the large blood absorption for wavelengths below 700 nm
makes it difﬁcult to perform measurements through even a
thin ﬁlm of blood, making it uncertain if a measurement is
feasible. Some form of ﬂushing of the artery is most likely
needed. Since carotenoids are preferentially absorbed in lipid-
rich plaque, it might be possible to attach some ﬂuorescent
molecule or stronger chromophore to a carotenoid or other
lipophilic molecule to increase the contrast between stable
and vulnerable plaque. The preferential uptake of endogenous
beta-carotene in plaque has been demonstrated by Prince,
Glenn, and MacNichol.14
The absorbance values in Fig. 1 are measured in pure
form. The absorbance peaks will change slightly due to the
chemical environment, so these spectra cannot be taken ex-
actly as the absorbance values that are expected from the tis-
sue. Neither are the many types of lipids in the plaque the
same as those used in the absorbtion measurements.1 The ab-
sorbance spectra should only be regarded as indications of
where variations in the reﬂectance spectra can be expected.
A histological section of a vulnerable plaque can be seen in
Fig. 7. It is apparent that the thickness of the ﬁbrous cap
Fig. 9 Reﬂectance spectra in the NIR region corresponding to the measurement points in Fig. 11.
Fig. 10 Reﬂectance spectra in the visible spectral region correspond-
ing to the measurement points in Fig. 11.
Fig. 11 Aorta sample. The circles show measurement points and the
numbers correspond to the reﬂectance spectra in Figs. 10 and 9. The
sample is approximately 15 cm long.
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varies over the extent of the plaque. Any clinical implemen-
tation of this method will need to have a lateral resolution less
than 1 mm, or vulnerable plaques might be incorrectly char-
acterized as stable even though they have a very thin cap on
the edge, where the mechanical forces are strongest.
The spectroscopic measurements are to a certain degree
sensitive to the thickness of the cap, as can be seen in Figs. 12
through 15. Even though a plaque has a large lipid core, it
gives a low value of Cl, since it is covered by a thick ﬁbrous
cap. However, in the literature a plaque with cap thickness
less than 65 m is deﬁned as a vulnerable plaque, and this is
not detectable with the current instrumentation.3 The deﬁni-
tion used in this work is partially based on the discrimination
that could be expected, given the geometry of the probes that
were used, and partially warranted by the deﬁnition given in
one of the references.4 If the minimum cap thickness of
65 m had been used, many points in the upper right quad-
rant of Figs. 12 through 15 would be considered stable instead
of vulnerable. If plaques with lipid cores less than 500 m
had been considered vulnerable if the cap was thin enough,
many points in the lower left quadrant of Figs. 12 through 15
would be vulnerable instead of stable. The deﬁnition used was
chosen to show that the method detects the presence of lipid
and is also partially sensitive to the thickness, but that prob-
ably an additional method with high resolution is needed to
measure the cap, e.g., optical coherence tomography, confocal
microscopy, or multiphoton microscopy. An array of very
small ﬁbers 10 m with very small ﬁber separation could
also achieve this. There are also lipid absorption peaks higher
up in the infrared spectrum where the penetration depth is
small due to the high water absorption. Using several wave-
lengths with different penetration depths, it could be possible
to calculate approximately at what depth the lipid core is. A
tomographic method that can also detect the lumen surface is
probably best, since the precise positioning of a probe inside a
coronary artery is difﬁcult. A sensor using reﬂection spectros-
copy could be used to scan the artery. If the presence of lipid
Fig. 15 Lipid index Cl for the visible region versus thickness of the
lipid core, measured with the circular ﬁber probe.
Fig. 12 Lipid index Cl versus thickness of lipid core, measured with
the circular ﬁber probe.
Fig. 13 Lipid index Cl versus thickness of lipid core, measured with
the linear ﬁber probe, using the ﬁber nearest to the excitation ﬁber as
the collection ﬁber. Using the other ﬁbers as collection ﬁbers gave
poorer correlation with the thickness of the lipid core.
Fig. 14 Lipid index Cl versus thickness of lipid core, measured with
the integrating sphere.
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is detected, a high resolution method could be used to make
an accurate measurement of the cap thickness.
The aorta is about a factor of 5 larger than the coronary
arteries. It must be determined if the method is still sensitive
when all sizes are scaled down. Light will penetrate deeper
into vessel structures, so a method that only collects light
scattered from the plaque will be important.
6 Conclusion
It is shown that NIRS can detect the presence of lipid in
plaque in the aorta with good sensitivity. It cannot, however,
determine accurately the thickness of the cap. Some other
high resolution tomographic method would probably have to
be used to determine this. Reﬂection spectra in the visible
region seem to be able to provide some information about
lipid content, but yield poorer correlation than the NIR spec-
tral region. Lateral resolution of at least 1 mm is necessary, as
the cap thickness can vary throughout the plaque area.
7 Future Studies
It remains to be determined if this detection modality is still
possible through a varying layer of blood, or if it is necessary
in some way to press the sensor against the vessel wall. The
additional imaging modality that needs to be added must also
be determined from viewpoints of resolution, contrast, size,
and complexity. It must be determined if the methods are also
sensitive in the smaller coronary arteries.
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Table 1 Sensitivities and speciﬁcities of the various measurements.
Circular
probe
NIR
Linear
probe
NIR
Integrating
sphere
NIR
Circular
probe
VIS
Sensitivity 88% 88% 44% 83%
Speciﬁcity 94% 81% 91% 79%
Lilledahl et al.: Reﬂection spectroscopy of atherosclerotic plaque
Journal of Biomedical Optics March/April 2006  Vol. 112021005-7

Paper IV
An analytic and numerical study of intravas-
cular thermography of vulnerable plaque
Magnus B. Lilledahl, Eivind L. P. Larsen and Lars O.
Svaasand. Physics in medicine and biology. In press.
To be published january 2007.

INSTITUTE OF PHYSICS PUBLISHING PHYSICS IN MEDICINE AND BIOLOGY
Phys. Med. Biol. 52 (2007) 961–979 doi:10.1088/0031-9155/52/4/007
An analytic and numerical study of intravascular
thermography of vulnerable plaque
M B Lilledahl, E L P Larsen and L O Svaasand
Norwegian University of Science and Technology, 7018 Trondheim, Norway
E-mail: lilledahl@iet.ntnu.no
Received 30 August 2006, in final form 12 December 2006
Published 24 January 2007
Online at stacks.iop.org/PMB/52/961
Abstract
Intravascular thermography has been proposed as a method for detecting
vulnerable plaque. A marker of vulnerability in a plaque is inflammation,
which is believed to reduce its mechanical stability. It has been hypothesized
that this inflammation leads to a higher metabolic rate and therefore higher heat
generation, causing increased temperature in the vicinity of the plaque. This
temperature increase could be measured intravascularly using a temperature
sensor, e.g., a thermistor or a thermocouple. The aim of this study is to present
a thorough mathematical and physical analysis of the thermal distribution that
can be expected in the plaque under various physiological conditions. To
get reasonable predictions on the expected temperature distributions, idealized
models with simple geometries are solved analytically. More realistic models,
with more complex geometries, are solved numerically using the finite element
method (FEM). Based on this analysis, the maximum temperature increase that
can be expected in a plaque due to increased metabolism is less than 0.1 K.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Cardiovascular disease is the most prevalent cause of death in the US and most of these deaths
are due to myocardial infarction (Thom et al 2006). These are usually caused by an occlusive
thrombosis in the coronary arteries, induced by the rupture or erosion of so-called vulnerable
atherosclerotic plaques (Davies and Thomas 1985).
Vulnerable plaques have several characteristic properties that are relevant for their
detection: a large lipid core covered by a thin fibrous cap and inflammation marked by
the presence of macrophages (Felton et al 1997). Inflammation decreases plaque stability by
the release of metalloproteinases which degrade the fibrous cap. It is hypothesized that this
inflammation increases the temperature at the plaque surface (Casscells et al 1996). Detecting
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inflamed plaques could yield important clinical information about which plaques are likely to
develop quickly and cause a coronary thrombosis.
The use of temperature measurements for detecting plaques was first proposed by Casscells
et al (1996). They investigated the temperature variation on the surface of carotid plaques,
excised during endarterectomy. The surface temperature was measured with a thermistor. They
measured temperature differences up to 2.2 K on the surface. In one instance, temperature
differences of 0.6 K were measured at two sites only 1 mm apart. It was shown that temperature
difference correlated positively with cell density in the plaque and negatively with the cap
thickness. These measurements were conducted at room temperature. Larger temperature
differences (0–5 K) were reported on measurements performed in an incubator at 37 ◦C, but
no further details were provided. Temperature was also measured with an infrared camera,
but no results were presented.
Several in vivo measurements have shown temperature heterogeneity in coronary arteries.
For a review of experimental results of thermography, see Madjid et al (2006). Some of
these have correlated temperature heterogeneity with the type of coronary disease (Stefanadis
et al 1999) and shown that it serves as a predictor for clinical outcome (Stefanadis 2001,
Schmermund et al 2003). Temperature heterogeneity has also been correlated with biomarkers,
e.g., C-reactive protein (Stefanadis et al 2000). A recent study by Rzeszutko et al (2006) found
that the maximal temperature difference between blood and vessel wall was found in the culprit
segment in 57.5% of the patients examined.
Two FEM studies on temperature distribution due to an atherosclerotic plaque have been
published (ten Have et al 2004, 2005). In the first study they investigated the effect of plaque
geometry and of blood flow on the measured temperature. The heat generation they used in
the plaques ranged from 0.1×109 W m−3 to 0.4×109 W m−3. These values were determined
by requiring that the resulting temperatures fit published experimental values. Perfusion of the
surrounding tissue was not included in their modelling of the temperature distribution. The
second study investigated how the probe geometry and sensor material affect the temperature
measurements.
There is a large discrepancy amongst the measured values published in the literature. The
aim of this study is to present a thorough mathematical and physical analysis of the thermal
distribution that can be expected in plaques under various conditions. This framework can then
be used to analyse experimental results. Since the published values vary so much, estimates of
metabolic rates are derived by indirect consideration instead of requiring a fit to experimental
values. Analytical models were investigated for geometries that are simple enough to be
solved analytically. This gives reasonable predictions on the temperature variations that
can be expected and physical insight into how various parameters affect the measurements.
Numerical calculations of more realistic models were computed with the finite element method
(FEM)
2. Physics
2.1. Physical model
The temperature distribution in the vessel wall is calculated assuming that the heat generated
in the tissue is transported by conduction, convection by the flowing blood in the lumen,
and perfusion in the surrounding tissue. The perfusion is modelled by the so-called bioheat
equation:
κ∇2T − ρtct ∂T
∂t
= −q + ρbcbω(T − T0). (1)
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This equation was first presented by Pennes (1948) and has been further analysed in
many works, e.g., Chen and Holmes (1980). The assumption in this equation is that constant
tissue temperature is maintained by the colder arterial blood removing heat from the tissue
when passing through the capillary network. The heat generated in the body’s core must be
transported to the lungs and skin via the blood. If the heat transport was via conduction alone,
very high temperatures would result in the centre of the body. For the blood to transport heat
away from the tissue, the temperature in the arterial network must necessarily be lower than the
venous network (this is not valid in the skin where the heat is dissipated and the blood is cooler
on the venous side). The last term in (1) models the removal of the heat due to perfusion. ω
is the volume of perfused blood per volume of tissue per unit time (see appendix A). T is the
temperature of the tissue, and T0 is the temperature of the arterial blood. q represents the heat
per unit volume per unit time (Q will be used for the total heat generated in a volume per unit
time). ρt and ρb are the densities of tissue and blood respectively, ct and cb are the specific
heats of tissue and blood respectively. κ is the thermal conductivity of tissue.
The total heat distribution in a system is the result of all the heat sources in the system.
We will assume that the temperature in the system can be divided into the temperature T1 due
to the heat generation from the plaque q, and T2 due to the heat qs generated by the rest of the
system. We thus write equation (1) as
κ∇2(T1 + T2) − ρtct ∂(T1 + T2)
∂t
= −(qs + q) + ρbcbω(T1 + T2 − T0). (2)
This equation can be divided into two separate equations:
κ∇2T1 − ρtct ∂T1
∂t
= −q + ρbcbω(T1) (3)
and
κ∇2T2 − ρtct ∂T2
∂t
= −qs + ρbcbω(T2 − T0). (4)
By adding these two equations, the solution for the total temperature distribution results.
Only (3) will be solved since T1 represents the deviation from normal temperature due to
the heat generation in the plaque, and this is the desired quantity. From now on T1 will be
referred to as T. The thermal gradients from (4) due to normal metabolism qs are relevant in
the measurement process. This is discussed in section 6.3. For a steady state, (3) becomes
∇2T = −q − PT
κ
. (5)
Here PT = cbρbωT is the amount of heat removed per unit volume and time due to
perfusion of the tissue. (5) is the equation solved in the analytic models. Radiation has been
proposed as a thermal transport mechanism but can have no significant effect in this system.
This is discussed in appendix B.
In the numerical models the convection by the blood flowing in the lumen is included.
For the blood it is assumed that the heat is transported by convection and conduction so that
the equation to be solved is
κb∇2T − ρbcb ∂T
∂t
= ρbcbvb · ∇T , (6)
where the last term represents the heat transport due to convection and vb is the velocity of the
blood.
To determine the velocity profile of the blood stream, the steady-state Navier–Stokes
equation for an incompressible fluid,
ρb(v · ∇)v = −∇p + η∇2v, (7)
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Table 1. Thermal properties used in the models. Diffusivity χ = κ
ρcp
. For a definition of the
perfusion parameters, see appendix A.
Specific Thermal Perfusion
Density heat cp conductivity Diffusivity χ Perfusion F factor
Material ρ (kg m−3)a (×103 J kg−1 K−1)b κ (W m−1 K−1)c (× 10−7 m2 s−1) (ml min−1 g−1)d P (W K−1 m−3)
Blood 1055 3.66 0.505 1.30 – –
Intima 1010 3.72 0.476 1.27 – –
Plaque 1010 3.72 0.484 1.25 – –
Media 1040 3.72 0.476 1.23 – –
Muscle – – 0.460 – 0.02 3.3 × 103
Fat 920 2.3 0.210 0.99 0.001 0.16 × 103
a Gandhi et al (1996).
b ten Have et al (2006).
c Dumas and Barozzi (1984), Valvano and Chitsabesan (1987) and Cohen (1977).
d Svaasand (1982).
was solved, where p is the pressure and η the dynamic viscosity. Blood is not a Newtonian
fluid (which is required for the validity of the Navier–Stokes equation, even though there are
ways to incorporate a non-Newtonian fluid), but we assume it is Newtonian for the velocities
and diameters in question.
2.2. Thermal and fluidic properties
The average fluid velocity (averaged in both space and time) is about 0.3 m s−1 in medium-
sized arteries (Marsden 1998). The velocity is dependent on pressure gradients, so 120/80
blood pressure will result in a variation in the velocity of the blood between systole and diastole
of about 30%. The numerical simulations were performed with a parabolic input velocity with
0.3 m s−1 average velocity except for the simulations in section 5.2.4, where the blood flow
was varied from 0 to 5 m s−1.
The dynamic viscosity of blood ranges from 1.5 × 10−3 to 4 × 10−3 Pa s for hematocrits
from 20 to 65% (not linearly) (Burton 2000). We used a value of 2.5 × 10−3 Pa s in all the
simulations. This corresponds to a hematocrit of 45%, which is in the normal range for adults.
The thermal properties of various tissue types are summarized in table 1. No perfusion
values were found for the media or adventitia, so values from skeletal muscle and fatty tissue
were used as upper and lower limits. As the perfusion in the myocardium is higher than in
skeletal muscle, the perfusion around the coronary arteries might be even higher (Svaasand
1982).
2.3. Heat generation
Several mechanisms for increased heat generation in plaques have been proposed (ten Have
et al 2005). These are higher metabolism of inflammatory cells, presence of uncoupling
proteins, lipid endocytosis and matrix metalloproteinase degrading the extracellular matrix.
Another proposed source of increased heat generation is the uncoupling protein thermogenin
(Diamantopoulos 2003, ten Have et al 2005), as this protein causes the energy that would
be converted to mechanical energy to be released as thermal heat instead. However, no
quantitative value of the metabolism in plaque exists for use in the models. Therefore, an
order of magnitude estimate of the likely temperature increase was derived from the following
considerations.
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The basal metabolic rate for a 70 kg man ranges from 5000–9000 kJ/day (Burton 2000).
This is equivalent to 58–104 W. Assuming that the density of a man is about 800 kg m−3 and
70% of the weight is living tissue gives a heat generation per volume of 663–1189 W m−3.
Under strong exercise there can be up to a 20-fold increase in the metabolism (Tortora and
Grabowski 2003), giving a maximal heat generation of about 2 × 104 W m−3.
In a study of alveolar macrophages the metabolism of a single cell was found to be
20 pW/cell (Thoren et al 1990). Assuming a tissue dense with macrophages of average size
103 µm3 gives a heat generation of 2 × 104 W m−3 (Lilledahl et al 2005).
In the work of Casscells et al (1996), thin samples excised during endarterectomy were
taken out and placed on a table in room temperature. Since the samples were thin (thickness
not specified in paper) most of the heat will be lost to the air and the table and not so much
along the tissue. The conductivity of air is 0.025 W K−1 m−1. Modelling the plaque as
a sphere with radius a = 2 mm completely surrounded by air and assuming a temperature
difference of 1 K at the surface, (9) yields a heat generation of 18 750 W m−3. Because
few experimental details were disclosed in the paper, this simplistic model is uncertain. The
calculation should be considered in the sense that the results of Casscells could be explained
by the heat generation we have used, rather than as an argument for a likely in-vivo value.
Bjørnheden and Bondjers (1987) found that for early lesions the oxygen consumption
increases, but decreases below normal levels for more developed lesions. The initial increase
was of the order of 50–100%. Whether these plaques had macrophage infiltration was not
specified. A reduction in metabolism in highly developed plaques will reduce the effect of the
higher metabolism due the macrophage infiltration.
Heinle (1987) reported a decreasing content of glucose, glycerol and ATP, and increasing
amounts of lactate with increasing distance into the vessel. This indicates an ineffective,
anaerobic metabolism, which will counteract the increased heat generation due to the
macrophages. This was in pre-necrotic core plaques, and it seems likely that the metabolism
would fall even further when a non-metabolizing necrotic core is present. Whether more heat
is generated under anaerobic conditions since more energy is converted into heat instead of
adenosine triphosphate (ATP), or less heat is generated since the overall energy turnover is
less, is unknown. Under aerobic conditions 60% of the metabolized energy is converted to
heat (Tortora and Grabowski 2003), so the heat generation cannot increase by more than 40%
under anaerobic conditions due to ineffective ATP production.
Based on these considerations we have used the metabolic rate of 2 × 104 W m−3 in our
models (a 20-fold increase over normal metabolism). This value is comparable to the heat
generated in a maximally working body or a tissue dense with macrophages. Based on the
results of Heinle (1987) and Bjørnheden and Bondjers (1987), where metabolic changes were
of the order of 50–100%, this order of magnitude estimate seems to represent an upper limit
on the metabolic rate that can be expected in a plaque. Since Bjørnheden and Bondjers (1987)
found oxygen consumption changes around 100%, 2 × 103 W m−3 seems like a likely value
of the increased metabolism (a doubling of normal metabolism.)
3. Analytical models
Analytical models gives physical insight and order of magnitude estimates that can be used
to validate numerical models, even though simplified geometries must be used. They are also
useful in providing estimates on expected experimental results. The only model which is
somewhat mathematically tractable and still realistic is a system with spherical symmetry (see
appendix C).
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A sphere with heat generation q and radius a can model the plaque when the blood flow
has been obstructed and the perfusion in the surrounding media neglected (or stopped by
the obstructed blood flow). Assuming that the sphere has thermal conductivity κ1, and is
surrounded by an infinite medium with no heat generation and thermal conductivity κ2, the
solutions as a function of the radial distance r of the steady-state heat equation (5) with P = 0
are
T1(r) = q6κ1 (a
2 − r2) + qa
2
3κ2
, (8)
T2(r) = qa
3
3κ2r
, (9)
for the sphere and the surroundings, respectively.
Adding perfusion in the surrounding medium gives a more realistic model of a plaque
in a vessel with obstructed blood flow, but with intact perfusion in the surrounding tissue.
Assuming perfusion P in the surrounding medium (equivalent to a heat sink of PT ), and
thermal conductivity κ in both regions, the solutions are given by
T1(r) = −qr
2
6κ
+
qa2
6κ
(
2
a
√
P/κ + 1
+ 1
)
, (10)
T2(r) = qa
3 exp (−√P/κ(r − a))
3κ(a
√
P + 1)r
, (11)
for the region of the heat generating sphere and the surroundings, respectively. From (11)
one can define a thermal penetration depth (where the temperature has dropped by e−1) in a
perfused media to be
d =
√
κ
P
. (12)
This was used to determine the necessary size of the geometries in the numerical models
so that the effects of the finite boundaries could be minimized.
If the heat producing region is embedded in a region of lower conductivity, this could
produce a higher temperature in the centre of the heat producing region, due to the insulating
effect of the lower conductivity material (e.g. fatty deposits). This situation can be modelled
by a heat producing sphere of radius a, with thermal conductivity κ1, surrounded by a shell
of radius b > a with thermal conductivity κ2 < κ1, which again is surrounded by an infinite
medium with thermal conductivity κ1. The solutions to this model for the three regions are
from centre and out,
T1(r) = − q6κ1
(
r2 − a2 b(2κ1 + κ2) − 2a(κ1 − κ2)
κ2b
)
, (13)
T2(r) = − q6κ2
(
2κ1a3
κ2r
− 2a
3(κ1 + κ2)
bκ2
)
, (14)
T3(r) = qa
3
3κ1r
. (15)
To find the increase in temperature at the centre of the plaque due to the insulating material,
we can take the ratio
f = T0(0)
Tins(0)
= 1
3
(
2κ1
κ2
+ 1
)
+
2a
3b
(
κ1
κ2
− 1
)
, (16)
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Figure 1. The geometry of the eccentric plaque. The outer cylinder has a diameter of 40 mm. The
crescent shaped plaque is embedded in the middle cylinder which represents the media.
where T0 is the solution from (8) and Tins is the solution with the insulating layer from (13).
Thus, the increase in temperature is proportional to the ratio κ1/κ2.
4. Numerical models
Numerical models are necessary to investigate more realistic geometries, as they cannot be
solved analytically. The commercial software Comsol Multiphysics (Comsol, Sweden) was
used to perform the simulations. Default values for mesh densities and numerical solvers were
used.
4.1. Geometry
The basic geometry of the models used in the numerical analysis consisted of a cylinder
of radius 2 mm and length 40 mm, representing the lumen. Surrounding the lumen was
another cylinder with thickness 3 mm and length 40 mm, representing the tunica media. Heat
generating plaques with two different shapes were embedded in this region, centred along the
length of the cylinder. One plaque was crescent shaped with an eccentric location. The other
was shaped like a hollow cylinder placed concentrically with the vessel axis (see figures 1
and 2). The sizes of the plaques were varied in the simulations. Heat was only generated in
the plaque, so the solution of the temperature T only represents the deviation from a normal
temperature distribution. Outside the region representing the tunica media was a 40 mm long
cylinder with radius 20 mm, which represented perfused tissue surrounding the vessel. The
tunica media is large compared to real values but was chosen to facilitate the drawing of the
plaque within the media for the FEM models. The effect on the calculated temperatures should
be small. The size of the outer cylinder was chosen to be about two thermal penetration depths
(according to (12)) to minimize the effect of the finite boundaries.
4.2. Thermal boundary conditions
The temperature deviation was fixed at T = 0 for all outer boundaries except at the outlet of
the vessel, where the temperature flux was set to convective flow. At all other boundaries,
continuous temperature and heat flux was imposed.
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Figure 2. The geometry for the concentric plaque model. The outer cylinder has a diameter of
40 mm. The plaque is the short cylinder and is embedded in the middle cylinder which represents
the media.
Numerical models must have a finite size, so boundary conditions cannot be at infinity.
Applying fixed temperature boundary conditions can lead to spurious results as unlikely high
heat fluxes are generated at the boundaries. To minimize the error of the boundaries, an upper
limit on the acceptable flux at the boundary is that
∮ j · dA/Q = Qj/Q  1, where j is
the heat flux, Q is the heat generated in the system and the integration is performed over the
outer surface of the model, except the outlet of the vessel. This condition states that most of
the generated heat is accounted for in the system that is analysed. In all systems that were
analysed (except for simulations with very low blood flow) the heat lost through the outer
boundary of the system was less than 10% of the energy generated in the system, indicating
that the finite boundaries will have little effect on the calculated temperatures. Furthermore,
the radius of the outer cylinder (20 mm) was chosen to be larger than the penetration depth in
the perfused tissue which was calculated to be d = 12 mm from (12).
Simulations of very low or no blood flow had higher thermal gradients at the surfaces.
To determine if this would have a large impact on the solution, a numerical solution of a
sphere of radius 1 mm in a perfused medium with radius 20 mm was compared to an analytic
solution of a sphere in a perfused medium extending to infinity. This models the situation
with no blood flow. The result is shown in figure 3. The flux through the outer boundary was
Qj = 6.6 × 10−5 W in the numerical calculations, and the total heat generation in the system
was Q = 8.3 × 10−5 W. Even though the flux through the boundary accounts for a large part
of the generated energy, the numerical solutions are very close to the analytic solution.
4.3. Fluid boundary conditions
The average blood velocity is about v = 0.3 m s−1 in coronary arteries, which is fairly low
compared to the dynamic viscosity (η = 2.5 × 10−3 Pa s). The Reynolds number is given by
Re = ρvl
η
. (17)
Here, l is a characteristic length of the system and ρ is the density of the fluid. With
l = 2 mm and using the density of blood from table 1 gives Re = 500. Usually, Re = 2300
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Figure 3. Difference between analytic and numerical models of a heat generating sphere. For the
analytic model the surrounding medium was infinite and for the numerical model the sphere was
embedded in another sphere with radius 20 mm. The graph shows the temperature as a function of
distance from the plaque centre. The heat generating sphere had a radius of 1 mm. The temperature
calculated by the numerical model is slightly lower due to the imposed zero temperature at the
boundary (see section 4.2), but the effect of the finite boundary on the temperature is small.
is given as a limit of laminar flow. Blood was therefore modelled with a parabolic velocity
profile (Poiseuille flow) with an average velocity of v = 0.3 m s−1 at the input and output as
it would be in laminar flow. At the surfaces of the vessel the boundary condition was set to
v = 0 (no slip condition).
5. Results
5.1. Analytic models
Assume a spheroidal plaque with radius a = 1 mm, with heat generation q = 2×104 W m−3,
embedded in an infinite medium representing the media. Using the physical properties from
table 1, (8) yields a 0.025 ◦C temperature increase at the centre of the plaque.
If we now include a perfusion of P = 3.3 × 103 W K−1 m−3 in the infinite medium
surrounding the plaque, the resulting temperature increase at the centre of the plaque becomes
0.020 ◦C.
An insulating layer could increase the temperature in the centre of the plaque, but notice
that the insulating region has no effect on the temperature distribution in the surrounding
medium (compare (9) and (15)). Using a sphere with radius a = 1 mm embedded in a 1 mm
thick insulating layer of fatty tissue with lower conductivity (see table 1) yields a value of
0.030 ◦C at the centre of the sphere.
5.2. Numerical models
5.2.1. Eccentric plaque. A crescent shaped, eccentric plaque, with positive remodelling into
the media (no stenosis), was simulated. The geometry is shown in figure 1. Figure 4 shows
variation in the highest recorded temperature in the plaque as a function of the plaque volume
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Figure 4. The highest recorded temperature in the plaque as a function of plaque volume.
A: high perfusion with blood flow; B: low perfusion with blood flow; C: high perfusion with no
blood flow; D: low perfusion with no blood flow. It can be seen that the blood flow in the vessel is
the most important factor for the temperature in the plaque
0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
Plaque thickness (mm)
Te
m
pe
ra
tu
re
 ( °
C)
Figure 5. The highest temperature in plaque for varying thickness of a concentric plaque. The
plaque thickness is the thickness of the cylinder walls that represent the plaque.
both with blood flow (0.3 m s−1) and without, and with low and high perfusion (P = 0.16 ×
103 W K−1 m−3 and P = 3.3 × 103 W K−1 m−3).
5.2.2. Concentric plaque. Some plaques have a concentric shape, although these are less
commonly of the vulnerable type. The geometry is shown in figure 2, where the plaque is
represented by the cylinder embedded in the media. Figure 5 shows the temperature in the
plaque for varying thickness of the plaque. The length of the plaque was 5.5 mm.
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Figure 6. A log–log plot of the temperature in the centre of an eccentric plaque for varying values
of heat generation in the plaque. We can see the dependence on the heat generation is linear as
predicted by equation (8). The slope of the plot is 3.5 ×10−6 K m3 W−1.
5.2.3. Variation in heat generation. To investigate how the temperature at the centre of the
plaque changes with varying metabolic rates, the heat generation in the plaque was varied
between 2×103 W m−3 and 6×105 W m−3. A large eccentric plaque with volume equal to the
largest plaque in section 5.2.1 was used for this simulation. The results are shown in figure 6.
5.2.4. Variation in blood flow. The average blood flow in medium sized arteries (such as
the coronary arteries) is about 0.3 m s−1. Due to pressure variations during diastole and
systole, the velocity will vary up to 30%. The pulsation of the blood was not modelled but the
upper and lower limits of the velocity were modelled and the resulting effect of the pulsating
blood must necessarily lie between these upper and lower limits. In figure 7 are plots of the
temperature at the surface and in the centre of the plaque for varying blood flows. Figures 8
and 9 show cross sections of the temperature distribution with and without flow in the lumen,
respectively.
5.2.5. Variation in perfusion. To get the functional dependence of the perfusion, this quantity
was varied from F = 0.012 ml min−1 g−1 for fatty tissue to F = 0.02 ml min−1 g−1 for
cardiac muscle (Svaasand 1982). Using (A.1) and (A.2) we find that this corresponds to heat
sinks of q = 3.3 × 103T W K−1 m−3 and q = 0.16 × 103T W K−1 m−3, respectively.
Arteries in the coronary tree can be surrounded either by thick adipose tissue or by cardiac
muscle. These tissue types have different perfusion rates (see table 1). To see how this affects
the temperature of the plaque, a large eccentric plaque was simulated with perfusion from 0
to 15 000 W K−1 m−3. The results are shown in figure 10.
6. Discussion
It was found that the temperature change in the centre of a plaque due to increased heat
generation was less than 0.1 K. We have used what we consider as an upper limit of the heat
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Figure 7. The variation in the temperature in the centre and at the surface of the plaque for varying
blood flows from 0 to 5 m s−1. The curve indicates that there is a certain threshold before the
blood flow has any significant effect and that the temperature decreases linearly at high flow rates.
The plaque surface is naturally more affected by the blood flow.
Figure 8. Thermal distribution in a vessel with flow. The temperature in the lumen is basically
unaffected by the heat generation in the plaque.
generation and reported temperature values at the centre of the plaque. The temperature values
at the surface of the plaque will therefore be significantly lower. This temperature seems too
small to be measured accurately in the experimentally difficult environment of an artery.
6.1. Comparison of analytic and numerical results
According to (10), the temperature dependence for a sphere in a perfused medium follows an
a2 dependence on the radius of the sphere, a 1/
√
P dependence on perfusion, and is linear
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Figure 9. Thermal distribution in a vessel with no flow.
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Figure 10. The plot shows the temperature in the plaque for varying degrees of perfusion in the
surrounding medium. Physiological realistic values are between 160 and 3330 K−1. The top graph
is the highest recorded value in a plaque, and the bottom is at the plaque surface, facing the lumen.
with the heat generation q. The a2 dependence on the radius is a V 2/3 dependence in terms
of volume. In figure 4 we see that for the no-flow case, the temperature calculated from the
numerical model follows a trend that is similar to the V 2/3 dependence that was expected
from the analytic model. This is similar to what was reported by ten Have et al (2004). The
differences between flow and no-flow conditions varied between 78–180%. This is higher
than the values reported by Stefanadis et al (2003). The presence of the catheter, reducing the
maximal flow compared to an empty artery, is the probable cause for this discrepancy. For
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the concentric model the T-dependence in figure 5 is in terms of plaque thickness instead of
volume, and it can be seen that the graph seems to follow the a2 dependence that was expected
from the analytic model.
Figure 10 shows that the temperature in the numerical results follows the 1/
√
P
dependence as predicted by the analytic model. It can be seen in figure 6 that T is linear
with q which was also predicted by the analytic model. The same dependence was also
reported by ten Have et al (2004).
In figure 7 we can see that the nearly linear shape of the logarithmic plot above a certain
threshold indicates that T ∝ log v, which is the same that was reported by Diamantopoulos
et al (2003). The loss of dependence at high velocities that Diamantopoulos et al (2003)
reported was not observed within the values simulated. However, at some point the reduction
in temperature with increased velocity must necessarily decrease. Diamantopoulos et al (2003)
found no temperature variations due to oscillations in the blood blow. This is in agreement
with figure 7 from which it can be determined that a 30% variation of blood flow only changes
the steady-state temperature by less than 0.01 K. The transient effect will be even smaller.
Since the analytic models compare well with the numerical models, the former are useful
for easily predicting the effect that changing various parameters will have on the resulting
temperature.
6.2. Heat generation
In the estimate of the heat generation in the plaque, a tissue that was assumed to be dense with
macrophages was used. Since the plaque is by no means dense with macrophages, the value
used in this work represents an upper bound on the heat generation. We have in this paper
placed the heat generation in the plaque centre, not the cap where the macrophage infiltration
usually resides. Even though the heat source will be closer to the lumen, possibly making the
heat generated there easier to measure, the volume they usually occupy is smaller than the
ones used in this study. The values reported in this study are of the highest temperature in
the plaque, not at the surface of the vessel. The temperatures reported here thus represent an
upper limit on the value that can be measured.
Using the article by Casscells et al (1996) to determine heat generation is very uncertain.
How ex vivo metabolism compares to in vivo metabolism is unknown. It could increase due to
increased oxygen supply, or decrease due to the lower availability of nutrients. In the analysis,
free or forced convection was not taken into account; the article by Casscells et al (1996) did
not contain enough information to determine these. These factors would increase the heat
loss to the air, and would increase the calculated metabolic rate. Despite these uncertainties,
equation (16) shows that a heat generation which can yield a temperature increase of 1 K in
air will yield about 0.05 K when embedded in a tissue since the thermal conductivity is about
20-fold higher.
6.3. Causes of published values
Several studies have reported temperatures higher than the values predicted in this paper.
Casscells et al (1996) found temperature variations above 1 ◦C, but as discussed in
section 6.2, the low thermal conductivity of air will give higher temperatures than if the
same heat generating region was surrounded by tissue.
Since it is the blood that transports heat away from the tissue and dissipates the heat
through the lungs and skin, a thermal gradient must necessarily exist between the blood and
tissue. The heart pumps about 5 l min−1 in an adult, resting person, and can rise to about
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20 l min−1 during heavy exercise (Tortora and Grabowski 2003). Based on the physical model
of the bioheat equation (1), the blood is heated to normal tissue temperature during its pass
through the capillaries. Thus, for the blood to transport away the heat Q generated by the
normal metabolism, a thermal gradient must exist between the blood and the tissue. The
magnitude of this can be calculated by the equation
T cbρbVb = Q. (18)
Vb is the volume of blood passing through the capillaries per unit time. Letting Vb =
5 l min−1 and Q = 100 W gives a temperature difference of T = 0.3 K, which is the
same as reported experimental values (Nybo et al 2002). This means that for the blood to
remove the heat generated in the body, the arterial blood must have a temperature about
0.3 K below tissue temperature. Because of this thermal gradient, the thermal contact between
the tissue and the temperature probe and how it is exposed to the cooler blood could have a
large impact on the measured values. This could for example explain the values measured by
Schmermund et al (2003) using a catheter from Volcano Therapeutics yielding temperatures
from 0.14–0.36 K. The increased thermal heterogeneity that was reported for patients with
stable angina, compared to a healthy vessel, could be attributed to the rough surface of a
heavily atherosclerotic vessel. However, as Stefanadis et al (1999) points out, patients with
stable and unstable angina and with acute myocardial infarction have the same degree of vessel
remodelling. Thus, the effect due to probe contact should be similar in all of these, but thermal
heterogeneity was still different in these patient groups. Positioning a temperature sensor in
the vessel lumen will affect the measured temperatures, both through conduction along the
catheter and disruption of normal blood flow. This has been investigated in detail for various
catheter designs by ten Have et al (2006).
Another question that needs an answer is whether temperature differences in surrounding
organs can affect the temperature measurements. Thermal penetration depth is defined by
equation (12). Using P = 3.3 × 103 W K−1 m−3 gives a thermal penetration depth of
12 mm. Clearly, if there is temperature heterogeneity in the myocardium, this will affect
the temperature along a vessel. This is not unlikely as an established diagnosis, determined
from positron emission tomography, is that stenotic coronary arteries can lead to regions of
the myocardium with increased metabolism but reduced perfusion. Increased metabolism
and reduced perfusion will lead to increased temperature. Likewise, if the lungs, which are
exposed to the much cooler ambient air, are within 12 mm of the coronary arteries, this would
affect the temperature measurements. Some thermography studies have been performed on
the aorta and this vessel passes diverse organs as liver, bowels and lungs which will affect the
temperature.
One study has reported temperature variations that are closer to the values predicted in
this paper (Toutouzas et al 2006).
6.4. Heat source location
We have in these studies modelled the heat generation in a plaque a certain distance below
the surface. However, the macrophages in a plaque are usually reported to be in the cap and
not in the lipid core. This could bring the location of the highest temperature in the plaque
closer to the surface, making it easier to measure. However, since the values in the numerical
studies are reported as the highest temperature in the plaque, not the temperature measured at
the surface, this value will not increase. Closer to the surface the plaque could to some degree
be insulated more from the perfusion but would be more strongly influenced by the blood
flow. It has been reported that there is increased vasculature in the media of large plaques
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which would indicate a higher perfusion rate (Davies and Thomas 1985) and more efficient
removal of heat from the plaque. When flow is present in the vessel, it accounts for the largest
part of the heat loss, but if the vessel is occluded, the perfusion is important for the resulting
temperature.
7. Conclusions
Based on the simulations and physical parameters in this study, the temperature increase that
can be expected in the centre of a plaque is less than 0.1 ◦C. All the reported temperatures
in this study are of the highest recorded temperature in the plaque. The temperature a sensor
could measure would be lower than this. The results depend on the estimated heat generation in
the plaque. A value significantly larger than estimated values was chosen, so that the resultant
temperatures gives an upper bound on the temperature increase that that can be expected.
Temperature differences of the order of 0.5 K and higher that are reported in the literature
could be due to normal temperature gradients in the body, but seem unlikely to be explained
by increased metabolism in the plaque.
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Appendix A. Perfusion
When deriving the heat equation for a perfused medium (5) it is assumed that qp is the energy
that leaves a unit volume per unit time through perfusion. If ω is the volume of blood leaving
a unit volume of tissue per unit time, then
qp = ωcbρbT, (A.1)
where T is the temperature difference between the tissue and the arterial blood. The
perfusion factor P is thus P = ωcbρb. ω is related to other measures of blood perfusion by
ω = Fρt = W/ρb, (A.2)
where F is the volume of perfused blood per unit mass of tissue per unit time and W is the
mass of perfused blood per unit volume of tissue per unit time (Svaasand 1982).
Appendix B. Heat transfer by radiation
There has been some dispute on whether radiation is an important heat transfer mechanism
in vivo. The Stefan–Boltzman law gives the transfer of energy by radiation between two
objects separated by a non-absorbing medium. Wien’s law gives the wavelength of maximum
emission for a given temperature. For 37 ◦C, this wavelength is 9.35 µm. At this wavelength
the optical penetration depth is about 17 µm (Hale and Querry 1973). Thus, if radiation is
a contributing factor, one must in the Stefan–Boltzman law enter the temperature difference
of objects which are of the order of 17 µm apart, which is on average how far a photon can
travel without being absorbed. Using (9), we find that the temperature gradient is 13 K m−1
at the plaque surface of a 1 mm3 plaque. This gives a temperature difference of two objects
separated 10 µm of 1.3 × 10−5 K. Using the Stefan–Boltzman law with this temperature
difference gives a heat flux due to radiation of 9 × 10−5 W m−2. Using (9) to find the thermal
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flux due to thermal conduction gives a value of 6.7 W m−2. This is a difference of five orders
of magnitude, showing that radiation is negligible.
Furthermore, in all measurements of thermal conductivity of a material the effect of heat
transport by radiation will be incorporated in the measurement, so that the effect of radiation
in an IR-absorbing medium is incorporated in the value of the thermal conductivity.
Appendix C. Dimensionality
Reducing dimensionality requires a symmetry plane or axis. This in effect requires an infinite
plane or axis or a symmetry plane/axis so large/long that edge effects are negligible. For
example, to use a polar, two-dimensional (2D) coordinate system would require that the plaque
extended infinitely far along the vessel axis. This is not in general the case, and a full three-
dimensional model should be used. In this study, the only geometry that could be reduced in
dimension was the concentric plaque where a 2D model of a longitudinal cross section (but
not the transverse) of the vessel could be used.
An example can illustrate the erroneous results that can be generated. Consider a
heat generating sphere (representing the plaque) with a diameter of 1 mm embedded in
an infinite medium (representing the tissue). Assume that the heat generation in the sphere is
104 W m−3 and that both regions have a thermal conductivity of 0.4 W K−1 m−1. The
temperature in the centre is then, by (8), 0.0125 K in the centre of the sphere. An (incorrectly)
simplified one-dimensional (1D) model of this sphere could be a 2 mm region with heat
generation 104 W m−1 surrounded by a thermally conductive medium from x = −∞ to
x = ∞.
The 1D model does not even have a finite solution when the boundary condition is zero
at infinity so the temperature must be set to zero at finite position. To choose this position the
sphere model was used to find where the temperature had dropped by one order of magnitude.
This gives 0.02 m by (9). The solution to the 1D model with heat generation from x = −c1
to x = c1 and zero temperature at ±c2 is
T1 = q
κ
(
c21 − x
)
+
2q
κ
c1(c2 − c1), (C.1)
T2 = 2q
κ
c1(c2 − x). (C.2)
The temperature at the centre of the heat generating region (the plaque) is then from
(C.1) 0.97 K. We see that the answer changes by two orders of magnitude following a
simplification (reduction of dimensionality) which at first sight might seem reasonable. The
physical explanation is that heat flux along one or two dimensions is suppressed.
Nor does a 2D model have a steady-state solution with zero temperature at infinity. The
solution in cylindrical coordinates for a disc with radius a embedded in a larger disc with
radius b and using zero temperature as the boundary condition is for the inner disc,
T (r) = −qr
2
4κ
+
qa2
2κ
(
ln
(
b
a
)
+
1
2
)
. (C.3)
Setting a = 1 mm, b = 20 mm and q = 104 W m−2 gives T = 0.087 K, about eight
times higher than the 3D model.
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Abstract
Cardiovascular disease is the primary cause of death in the United States, the
majority of these caused by the rupture of vulnerable plaques. An important
feature of vulnerable plaques is the thickness of the fibrous cap that covers the
necrotic core. A thickness of less than 65 µm has been proposed as a value
that renders the plaque prone to rupture. This work shows that multiphoton
microscopy can image the plaque with µm resolution to a depth deeper than
65µm. The fibrous cap emits primarily second harmonic generation due to
collagen in contrast to the necrotic core and healthy artery which emits primarily
two-photon excited fluorescence from elastin. This gives a good demarcation
of the fibrous cap from underlying layers, facilitating the measurement of the
fibrous cap thickness. Based on a measure of the collagen/elastin ratio, plaques
were detected with a sensitivty of 65% and specificity of 81%. Furthermore the
technique gives detailed information on the structure of the collagen network
in the fibrous cap which gives a direct measure of its mechanical strength and
thus also the vulnerability to rupture.
2
1 Introduction
Coronary heart disease is the cause of the majority of deaths in the United
States[1]. Most of these deaths are caused by coronary thrombosis occurring
at an atherosclerotic plaque, leading to myocardial infarction[2]. Plaques prone
to developing thrombosis are denoted as vulnerable plaques[3]. These plaques
can lead to thrombosis either by rupture of a thin fibrous cap covering a lipid
core, or by erosion of the endothelium. Plaques prone to rupture are charac-
terized by a large, lipid-rich necrotic core, covered by a thin, fibrous cap, and
by infiltration of numerous macrophages[4]. The plaque cap consists mainly
of collagen and a cap thickness of <65 µm has been proposed as a value that
renders the plaque unstable[5]. There is currently no clinically accepted method
for detecting vulnerable plaque, but numerous detection modalities are being
investigated, e.g. optical coherence tomography (OCT), magnetic resonance
imaging, intravascular ultrasound (IVUS), near infrared spectroscopy and com-
puted tomography[3].
Autopsy studies have shown that there exist several vulnerable plaques in the
coronary tree in addition to the culprit lesion[5]. This has led to the hypothesis
that perhaps a more detailed stratification of plaque vulnerability is necessary to
determine which plaque is the most likely to rupture. For example, polarization
sensitive OCT has been proposed as an improvement over conventional OCT[6].
The birefringence of collagen in the fibrous cap will affect the polarization of the
light, which can be used to infer properties about the fiber structure. Another
way to collect additional information, is to improve the resolution of the imaging
modality. In the same way that OCT improves the resolution by an order of
magnitude compared to IVUS[7] (100 µm → 10 µm), multiphoton microscopy
(MPM) can improve the resolution by another order of magnitude (10 µm → 1
µm). The increase in resolution with MPM compared to OCT is accompanied
by a decrease in penetration depth, usually reported to be a few 100 µm in
biological tissue even though one study reported a penetration depth of 1 mm[8].
Multiphoton microscopy uses the nonlinear optical properties of tissue and
can achieve three dimensional microscopy. Second order nonlinear optical phe-
nomena depend quadratically on the intensity of the light, so that for a focused
beam the signal is only generated in a small volume around the focus. The
longer wavelength of the light used in MPM also gives increased penetration
depth and reduced out-of-focus photobleaching compared to conventional laser
scanning microscopy.
In biomedical application, the most common nonlinear effects used for mi-
croscopy are second harmonic generation (SHG) and two-photon excited fluo-
rescence (TPEF). SHG is generated by noncentrosymmetric molecules such as
collagen, and autofluorescence generated by two-photon excitation is seen from
collagen, elastin and cellular components[9]. Elastin is abundant in the media
of the aorta and collagen is the primary component in the cap of atheroscle-
rotic plaques. MPM may thus be used to study the formation and progression
of atherosclerotic plaques. In addition, it could have other applications in the
management of cardiovascular disease, e.g. to monitor restenosis after stenting,
and assess the effect of medication.
An advantage of MPM over regular histology is that it can be performed
on intact tissue, and carries the promise of in-vivo monitoring of atheroscle-
rotic plaques which is of great clinical value. A cathether-based intravascular
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microscopy probe could be developed along the lines of existing intravascular
OCT probes, but with additional scanning optics[10]. Several miniaturized,
intra-vital microscopes for MPM have been tested[11, 12, 13, 14, 15]. However,
for intravascular applications, further minaturization is necessary, which could
be realized by microoptical devices.
The goal of this study is thus to investigate the physiological information
of the vascular structure that can be detected by MPM, and to what degree
healthy vessels and atherosclerotic lesions can be classified compared to histo-
logical classification[16, 17, 18]. The spectral response of various tissue struc-
tures is reported and penetration depths in tissue in various pathological states
are found. Photobleaching and photodamage can be incurred in tissue during
laser irradiation, and these processes are investigated as their understanding is
necessary to develop a safe in-vivo imaging modality.
2 Materials and Methods
2.1 Materials
Eight specimens of human aortas were excised during autopsy from 8 different
patients (54.5 ± 10.9 years, 5 male, 3 female). The samples were put in closed
containers, with some tissue paper soaked in phosphate buffered saline (the
tissue samples were not in contact with the paper tissue) and stored at 4◦C.
Measurements were performed 1.45± 1.75 days after autopsy.
After microscopy the samples were fixed in formalin and embedded in paraf-
fin. Thin sections were cut and stained with Hematoxylin-Eosin-Saffron (HES),
Elastica and Van Gieson. HES stains cell nuclei black, cytoplasm pink, and
connective fibers yellow. Elastica stains elastic fibers dark purple. Van Gieson
stains muscle cells yellow and connective fibers red.
2.2 Instrumentation
The samples were investigated using a laser scanning inverted microscope (Zeiss
LSM 510 Meta). Excitation was provided by a Ti:Sapphire laser (Coherent Mira,
model 900 F), pumped by a 5W solid state laser (Coherent Verdi). The output
of the Ti:Sapphire laser was about 750 mW, mode-locked at 800 nm. All the
measurements were performed at 800 nm except the measurements described
in section 2.3.3 where the wavelength was tuned from 800 nm to 840 nm in
10 nm increments. A plan-apochromat 40x 1.2 NA water immersion objective
was used in all the measurements. An acusto-optic modulator (AOM) was
used to regulate the power output. A setting of the AOM at 80%, which was
used in all the measurements unless otherwise noted, gave about 20 mW at
the objective. Laser power was measured by a Coherent LM-10 laser meter.
The microscope was equiped with a Zeiss metadector, which uses a grating
to disperse the generated light to 32 different channels in the spectral range
from 377 nm to 710 nm at about 10 nm intervals. For all the measurements
SHG was collected at 387-409 nm and TPEF at 473-505 nm, except for the
measurements in section 2.3.3 where the signals were collected separatley in
each of the 32 channels. All measurements were performed in the reflection
mode (epi-collection).
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The emitted fluorescence of a solution of fluorescein (280 µM) was measured
in the microscope and compared with the one-photon fluorescence of the same
solution, measured in a spectrofluorimeter (Fluorolog 3 Jobin Yvon, The Horiba
Group). Since the normalized spectra overlapped well with mean deviation of
5%, no further spectral calibration of the emission signals was performed.
The transmission in the system was measured by comparing the power at
the laser output and at the objective for wavelengths from 800-840 nm to give
the relative transmission,
Tr(λ) =
Pobj(λ)
Plas(λ)
. (1)
This was used to calibrate the spectral measurements (see section 2.3.3 for
details).
2.3 Study protocol
2.3.1 Sample preparation
The aorta samples were cut into pieces of about 5 x 5 mm for microscopic
investigation. Out of the 8 aorta specimens, a total of 24 smaller samples were
obtained. The samples were placed in a glass well with the lumen side of the
vessel facing the coverglass. In the following, x and y will refer to the axes
parallel to the lumen, and z to the axis perpendicular to the lumen.
2.3.2 Image collection
Selection of measurement sites
The sample holder was placed in the microscope and a scan over an area cov-
ering 2.3 mm x 2.3 mm was carried out. Based on these images, three primary
measurement sites were defined as well as three reference sites. The measure-
ments in the remainder of this section and section 2.3.3 were then performed
on each of the primary measurement sites. The images collected at each site
covered an area of 230 x 230 µm. The reference sites were shifted 115 µm from
the primary sites, thereby covering half of the primary measurement sites, and
thus served as an indication of whether any changes had occurred in the tissue
during the study protocol. Images of the reference sites were collected at the
beginning and end of the protocol.
Z-stack of images
At each of the primary measurement sites, a z-stack of images was collected.
Each image covered 230 x 230 µm, and frames were collected at 4 µm intervals
in the z-direction. The average SHG and TPEF intensities, Is(z) and It(z),
were calculated for each frame to determine how the generated signals varied as
a function of z. Is(z) and It(z) were normalized by dividing by their maximum
value, Is,max and It,max(z), respectively,
Is,norm(z) =
Is(z)
Is,max
It,norm(z) =
It(z)
It,max
. (2)
The depth z where Is,norm(z) and It,norm(z) had dropped to e−1 was deter-
mined.
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At structures within the stack that were deemed interesting, single plane
images were collected at higher resolution and longer acquisition times.
At a slice approximately 25 µm below the surface, the number of pixels
covered by fibrous structure was counted. This depth was chosen so that no
surface would be present in the images due to tilted image plane or surface
irregularities, and to ensure that the signal was still strong. A few images were
manually investigated to determine the background signal. The background
signal was defined as the signal level in regions of the images where no fibrillar
structure could be perceived, and determined to be 30 (out of 255) in the SHG
images and 50 (out of 255) in the TPEF images. These values were then used
as cut-off values for thresholding the images into regions containing fibrous
structure, and regions defined as background. The ratio of SHG to TPEF was
used as a measure of a collagen-to-elastin ratio Rc/e, and was computed as the
ratio of the number of pixels N with values above threshold.
Rc/e =
NSHG
NTPEF
. (3)
Cross-sectional images
Cross sectional images in the x, z and y, z planes were collected. Each line
parallel to the surface was 230 µm and each line was collected with a z interval
of 0.46 µm. The gain of the detectors was increased through the scan to improve
signals from deeper layers without saturating the signal at the surface.
2.3.3 Spectral response
At each primary site, the signal from one image frame was collected in each
of the 32 channels of the spectral detector. The excitation light was tuned
from 800 to 840 nm in 10 nm intervals. The excitation power, Pl(λex), was
measured at the output of the laser for each wavelength and the resulting spectra
were calibrated by dividing by (Pl(λex)Tr(λex))2. The images were 230 x 230
µm. The adjustment of gain and offset were kept constant for all the spectral
measurements of the samples.
2.3.4 Photobleaching and photodamage
To investigate the response of the tissue to long illumination times at various
excitation powers, an area of 115 x 115 µm was scanned 200 times and the
image was stored for each scan. Each scan took 1.97 s. The imaging plane was
placed 10-20 µm under the surface. The laser power was varied from 50-100%
in increments of 10%, which corresponded to about 10-35 mW at the objective.
If structural tissue changes were severe, the imaging series was halted before the
200 scans were completed. After the procedure had been completed a z-stack
of images through the damage was collected. These images were collected with
a frame size of 230 x 230 µm to assess the lateral and transversal extent of the
photodamage.
Finite element analysis (FEM) of the thermal distribution in the tissue was
performed to determine whether thermal changes in the tissue were incurred
due to 1-photon or 2-photon absorption. Details of the analysis are given in
appendix A.
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3 Results
3.1 General features
SHG and TPEF images demonstrated different structures and distributions of
connective fibers. The SHG in the images is due to collagen, and fibrous struc-
tures with TPEF, but without SHG, was interpreted as elastin. SHG is shown
in red and TPEF in green in all the images. All the presented images have
been processed to enhance contrast, so signal levels between SHG and TPEF
can therefore not be compared directly.
Normal arteries were defined by no intimal changes observed in the histologi-
cal images (see Fig. 1d-f). Thus, atherosclerotic lesions of type I - III according
to the American Heart Association (AHA) classification are included in this
group[17]. These early lesions are recognized by increased lipid content but
without intimal disruptions.
In the MPM images of normal arteries, individual elastin fibers could be
seen clearly down to a size of about 1 µm. The structure of the fibrous network
varied but some general features were observed. On the surface a thin layer
of elastic fibers over a layer of collagen was observed (Fig. 1a). Below one
or more of these layers was a layer of thicker, ordered elastic fibers with some
scattered thicker collagen fibers (Fig. 1b). Next, a layer of thin, ordered elastic
fibers was found, where the fibers were oriented at 90 degrees to the above layer
(Fig. 1c). In the cross sectional images, layers of elastic laminas could clearly
be distinguished (Fig. 2a). The large scale images (2.3 x 2.3 mm) had lower
resolution than the other images, but yielded structure information about the
connective fibers at a different size scale (Fig. 3a).
Atherosclerotic plaques were classified macroscopically by being clearly raised
from the surrounding lumen surface and where the histological images showed
the presence of a collagen cap over a lipid core (Fig. 4d-f). This corresponds to
type V plaque in the AHA classification (fibroatheroma).
In the MPM images of the cap of an atherosclerotic plaque, the collagen
appeared in thick bundles, in a non-directional structure (Fig. 4a), and were
different from the collagen fibers seen in the normal vessel. There was signifi-
cantly more collagen in the plaque cap than in the normal aorta. Small, round,
fluorescent objects of various sizes could be seen clustered in the spaces between
the collagen fibers. Plaques with a macroscopically yellow color seemed to have
more of these fluorescent objects, though this was not confirmed quantitatively.
In one instance the fibrous cap of a highly developed plaque was dissected, ex-
posing the lipid core. The inside of the plaque was placed against the coverglass
and the resulting image is shown in Fig. 4b. Many fluorescent objects with
various sizes and shapes can be seen. The large scale images also showed such
fluorescent objects and in this image their location relative to the collagen fibers
can be seen (Fig. 3b). The fibers seem to have some directional orientation at
this scale.
Calcified plaques (type Vb) were recognized macroscopically by very hard
areas and in the histological images by an empty area surrounded by a dark
purple color in the HES stained images. An MPM image of a calcification
can be seen in Fig. 4c. These areas exhibited very strong TPEF and only
a non-fibrillar structure could be seen. Some SHG could be seen within the
calcification.
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3.2 Spectral response
The spectrum of collagen was obtained from an image rich in collagen, seen by
strong SHG. The image obtained with 800 nm excitation was used to define
regions in the image as collagen. Pixels where the SHG was greater than half of
the SHG from the pixel with the maximum value were defined as collagen. The
same pixels were used to obtain the spectra at all excitation wavelengths (Fig.
5a).
The spectra of elastin were found by defining a region of interest (ROI) in
an image where fibers exhibiting TPEF could be seen, but where there was
no fibrillar structure in the SHG (i.e. only background). The spectra were
extracted from the pixels within this ROI (Fig. 5b).
A ROI that only contained the non-fibrillar structure related to calcifications
were used to extract the spectra of the calcification (Fig. 5c). The TPEF signal
from the calcification was very strong so excitation power was reduced by setting
the AOM to 70% when measuring the spectra to avoid saturation.
The autofluorescence from the objects seen in the lipid core were strong
compared to the signal from the conective tissue (Fig. 4b). A spectrum of one
of the fluorescent objects within the fibrous cap was extracted by defining a
ROI that only contained one of these objects and is shown in Fig. 5d. This is
markedly different from the autofluorescence from the connective fibers.
3.3 Penetration depth
The depth where maximum signal was found, and the depth where the nor-
malized signal had fallen to e−1 were determined as described in section 2.3.2.
The samples were classified into normal vessel and fibroatheromas based on his-
tology, according to the description in section 3.1. For each of these classes,
the mean values of the depth of the maximum signal and the depth where the
normalized signal had fallen to e−1 were determined. These values are plotted
in Fig. 6.
3.4 Collagen-elastin ratio
By defining that the presence of a fibrous cap is detected by a collagen-elastin
ratio Rc/e of greater than one, the MPM images could be used to detect the
presence of a plaque with a sensitivity of 65% and a specificity of 81% with
histology as the reference (14 plaques and 9 normal samples. Calcified plaques
were excluded). Sensitivity was defined as the number of detected plaques minus
the number of false negatives divided by the total number of plaques. The
specificity was defined as the number of plaques detected minus the number of
false positives divided by the total number of plaques. The average value of
Rc/e for samples classified as normal was 0.44, and 16.5 for plaques.
3.5 Photobleaching and photodamage
The reference sites were displaced 115 µm from the primary measurement sites,
thereby containing half of the primary measurement sites (which were 230 x 230
µm). No changes could be seen in these images at the end of the study protocol.
During the measurements described in section 2.3.4 significant bleaching and
tissue changes were incurred. After some time bubbles appeared in the images
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and increased in size with time (Fig. 7a). The higher the incident powers, the
earlier the bubbles appeared (within a few seconds), and the faster they grew.
The z-stacks of images collected about 30 minutes after the bleaching/heating
procedure indicated that the bubbles caused irreversible damage (Fig. 7b).
They also showed that damage was confined closely to the illuminated area and
that damage could only be seen in a layer 15-20 µm thick.
A finite element model of the temperature distribution in the tissue was
developed (see appendix A). Based on this model, it was shown that the tem-
perature is close to the steady state temperature within one second (Fig. 8b).
Since the equation of heat (Eq. (4)) is linear, the shape of the time develop-
ment is independent of the amount of heat generated as long as it is similarly
distributed. Increasing the heat generation will only raise the graph vertically.
The bubbles, however, appeared as late as after 30-40 s for low excitation pow-
ers. The spatial distribution of the temperature around the focus for linear
absorption and second order absorption can be seen in Fig. 8a.
Such a system, where there is a process with a given rate (defined as the
inverse of the time of the appearance of bubbles) which is a function of temper-
ature (defined to be proportional to the square of the incident power) can be
described by an Arrhenius type equation. An Arrhenius plot of the inverse of
the time of bubble formation versus the inverse of the incident power squared,
is plotted in Fig. 8d.
4 Discussion
4.1 Tissue characterization
MPM can detect caps of atherosclerotic plaques without exogenous staining,
and with good contrast compared to healthy vessels. Images can be collected
down to a depth of >65 µm, providing a measure of one of the key features
of vulnerable plaques. Three dimensional images with µm resolution of the
structural protein network can be generated without having to cut numerous
histological sections, yielding important information on the mechanical strength
of the cap.
SHG is only generated by fibrillar collagen in biological tissue[19]. The strong
SHG from the plaque cap, known to be rich in collagen I and III, confirmes this
(Fig. 2b)[18]. We have therefore assumed fibrillar structure producing SHG to
be collagen. The SHG that can be seen in the spectra other than collagen could
be background signal generated at various surfaces within the optical system as
SHG is known to be generated at interfaces (Fig. 5b-c).
TPEF on the other hand are seen from many biological structures. The aut-
ofluorescence spectra of elastin and collagen are very similar (Figs. 5a and 5b).
This is in agreement with another study that found significant spectral overlap
in the autofluorescence from collagen and elastin[20]. This study reported that
elastin had a fluorescent peak at 495 nm and cellular components at 510 nm[20].
These peaks can be seen in our spectra but are present in both collagen and
elastin spectra, rather than directly related specifically to elastin or cellular com-
ponents (Fig. 5). Based on the abundance of autofluorescent fibers in healthy
elastic artery (Fig. 1) and previous studies on cardiovascular structures[20, 21],
fibrous structures without SHG but with TPEF were classified as elastin. An-
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other study on atherosclerotic mice found that collagen had autofluorescence
in the blue part of the spectrum whereas elastin gave autofluorescence cover-
ing a wider spectral range, which does not agree with our results[21]. Some
TPEF without SHG were seen from fibers in the plaque cap (Fig. 4a). This
autofluorescence seemed to come from the surface of the collagen fiber bundles.
Whether this is due to elastin fibers or collagen not generating SHG has not
been determined.
The thin, disorganized elastic fibers seen at the surface of the healthy ves-
sels probably belong to the subendothelial connective tissue, while the thicker
ordered layers are the elastic laminas (Fig. 1a-c). Scattered collagen fibers can
be seen, apparent in Fig. 3a.
The structure of the fibrous cap could be imaged at several levels of detail
(compare Fig. 4a and Fig. 3b). This fibrous structure is directly related to the
mechanical strength of the plaques, and might yield some insight into why some
plaques rupture and others do not. The structure of the collagen fibers can
perhaps also be used to better understand the nature of the signals collected by
polarization sensitive OCT.
The origin of the fluorescent objects seen in the fibrous caps and lipid cores
have not been determined but could arise from several sources. In the plaques
the objects seem to be clustered in small groups between the collagen fibers (Fig.
4a). This could be foam cells (macrophages with intracellular lipid droplets).
The lipid core is mainly necrotic and the fluorescent objects seen here appear
in different sizes which could be related to extracellular lipid droplets (Fig.
4b). The abundance of the fluorescent objects within the yellow plaque and
within the plaque core supports the hypothesis that these objects are related to
lipid-related substances. Blankenhorn reported strong, green one-photon aut-
ofluorescence from the lipid core of atherosclerotic plaques and related this to
carotenoids which are known to be lipophilic[22]. Another study found one-
photon autofluorescence from various biochemical components known to be
present in atherosclerotic plaques, e.g. oxidized lipoproteins and cholesterol
esters, further supporting the hypothesis that that TPEF signal is related to
lipid-rich substances in the plaques[23]. The autofluorescence from some of the
unidentified objects that were observed in the plaque caps had a fluorescent
peak at 575 nm (Fig. 5d). Since the images collected in this study, except the
spectral measurements, measured the fluorescence in the interval from 473 nm to
505 nm, the objects with a fluorescent peak at 575 were probably not detected.
The strong TPEF from the lipid core could further enhance the demarcation
between the fibrous cap and the lipid core. However, all the plaques imaged in
this study had plaques thicker than the penetration depth of the system, so this
was not confirmed.
The spectral calibration of the metadetector with fluorescein was limited by
low signals below 475 nm and above 625 nm, so that inaccuracies might exist
in these parts of the spectra. Furthermore since the spectra were generated at
different depths and the excitation power decreases with depth, the intensity of
the measured spectra can not directly be compared.
The technique was able to differentiate normal vessels from atherosclerotic
plaques based on the collagen/elastin ratio with fairly good sensitivity and speci-
ficity (65% and 81% respectively). The erroneous classifications were due to
some samples with high collagen content in the intima even though they ap-
peared normal in the histological sections. In one instance the fibrous cap was
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only visible down to a depth of 20 µm in the MPM images, even though a thick
cap was seen in the histology. This also generated an erroneous classification.
A limitation of these values is that the same observer performed both classi-
fications and was only blinded to the histological results and not vice versa.
Another limitation of the study is that the position of the MPM measurements
and histological sections are not necessarily colocalized in the samples.
The collagen/elastin ratio, Rc/e, could be calculated for each layer in the
vessel wall yielding an image of the fibrous cap since this type of tissue has a
much higher value of Rc/e compared to the normal vessel. An important feature
Rc/e is the large difference in its value between the vessels classified as normal
and those classified as plaque, mean values of 0.44 and 16.5, respectively. This
is more than an order of magnitude difference in the signal and could yield
improvements over methods like OCT and ultrasound where contrast in the
signal between different tissue types is often a limiting factor.
Imaging was acheived down to a depth of about 100 µm which represents
the upper layers of the relativly thick aorta (2-3 mm) (Fig. 6). The cornary
arteries are much thinner so that more of the vessel anatomy could be imaged.
The penetration depth in tissue is determined by scattering, which reduces the
power at the focus, and dispersion which degrades the pulse shape at the focus.
The effect of scattering can be reduced by using an objective with a smaller
numerical aperture, albeit at a loss in resolution. However, the generated signal
will be lower since a less tight focusing will reduce field intensities, resulting in
less second order processes. The best trade off will thus depend on the resolution
necessary for the application at hand.
Since scattered photons do not affect the collected signal (as they do in
OCT), the loss due to scattering can to some degree be compensated for by in-
creasing the excitation power. Of course, availability of laser sources and heating
due to linear absorption will limit this approach. However, as was observed in
this study, the heat damage seems to arise from a second order process, so the
reduction in light at the focus due to scattering can be compensated for by
increasing the incident power without creating tissue damage.
The penetration depths reported in this study do not necessarily compare
to in-vivo values. As described by Zoumi et al. the fiber structure changes
significantly under physiological pressures and thereby also the scattering[20].
Also, the present study investigated the aorta, and values for the coronary
arteries could be different. One feature of vulnerable plaques is a fibrous cap
thinner than 65 µm, so this feature of vulnerable plaques can be detected with
MPM.
4.2 Photobleaching and photodamage
Significant photobleaching was observed during the procedure described in sec-
tion 2.3.4. Photobleaching was seen to strongly affect the TPEF signal. The
SHG signal also decayed during the procedure, albeit at a slower rate. After a
certain time, dependent on the incident power, bubbles appeared in the images.
The photodamage was incurred in a very narrow region, only 15-20 µm deep,
indicating that the damage arises from second order absorption. This can be
appreciated from the spatial dependence of the temperature determined from
the finite element model (Fig. 8b), where the assumption of second order ab-
sorption better describes the extent of the photodamage. Using reported values
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of linear absorption in the aorta yielded a maximum temperature increase of
2.3 K after 200 s. In this case we assumed that convection at the upper surfaces
kept the surface temperature close to the temperature of the surrounding air,
so that fixed temperature was used as the boundary condition. We also used
thermal insulation as the boundary condition for all the surfaces, resulting in a
temperature increase of 8.8 K after 200 s. These temperatures seem too small
to generate the observed bubble formation, further indicating that nonlinear
absorption is the primary source of the damage.
The bubble formation could be due to gas release of absorbed gases in the
tissue due to the reduction in the amount of gas that can be dissolved in the
tissue with increasing temperature. This process must be well understood before
a clinical tool can be developed, so that excitation powers can be kept well within
safe levels.
5 Conclusion
MPM can assess tissue structure at a resolution not achievable by other imaging
modalities for atherosclerotic plaque. Fibrous cap can be imaged to a depth of
>65 µm with good contrast compared to underlying layers, thereby measuring
one of the key characteristics of vulnerable plaque. The mechanical stability of a
vulnerable plaque is directly related to the likelihood of rupture. The network of
collagen fibers is what determines the mechanical stability and this can imaged
by MPM.
Several characteristic physiological features of vessels can be seen with MPM,
e.g. elastic laminas and collagen fibers in the plaque cap. All images in this
study were collected in the reflection mode and the technique can therefore be
transfered to an in-vivo intravascular imaging modality. The information could
have important applications, both clinically, and in pathophysiological research.
A Finite element model
A FEM model was used to find the temperature distribution in the samples
during irradiation. A commercial software (Comsol multiphysics, Comsol AB,
Sweden) was used to perform the analysis. Default settings for mesh densities
and solvers were used.
The equation to be solved to find the temperature T is the heat equation,
∇2T − 1
χ
∂T
∂t
= − q
κ
, (4)
where χ = κρcp is the diffusivity. κ is the thermal conductivity, ρ the density
and cp the specific heat. See table 1 for the values used in the model. q is the
heat generation per unit volume per unit time, see below for values used.
A water immersion objective with NA = 1.2 was used in the measurements
and this yields a cone of illumination with angle to the illumination axis of
about 60 degrees. We will assume that the shape of the beam is a perfect cone
so that the radius of the cone is given by r =
√
3∆z where ∆z is the distance
from the focus. This geomtrical optics approximation to the light distribution is
not valid near the focus, but since we are scanning the beam over a large area,
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and only looking for approximate solutions, the details of the light distribution
near the focus is not important. Since the beam is scanned over an area with
sides a = 115 µm the total area illuminated by the beam a distance ∆z from
the focus is At = pi(
√
3∆z)2 + a2 + 4
√
3∆za. The area of a cross-section of the
cone perpendicular to the illumination axis is Ac = pi(
√
3∆z + 0.25µm)2. The
term 0.25 µm is added for the finite waist size of the beam at the focus.
The change in intensity due to absorption in a layer ∆z (i.e the heat gen-
erated per area per time) is given by ∆I = µ(1)a I∆z, where µ
(1)
a is the linear
absorption coefficient. Since I = PAc , the heat generated per unit volume per
unit time is then
q =
∆IAc
At∆z
=
µaI∆zAc
At∆z
=
µP (z)
At
. (5)
For two-photon absorption the absorption is quadratic in the intensity so
that ∆I = µ(2)a I2∆x, where µ
(2)
a is a nonlinear absorption coefficient. The heat
generated per unit volume per unit time is then,
q =
µ(2)P (z)2
AcAt
. (6)
Eq. (5) and (6) were used for the heat generation in the FEM models. Since
the beams are focused and not collimated the absorption coefficients should
include a factor between 1 and 2 due to the increased pathlength but this was
not taken into account. The reported values should be interpreted with this in
mind. Linear absorption and scattering coefficients of human aorta tissue are
µa = 80 m−1 and µs = 250 m−1[24]. Values reported in the literature vary but
we have used the highest value found. The power as a function of distance from
glass/tissue interface z was thus described by P = P exp(−(µa + µs)z).
The geometry (see Fig. 8c) consisted of a disc with radius 5 mm, thickness
170 µm, made of glass, representing the coverglass. The tissue was modeled
as box with sides 4 x 4 x 2 mm, with the light cone inscribed. The boundary
condition at the bottom of the glass was set to thermal insulation while all other
boundaries were set to constant temperature.
Using the reported value of the linear absorption coefficient yielded a max-
imum temperature increase of 2.3 K after 200 s. The nonlinear absorption
coefficient is not known but the normalized temperature distribution near the
focus is shown in Fig. 8a. The temperature as a function of time is shown in
Fig. 8b. The structure was also simulated with all boundaries set to thermal
insulation which resulted in a temperature increase of 8.8 K after 200 s.
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Thermal conductivity, Specific heat, Density, ρ
Material κ (W/m·K) cp (J/kg·K) (kg/m3)
Tissue 0.4 4000 1000
Glass 0.8 800 2600
Table 1: Thermal properties used in the FEM model
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Figure 1: MPM images of normal vessel in the x, y plane (green is TPEF and
red SHG) and corresponding histological images in the x, z plane. a) Normal
vessel at the surface. There is a thin layer of elastic fibers over a layer of thin,
wavy collagen fibers. The dark areas are regions where the wavy surface is below
the image plane. b) A dense layer of relatively thick, ordered elastic fibers, was
usually seen below the layers of thinner elastic fibers at the surface. Thick,
randomly oriented collagen fibers can be seen in between. c) Image taken about
20 microns below the surface. Several layers can be seen since they are at an
angle to the image plane. The deepest structure is oriented 90◦ to the layer
above. Figures d-f show histological sections of normal aorta at 10x. d) HES
stain. e) Elastica stain were the elastica laminas can clearly be seen. f) Van
Gieson stain. Connective fibers are stained red. Bars are 20 µm in the MPM
images and 200 µm in the histology images.
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Figure 2: Cross sectional images (x, z plane). Green is TPEF and red is SHG.
a) The elastic laminas of a normal aorta can clearly be seen. b) An early lesion.
Layers of collagen about 20 µm thick over elastic laminas. c) Cross section of a
thick fibrous cap. The horizontal fluorescent points in the top is at the surface
of the coverglass. Collagen layers can be seen down to a depth of about 60 µm.
Bars are 20 µm.
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Figure 3: These images show the structure of the fibrous networks at a larger
scale than the previous images, covering an area of 2.3 x 2.3 mm. Green is
TPEF and red is SHG a) Normal aorta. Notice the scattered collagen fibers
in the dense elastin network. b) Atherosclerotic plaque. Notice the clusters of
small fluorescent objects, clustered in the spaces between the fibers. Bars are
100 µm.
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Figure 4: a) The cap of a thick fibroatheroma showing bundles of collagen
fibers. Also notice the small fluorescent objects of unknown origin that might
be autofluorescence from lipid deposits or cellular structures. b) The inside
of an atherosclerotic plaque. A large amount of fluorescent objects was seen
that might be attributable to lipid droplets within the necrotic core. Also,
some collagen fibers can be seen. The gain could not be adjusted separately
for the SHG and TPEF signals, so that to get adequate SHG signal, some of
the autofluorescens saturated. c) Calcified plaques showed strong non-fibrillar
autoflourescence. Some SHG can be seen that seems to emanate from within
the calcification. d-e) Histology of a fibroatheroma. d) HES stain. e) Elastica
stain, showing no elastic fibers within the plaque. f) Van Gieson stain, where
the red indicates the connective tissue within the cap. Bar is 20 µm in the MPM
images and 200 µm in the histology images.
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Figure 5: Emission spectra for various tissue components, measured with dif-
ferent excitations wavelengths. a) Collagen. b) Elastin. c) Calcification. d)
Fluorescent object within the fibrous cap of a plaque.
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Figure 6: The mean of the penetration depth defined as the point where the
signal had fallen to e−1 of the maximum value, and the mean of the depth where
the maximum signal was found, for various vessel states. It is the difference
between these two that defines the penetration depth in the sense of signal
decay due to scattering and absorption. The first value indicates how deep we
were able to see structures with the current experimental setup. The error bars
represent the standard deviation.
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Figure 7: a) Bubble formation in the tissue during the bleaching/heating pro-
cedure. Image is 115 x 115 µm b) Image taken 30 minutes after heating of
tissue, indicating that the damage incurred is irreversible and confined to the
illuminated region. Image is 230 x 230 µm.
23
Figure 8: a) Temperature close to focus calculated by finite element method.
Since the thermal changes in the tissue were localized to about 15-20 µm the
thermal shape of the nonlinear absorption better describes this observed effect.
Also notice the maximum for the linear absorption is displaced from the focus.
Since the beam is scanned over an area that is much larger than the focus,
the area scanned by the beam only increases significantly after the cone of the
beam has become on the order of the scanned area. b) Time dependence of
the temperature at the focus, calculated with the finite element model, with
nonlinear absorption causing the heating. It is clear that the temperature is
very close to the steady state value after only one second. However, bubble
formation was at low excitation power first observed at times of around 40
s. This indicates that there is a significant time delay between the observed
phenomena (bubbles) and the onset of steady state temperature. c) Geometry
used in the FEM simulation. The disk represents the coverglass, the box is
the tissue sample and the cone inscribed in the box defines the area with heat
generation. d) An Arrhenius plot where the rate is defined as the inverse of the
time of bubble formation and the temperature is assumed to be proportional to
the square of the excitation power.
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